0001038133-19-000037.txt : 20190508 0001038133-19-000037.hdr.sgml : 20190508 20190508133546 ACCESSION NUMBER: 0001038133-19-000037 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 77 CONFORMED PERIOD OF REPORT: 20190331 FILED AS OF DATE: 20190508 DATE AS OF CHANGE: 20190508 FILER: COMPANY DATA: COMPANY CONFORMED NAME: HESKA CORP CENTRAL INDEX KEY: 0001038133 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 770192527 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-22427 FILM NUMBER: 19806055 BUSINESS ADDRESS: STREET 1: 3760 ROCKY MOUNTAIN AVENUE CITY: LOVELAND STATE: CO ZIP: 80538 BUSINESS PHONE: 9704937272 MAIL ADDRESS: STREET 1: 3760 ROCKY MOUNTAIN AVENUE CITY: LOVELAND STATE: CO ZIP: 80538 10-Q 1 heska-03312019x10q.htm 10-Q Document




UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
(Mark One)
x
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2019
OR
o
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
For the transition period from _________________ to _______________________
Commission file number: 0-22427
heskalogowhtbkgd07.jpg
HESKA CORPORATION
(Exact name of registrant as specified in its charter)
Delaware
77-0192527
(State or other jurisdiction of
incorporation or organization)
(I.R.S. Employer
Identification Number)

3760 Rocky Mountain Avenue
Loveland, Colorado


80538
(Address of principal executive offices)
(Zip Code)

Registrant's telephone number, including area code: (970) 493-7272

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes x   No o
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).  Yes x  No o
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company.  See the definitions of "large accelerated filer," "accelerated filer", "smaller reporting company" and "emerging growth company" in Rule 12b-2 of the Exchange Act.
Large accelerated filer o
Accelerated filer x
Non-accelerated filer o
Smaller Reporting Company ¨
 
Emerging growth company o

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act).  Yes o  No x






Securities registered pursuant to Section 12 (b) of the Securities Exchange Act of 1934:
Title of each class
Trading Symbol
Name of each exchange where registered
Common stock, $0.01 par value
HSKA
The Nasdaq Stock Market LLC

7,750,652 shares of the Registrant's Public Common Stock, $.01 par value, were outstanding at May 7, 2019.





TABLE OF CONTENTS
 
 
 
 
Page
PART I - FINANCIAL INFORMATION
 
 
Item 1.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
       Note 2, Revenue
 
 
 
 
 
 
       Note 5, Income Taxes
 
 
       Note 6, Leases
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Item 2.
 
Item 3.
 
Item 4.
PART II - OTHER INFORMATION
 
 
Item 1.
 
Item 1A.
 
Item 2.
 
Item 6.
 
 

HESKA, ALLERCEPT, HemaTrue, Solo Step, Element DC, Element HT5, Element POC, Element i, Element COAG and Element DC5X are registered trademarks and Element RC is a trademark of Heska Corporation. DRI-CHEM is a registered trademark of FUJIFILM Corporation. TRI-HEART is a registered trademark of Intervet Inc., d/b/a Merck Animal Health, formerly known as Schering-Plough Animal Health Corporation ("Merck Animal Health"), which is a unit of Merck & Co., Inc., in the United States and is a registered trademark of Heska Corporation in other countries. This quarterly report on Form 10-Q also refers to trademarks and trade names of other organizations.

- i-



PART I. FINANCIAL INFORMATION
Item 1. Financial Statements

HESKA CORPORATION AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS
(in thousands, except share and per share amounts)
 
 
March 31,
 
December 31,
 
 
2019
 
2018
 
 
(unaudited)
 
 
ASSETS
Current assets:
 
 

 
 

Cash and cash equivalents
 
$
9,101

 
$
13,389

Accounts receivable, net of allowance for doubtful accounts of $259 and $245, respectively
 
16,202

 
16,454

Inventories, net
 
27,388

 
25,104

Net investment in leases, current, net of allowance for doubtful accounts of $40 and $40, respectively
 
3,225

 
2,989

Other current assets
 
4,620

 
4,471

Total current assets
 
60,536

 
62,407

 
 
 
 
 
Property and equipment, net
 
15,511

 
15,981

Operating lease right-of-use assets
 
6,414

 
—

Goodwill
 
27,311

 
26,679

Other intangible assets, net
 
9,923

 
9,764

Deferred tax asset, net
 
15,176

 
14,121

Net investment in leases, non-current
 
12,615

 
11,908

Investments in unconsolidated affiliates
 
7,837

 
8,018

Other non-current assets
 
7,457

 
7,574

Total assets
 
$
162,780

 
$
156,452

 
 
 
 
 
LIABILITIES, MEZZANINE EQUITY AND STOCKHOLDERS' EQUITY
Current liabilities:
 
 

 
 

Accounts payable
 
$
7,746

 
$
7,469

Due to – related parties
 
—

 
226

Accrued liabilities
 
10,647

 
10,142

Current operating lease liability
 
1,693

 
—

Current portion of deferred revenue, and other
 
2,704

 
2,526

Total current liabilities
 
22,790

 
20,363

 
 
 
 
 
Deferred revenue, net of current portion
 
6,728

 
7,082

Line of credit and other long-term borrowings
 
6,026

 
6,031

Non-current operating lease liability
 
5,122

 
—

Other liabilities
 
175

 
567

Total liabilities
 
40,841

 
34,043

 
 
 
 
 
Commitments and contingencies (Note 14)
 


 


 
 
 
 
 
Redeemable non-controlling interest and mezzanine equity
 
662

 
—

 
 
 
 
 
Stockholders' equity:
 
 

 
 

Preferred stock, $.01 par value, 2,500,000 shares authorized, none issued or outstanding
 
—

 
—

Common stock, $.01 par value, 10,250,000 and 10,250,000 shares authorized, respectively, none issued or outstanding
 
—

 
—

Public common stock, $.01 par value, 10,250,000 and 10,250,000 shares authorized, 7,746,602 and 7,675,692 shares issued and outstanding, respectively
 
77

 
77

Additional paid-in capital
 
255,150

 
257,034

Accumulated other comprehensive income
 
215

 
277

Accumulated deficit
 
(134,165
)
 
(134,979
)
Total stockholders' equity
 
121,277

 
122,409

Total liabilities, mezzanine equity and stockholders' equity
 
$
162,780

 
$
156,452


See accompanying notes to condensed consolidated financial statements.

-1-



HESKA CORPORATION AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF INCOME
(in thousands, except per share amounts)
(unaudited)
 
 
Three Months Ended March 31,
 
 
2019
 
2018
Revenue:
 
 
 
 

Core companion animal
 
$
24,716

 
$
26,819

Other vaccines and pharmaceuticals
 
4,795

 
5,946

Total revenue, net
 
29,511

 
32,765

 
 
 
 
 
Cost of revenue
 
16,968

 
19,458

 
 
 
 
 
Gross profit
 
12,543

 
13,307

 
 
 
 
 
Operating expenses:
 
 
 
 

Selling and marketing
 
7,033

 
6,140

Research and development
 
1,366

 
670

General and administrative
 
4,219

 
4,626

Total operating expenses
 
12,618

 
11,436

Operating (loss) income
 
(75
)
 
1,871

Interest and other income, net
 
(16
)
 
(4
)
(Loss) income before income taxes and equity in losses of unconsolidated affiliates
 
(59
)
 
1,875

Income tax (benefit) expense:
 
 
 
 

Current income tax expense
 
45

 
17

Deferred income tax benefit
 
(1,055
)
 
(297
)
Total income tax benefit
 
(1,010
)
 
(280
)
 
 
 
 
 
Net income before equity in losses of unconsolidated affiliates
 
951

 
2,155

Equity in losses of unconsolidated affiliates
 
(181
)
 
—

Net income after equity in losses of unconsolidated affiliates
 
770

 
2,155

Net loss attributable to redeemable non-controlling interest
 
(44
)
 
—

Net income attributable to Heska Corporation
 
$
814

 
$
2,155

 
 
 
 
 
Basic earnings per share attributable to Heska Corporation
 
$
0.11

 
$
0.30

Diluted earnings per share attributable to Heska Corporation
 
$
0.10

 
$
0.28

 
 
 
 
 
Weighted average outstanding shares used to compute basic earnings per share attributable to Heska Corporation
 
7,459

 
7,102

Weighted average outstanding shares used to compute diluted earnings per share attributable to Heska Corporation
 
7,965

 
7,711

 
See accompanying notes to condensed consolidated financial statements.


-2-



HESKA CORPORATION AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
(in thousands) 
(unaudited)

 
 
Three Months Ended March 31,
 
 
2019
 
2018
Net income after equity in losses of unconsolidated affiliates
 
$
770

 
$
2,155

Other comprehensive income (loss):
 
 
 
 

Foreign currency translation
 
(62
)
 
81

Comprehensive income
 
708

 
2,236

 
 
 
 
 
Comprehensive loss attributable to redeemable non-controlling interest
 
(44
)
 
—

Comprehensive income attributable to Heska Corporation
 
$
752

 
$
2,236

 
See accompanying notes to condensed consolidated financial statements.


-3-



HESKA CORPORATION AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY
(in thousands) 
(unaudited)

 
 
 
 
Common Stock
 
 
Additional
Paid-in
Capital
 
Accumulated
Other
Comprehensive
Income
 
 
 
Accumulated
Deficit
 
 
Total
Stockholders'
Equity
Three Months Ended March 31, 2018 and 2019
 
Shares
 
Amount
 
Balances, December 31, 2017
 
7,303

 
$
73

 
$
243,598

 
$
232

 
$
(143,463
)
 
$
100,440

Adoption of accounting standards
 
—

 
—

 
—

 
—

 
2,634

 
2,634

Balances, January 1, 2018, as adjusted
 
7,303

 
73

 
243,598

 
232

 
(140,829
)
 
103,074

Net income attributable to Heska Corporation
 
—

 
—

 
—

 
—

 
2,155

 
2,155

Issuance of common stock, net of shares withheld for employee taxes
 
116

 
1

 
(1,285
)
 
—

 
—

 
(1,284
)
Stock-based compensation
 
—

 
—

 
1,064

 
—

 
—

 
1,064

Other comprehensive income
 
—

 
—

 
—

 
81

 
—

 
81

Balances, March 31, 2018
 
7,419

 
$
74

 
$
243,377

 
$
313

 
$
(138,674
)
 
$
105,090

 
 
 
 
 
 
 
 
 
 
 
 
 
Balances, December 31, 2018
 
7,676

 
$
77

 
$
257,034

 
$
277

 
$
(134,979
)
 
$
122,409

Net income attributable to Heska Corporation
 
—

 
—

 
—

 
—

 
814

 
814

Issuance of common stock, net of shares withheld for employee taxes
 
71

 
—

 
(3,070
)
 
—

 
—

 
(3,070
)
Stock-based compensation
 
—

 
—

 
1,186

 
—

 
—

 
1,186

Other comprehensive loss
 
—

 
—

 
—

 
(62
)
 
—

 
(62
)
Balances, March 31, 2019
 
7,747

 
$
77

 
$
255,150

 
$
215

 
$
(134,165
)
 
$
121,277

 
 
 
 
 
 
 
 
 
 
 
 
 
Note: Excludes amounts related to redeemable non-controlling interests recorded in mezzanine equity.
See accompanying notes to condensed consolidated financial statements.

-4-



HESKA CORPORATION AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands)
(unaudited)
 
 
Three Months Ended
March 31,
 
 
2019
 
2018
CASH FLOWS FROM OPERATING ACTIVITIES:
 
 
 
 
Net income after equity in losses from unconsolidated affiliates
 
$
770

 
$
2,155

Adjustments to reconcile net income to cash provided by operating activities:
 
 

 
 

Depreciation and amortization
 
1,265

 
1,196

Non-cash impact of operating leases
 
375

 
—

Deferred income tax benefit
 
(1,055
)
 
(297
)
Stock-based compensation
 
1,186

 
1,064

Other losses
 
191

 
10

Changes in operating assets and liabilities (net of the effect of acquisitions):
 
 

 
 

Accounts receivable
 
624

 
1,465

Inventories
 
(1,052
)
 
2,047

Due from related parties
 
—

 
1

Lease receivable, current
 
(237
)
 
(233
)
Other current assets
 
(151
)
 
257

Accounts payable
 
(110
)
 
(3,265
)
Due to related parties
 
(226
)
 
(1,026
)
Accrued liabilities and other
 
39

 
2,981

Lease receivable, non-current
 
(668
)
 
(754
)
Other non-current assets
 
101

 
244

Deferred revenue and other
 
(325
)
 
(1,638
)
Net cash provided by operating activities
 
727

 
4,207

CASH FLOWS FROM INVESTING ACTIVITIES:
 
 
 
 
Investment in subsidiary, net of cash acquired
 
(224
)
 
—

Purchases of property and equipment
 
(234
)
 
(375
)
Net cash used in investing activities
 
(458
)
 
(375
)
CASH FLOWS FROM FINANCING ACTIVITIES:
 
 
 
 
Proceeds from issuance of common stock
 
410

 
288

Repurchase of common stock
 
(3,480
)
 
(1,571
)
Distributions to non-controlling interest members
 
—

 
(126
)
Repayments of other debt
 
(1,486
)
 
—

Net cash used in financing activities
 
(4,556
)
 
(1,409
)
NET EFFECT OF EXCHANGE RATE CHANGES ON CASH
 
(1
)
 
44

NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS
 
(4,288
)
 
2,467

CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD
 
13,389

 
9,659

CASH AND CASH EQUIVALENTS, END OF PERIOD
 
$
9,101

 
$
12,126

 
 
 
 
 
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:
 
 
 
 
Non-cash transfers of equipment between inventory and property and equipment, net
 
$
227

 
$
251


See accompanying notes to condensed consolidated financial statements.

-5-

HESKA CORPORATION AND SUBSIDIARIES
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS



1.    OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Heska Corporation and its wholly-owned subsidiaries ("Heska", the "Company", "we" or "our") sell veterinary and animal health diagnostic and specialty products. Our offerings include Point of Care diagnostic laboratory instruments and supplies; digital imaging diagnostic products, software and services; vaccines; local and cloud-based data services; allergy testing and immunotherapy; and single-use offerings such as in-clinic diagnostic tests and heartworm preventive products. Our core focus is on supporting veterinarians in the canine and feline healthcare space.
Basis of Presentation and Consolidation
In the opinion of management, the accompanying unaudited Condensed Consolidated Financial Statements contain all adjustments, consisting of normal, recurring adjustments, necessary to present fairly the financial position of the Company as of March 31, 2019 and December 31, 2018, the results of our operations, statements of stockholders' equity and cash flows for the three months ended March 31, 2019 and 2018.
The unaudited Condensed Consolidated Financial Statements included herein have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission ("SEC"). Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America ("GAAP") have been condensed or omitted pursuant to such rules and regulations. Our unaudited Condensed Consolidated Financial Statements include our accounts and the accounts of our wholly-owned subsidiaries since their respective dates of acquisitions. All intercompany accounts and transactions have been eliminated in consolidation. Where our ownership of a subsidiary is less than 100%, the non-controlling interest is reported on our Condensed Consolidated Balance Sheets. The non-controlling interest in our consolidated net income is reported as "Net loss attributable to redeemable non-controlling interest" on our Condensed Consolidated Statements of Income. These unaudited Condensed Consolidated Financial Statements should be read in conjunction with the audited Consolidated Financial Statements and Notes thereto contained in our Annual Report on Form 10-K for the fiscal year ended December 31, 2018 and other financial information filed with the SEC.
Reclassification
To maintain consistency and comparability, certain amounts in the financial statements have been reclassified to conform to current year presentation.
Use of Estimates
The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates are required when establishing the allowance for doubtful accounts and the net realizable value of inventory; determining future costs associated with warranties provided; determining the period over which our obligations are fulfilled under agreements to license product rights and/or technology rights; evaluating long-lived and intangible assets and investments for estimated useful lives and impairment; estimating the useful lives of instruments under leasing arrangements; determining the allocation of purchase price under purchase accounting; estimating the expense associated with the granting of stock; determining the need for, and the amount of a valuation allowance on deferred tax assets; and determining the value of the non-controlling interest in a business combination.

-6-

HESKA CORPORATION AND SUBSIDIARIES
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - (Continued)


Critical Accounting Policies
Our accounting policies are described in our audited Consolidated Financial Statements and Notes thereto contained in our Annual Report on Form 10-K for the year ended December 31, 2018 and other than the recently adopted accounting pronouncements described below, have not changed significantly since such filing.
Adoption of New Accounting Pronouncements

Effective January 1, 2019, we adopted ASU 2018-07, Compensation – Stock Compensation (Topic 718), Improvements to Non-employee Share-Based Payment Accounting. This ASU is intended to simplify aspects of share-based compensation issued to non-employees by making the guidance consistent with accounting for employee share-based compensation. Guidance related to the stock compensation granted to employees is followed for non-employees, including the measurement date, valuation approach and performance conditions. The expense is recognized in the same period as though cash were paid for the good or service, ratably over the service period. The adoption of this ASU did not have an impact on our consolidated financial statements but did have a minimal impact on our related disclosures.

Effective January 1, 2019, we adopted ASU 2018-02, Income Statement-Reporting Comprehensive Income (Topic 220): Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income. The ASU permits companies to elect a reclassification of the disproportionate tax effects in accumulated other comprehensive income ("AOCI") caused by the Tax Cuts and Jobs Act of 2017 to retained earnings. As of March 31, 2019, the Company does not have any disproportionate income tax effects in AOCI to reclassify. However, if the Company did have disproportionate income tax effects in AOCI in the future, it would reclassify them to retained earnings.

In February 2016, the FASB issued ASU 2016-02, Leases (Topic 842), which supersedes ASC 840, Leases. This update requires lessees to recognize a right-of-use (“ROU”) asset and a lease liability for all leases, including operating leases, with terms greater than 12 months on its balance sheet. The update also expands the required quantitative and qualitative disclosures by lessees and lessors about the amount, timing and uncertainty of cash flows arising from leases. The accounting for lessors does not fundamentally change except for changes to conform and align guidance to the lessee guidance as well as to the new revenue recognition guidance in ASU 2014-09, Revenue from Contracts with Customers (Topic 606). Subsequent to the issuance of Topic 842, the FASB clarified the guidance through several ASUs; hereinafter the collection of lease guidance is referred to as “ASC 842”.

The Company adopted ASC 842 on January 1, 2019, using the modified retrospective approach for all lease arrangements at the beginning of the period of adoption. Results for reporting periods beginning January 1, 2019 are presented under ASC 842, while prior period amounts were not adjusted and continue to be reported in accordance with the Company’s historic accounting under ASC 840, Leases. For leases that commenced before the effective date of ASC 842, the Company elected the permitted practical expedients to not reassess the following: (i) whether any expired or existing contracts contain leases; (ii) the lease classification for any expired or existing leases; and (iii) initial direct costs for any existing leases. The Company also elected to exclude leases with a term of 12 months or less from the recognized ROU assets and lease liabilities.

Adoption of the standard did not have a material net impact in our Condensed Consolidated Balance Sheets, Condensed Consolidated Statements of Income or Condensed Consolidated Statements of Cash Flows. The most significant impact was the recognition of ROU assets and lease liabilities for the operating leases, of which we are the lessee. As a result of the cumulative impact of adopting ASC 842, the Company recorded operating lease ROU assets of $6.5 million and operating lease liabilities of $6.9 million as of January 1,

-7-

HESKA CORPORATION AND SUBSIDIARIES
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - (Continued)


2019, primarily related to building, vehicle, and office equipment leases, based on the present value of the future lease payments on the date of adoption. As a lessor, accounting for our subscription agreements will remain substantially unchanged. Refer to Note 6 for additional disclosures required by ASC 842.
The Company determines if an arrangement is a lease at inception based on whether control of an identified asset is transferred. For leases where the Company is the lessee, ROU assets represent the Company’s right to use an underlying asset for the lease term and lease liabilities represent an obligation to make lease payments arising from the lease. ROU assets and lease liabilities are recognized at the lease commencement date based on the present value of lease payments over the lease term. As most of the Company’s leases do not provide an implicit interest rate, the Company uses its incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. The lease terms used to calculate the ROU asset and related lease liability include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. Lease expense for operating leases is recognized on a straight-line basis over the lease term as an operating expense while the expense for finance leases is recognized as amortization expense and interest expense. The Company has lease agreements which require payments for lease and non-lease components and has elected to account for these as a single lease component for our building and office equipment leases, but as separate components for our vehicle leases.

Our revenue under subscription agreements relates to both operating-type lease (“OTL”) arrangements or sales-type lease (“STL”) arrangements. Determination of an OTL or STL is primarily determined as a result of the length of the contract as compared to the estimated useful life of the instrument, among other factors. A STL results in earlier recognition of instrument revenue. The cost of the customer-leased instruments is removed from inventory and recognized in the Consolidated Statements of Income. There is no residual value taken into consideration as it does not meet our capitalization requirements. Instrument lease revenue for OTL agreements is recognized on a straight-line basis over the life of the lease and included with the predominant non-lease components in consumable revenue. The costs of customer-leased instruments are recorded within property and equipment in the accompanying Consolidated Balance Sheets and depreciated over the instrument’s estimated useful life. The depreciation expense is reflected in cost of revenue in the accompanying Consolidated Statements of Income. The OTLs and STLs are not cancellable until after an initial term and include an option to renew.
For lease arrangements with lease and non-lease components where the Company is the lessor, the Company allocates the contracts transaction price to the lease and non-lease components on a relative standalone selling price basis using the Company’s best estimate of the standalone selling price of each distinct product or service in the contract. The primary method used to estimate standalone selling price is the price observed in standalone sales to customers of a prior period. Changes in these values can impact the amount of consideration allocated to each component of the contract. When prices in standalone sales are not available, we may use a cost-plus margin approach. Allocation of the transaction price is determined at the inception of the lease arrangement. The Company’s leases consist of leases with fixed and variable lease payments. For those leases with variable lease payments, the variable lease payment is typically based upon purchase of consumables used with the leased instruments and included in consumable revenue.
  
Accounting Pronouncements Not Yet Adopted

In June 2016, the FASB issued ASU 2016-13, Financial Instruments - Credit Losses (Topic 326), which requires that financial assets measured at amortized cost be presented at the net amount expected to be collected. The allowance for credit losses is a valuation account that is deducted from the amortized cost basis of the financial asset to present the net carrying value at the amount expected to be collected. The income statement reflects the measurement of credit losses for newly recognized financial assets, as well as the increases or decreases of expected credit losses that have taken place during the period. The measurement of

-8-

HESKA CORPORATION AND SUBSIDIARIES
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - (Continued)


expected credit losses is based upon historical experience, current conditions and reasonable and supportable forecasts that affect the collectability of the reported amount. In November 2018, the FASB issued ASU 2018-19, Codification Improvements to Topic 326, Financial Instruments - Credit Losses. This ASU clarifies that receivables from operating leases are accounted for using the lease guidance and not as financial instruments. The amendments in this update are effective for fiscal years beginning after December 15, 2019 and interim periods within those annual periods. Early adoption for fiscal year beginning after December 15, 2018 is permitted. We will adopt the provisions of this ASU in the first quarter of 2020. We are currently evaluating the effect of this update on our consolidated financial statements.

2.     REVENUE

We separate our goods and services among:

•
Point of Care laboratory products including instruments, consumables and services;
•
Point of Care imaging products including instruments, software and services;
•
Single use pharmaceuticals, vaccines and diagnostic tests primarily related to companion animals; and
•
Other vaccines and pharmaceuticals ("OVP").
The following table summarizes our Core Companion Animal ("CCA") revenue (in thousands):
 
Three Months Ended March 31,
 
2019
 
2018
Point of Care laboratory revenue:
$
15,961

 
$
13,641

    Consumables
12,317

 
10,821

    Sales-type leases
1,742

 
1,538

    Outright instrument sales
1,528

 
811

    Other
374

 
471

 
 
 
 
Point of Care imaging revenue:
5,410

 
5,972

    Outright instrument sales
4,546

 
5,137

    Service revenue
562

 
556

    Operating type leases and other
302

 
279

 
 
 
 
Other CCA revenue:
3,345

 
7,206

    Other pharmaceuticals, vaccines and diagnostic tests
3,246

 
7,109

    Research and development, license and royalty revenue
99

 
97

 
 
 
 
Total CCA revenue
$
24,716

 
$
26,819



-9-

HESKA CORPORATION AND SUBSIDIARIES
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - (Continued)


Revenue from our OVP segment consists of revenue generated from contract manufacturing agreements and from other license, research and development revenue. The following table summarizes our OVP revenue (in thousands):
 
Three Months Ended March 31,
 
2019
 
2018
Contract manufacturing
$
4,666

 
$
5,791

License, research and development
129

 
155

Total OVP revenue
$
4,795

 
$
5,946


Remaining Performance Obligations

Remaining performance obligations represent the aggregate transaction price allocated to performance obligations with an original contract term greater than one year which are fully or partially unsatisfied at the end of the period. Remaining performance obligations include noncancelable purchase orders, the non-lease portion of minimum purchase commitments under long-term supply arrangements, extended warranty, service and other long-term contracts. Remaining performance obligations do not include revenue from contracts with customers with an original term of one year or less, revenue from long-term supply arrangements with no minimum purchase requirements, revenue expected from purchases made in excess of the minimum purchase requirements, or revenue from instruments leased to customers. While the remaining performance obligation disclosure is similar in concept to backlog, the definition of remaining performance obligations excludes leases and contracts that provide the customer with the right to cancel or terminate for convenience with no substantial penalty, even if historical experience indicates the likelihood of cancellation or termination is remote. Additionally, the Company has elected to exclude contracts with customers with an original term of one year or less from remaining performance obligations.

As of March 31, 2019, the aggregate amount of the transaction price allocated to remaining minimum performance obligations was approximately $87.2 million. As of March 31, 2019, the Company expects to recognize revenue as follows (in thousands):
Year Ending December 31,
Revenue
2019 (remaining)
$
18,023

2020
21,101

2021
17,078

2022
13,925

2023
10,337

Thereafter
6,727

 
$
87,191


Contract Balances

The timing of revenue recognition, billings and cash collections results in billed accounts receivable, unbilled receivables (contract assets) and deferred revenue, and customer deposits and billings in excess of revenue recognized (contract liabilities) on the Condensed Consolidated Balance Sheets. In addition, the Company defers certain costs incurred to obtain contracts (contract costs).


-10-

HESKA CORPORATION AND SUBSIDIARIES
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - (Continued)


Contract Receivables

Certain unbilled receivable balances related to long-term contracts for which we provide a free term to the customer but have recognized revenue are recorded in other current and other non-current assets. We have no further performance obligations related to these receivable balances and the collection of these balances occurs over the term of the underlying contract. The balances as of March 31, 2019 were $0.9 million and $3.4 million for current and non-current assets, respectively, shown net of related unearned interest. The balances as of December 31, 2018 were $0.9 million and $3.3 million for current and non-current assets, respectively, shown net of related unearned interest.

Contract Liabilities

The Company receives cash payments from customers for licensing fees or other arrangements that extend for a specified term. These contract liabilities are classified as either current or long-term in the Condensed Consolidated Balance Sheets based on the timing of when the Company expects to recognize revenue. As of March 31, 2019 and December 31, 2018, contract liabilities were $9.2 million and $9.6 million, respectively, and are included within "Current portion of deferred revenue, and other" and "Deferred revenue, net of current portion" in the accompanying Condensed Consolidated Balance Sheets. The decrease in the contract liability balance during the three-month period ended March 31, 2019 is $0.7 million of revenue recognized during the period, offset by $0.4 million of additional deferred sales in 2019.

Contract Costs

The Company capitalizes certain direct incremental costs incurred to obtain customer contracts, typically sales-related commissions, where the recognition period for the related revenue is greater than one year. Contract costs are classified as current or non-current, and are included in "Other current assets" and "Other non-current assets" in the Condensed Consolidated Balance Sheets based on the timing of when the Company expects to recognize the expense. Contract costs are generally amortized into selling and marketing expense with a certain percentage recognized immediately based upon placement of the instrument with the remainder recognized on a straight-line basis (which is consistent with the transfer of control for the related goods or services) over the average term of the underlying contracts, approximately 6 years. Management assesses these costs for impairment at least quarterly on a portfolio basis and as “triggering” events occur that indicate it is more-likely-than-not that an impairment exists. The balance of contract costs as of March 31, 2019 and December 31, 2018 was $2.5 million and $2.5 million, respectively. Amortization expense for the three-month period ended March 31, 2019 was approximately $0.2 million, offset by approximately $0.3 million of additional contract costs capitalized.

Contract liabilities are reported on the accompanying Condensed Consolidated Balance Sheets on a contract-by-contract basis whereas contract costs are calculated and reported on a portfolio basis.

3.    ACQUISITIONS AND RELATED PARTY ITEMS
Optomed
On February 22, 2019, Heska acquired 70% of the equity of Optomed, a French-based endoscopy company, in exchange for approximately $0.2 million in cash and the assumption of approximately $1.5 million in debt. As part of the purchase, Heska entered into put options and call options on the remaining 30% minority interest. The written put options can be exercised based on the achievement of certain financial conditions over a specified period of time for a fixed amount. The options are not currently exercisable at the acquisition date or the reporting date. The estimated value of the non-controlling interest is inclusive of the probability

-11-

HESKA CORPORATION AND SUBSIDIARIES
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - (Continued)


weighted outcome of the options described herein. The Company is in process of finalizing its purchase price allocation. As part of the purchase agreement, Heska has committed to a purchase from the minority interest holder, within six months from the acquisition date, real estate in the amount of approximately $1.0 million, which is currently under lease by Optomed.
Cuattro Veterinary Acquisitions
In February 2013, the Company acquired a majority interest in Cuattro Veterinary USA, LLC, which was owned by Kevin S. Wilson, among other members. The subsidiary was subsequently renamed Heska Imaging US, LLC ("US Imaging"). The remaining minority position in US Imaging was subject to purchase by Heska under a performance-based put option which was exercised in March 2017. In May 2017, we purchased the remaining minority interest position in US Imaging.

In May 2016, the Company closed a transaction to acquire Cuattro Veterinary, LLC ("International Imaging"), which was owned by Kevin S. Wilson, among other members. International Imaging is a provider to international markets of digital radiography technologies for veterinarians. As a leading provider of advanced veterinary diagnostic and specialty products, we made the acquisition in an effort to combine International Imaging's global reach with our domestic success in the imaging and laboratory markets in the United States.

In June 2017, the Company consolidated its assets and liabilities in the US Imaging and International Imaging companies into Heska Imaging, LLC ("Heska Imaging"). Cuattro, LLC ("Cuattro") is owned by Kevin S. Wilson, the CEO and President of the Company in addition to Mrs. Wilson and trusts for the benefit of Mr. and Mrs. Wilson's children and family. Steven M. Asakowicz and Rodney A. Lippincott, members of Cuattro Veterinary USA, LLC and Cuattro International prior the acquisitions, each serve as Executive Vice President, Companion Animal Health Sales for the Company.
Purchase Agreement for Certain Assets
On December 21, 2018, the Company closed a transaction (the "Asset Acquisition") to acquire certain assets from Cuattro, all related to the CCA segment. Pursuant to the Asset Acquisition, dated November 26, 2018, the Company issued 54,763 shares of the Company's common stock, $0.01 par value per share (the "Common Stock"), to Cuattro on the Closing Date, at an aggregate value equal to approximately $5.4 million based on the adjusted closing price per share of the Common Stock as reported on the Nasdaq Stock Market on the Asset Acquisition agreement date. These shares were issued to Cuattro in a private placement in reliance upon an exemption from the registration requirements of the Securities Act pursuant to Section 4(a)(2) thereof and the safe harbor provided by Rule 506 of Regulation D promulgated thereunder. In addition to the Common Stock, the Company paid cash in the amount of $2.8 million to Cuattro as part of the transaction. The total purchase price was determined based on a valuation report from an independent third party. Part of the Asset Acquisition was an agreement to terminate the supply and license agreement that Heska had been operating under since the acquisition of Cuattro Veterinary USA, LLC.
The Company evaluated the acquisition of the purchased assets under ASC 805, Business Combinations and ASU 2017-01, Business Combinations (Topic 805) and concluded that as substantially all of the fair value of the gross assets acquired is concentrated in an identifiable group of similar assets, the transaction did not meet the requirements to be accounted for as a business combination and therefore was accounted for as an asset acquisition. Accordingly, the purchase price of the purchased assets was allocated entirely to an identifiable intangible asset. In addition to the software assets acquired, Cuattro is obligated, without further compensation, to assist the Company with the implementation of third-party image hosting platform and necessary data migration.

-12-

HESKA CORPORATION AND SUBSIDIARIES
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - (Continued)


Other Related Party Activities
Cuattro charged Heska Imaging $6.0 thousand and $1.7 million during the three months ended March 31, 2019 and 2018, respectively. The charge in 2019 relates to minor inventory purchases as the Company transitions the digital imaging software assets away from Cuattro. The charge in 2018 was primarily for digital imaging products, pursuant to an underlying supply contract which was terminated in December 2018.

The Company had no receivables from or payables to Cuattro as of March 31, 2019. Heska Imaging owed Cuattro $0.2 million as of December 31, 2018, which is reported in "Due to – related parties" on the Company's Condensed Consolidated Balance Sheets.

4.    INVESTMENTS IN UNCONSOLIDATED AFFILIATES
The carrying values of investments in unconsolidated affiliates, categorized by type of investment, is as follows (in thousands):
 
March 31, 2019
 
December 31, 2018
Equity method investment
$
4,819

 
$
5,000

Non-marketable equity security investment
3,018

 
3,018

 
$
7,837

 
$
8,018

Equity Method Investment
On September 24, 2018, we invested $5.1 million, including costs, in exchange for a 28.7% interest of a business as part of our product development strategy. The Company accounts for this investment using the equity method of accounting. Under the equity method, the carrying value of the investment is adjusted for the Company's proportionate share of the investee's reported earnings or losses with the corresponding share of earnings or losses reported as Equity in Losses of Unconsolidated Affiliates, listed below Net income before equity in losses of unconsolidated affiliates within the Condensed Consolidated Statements of Income. Additionally, the Company also entered into a 15-year Manufacturing Supply Agreement, which grants the Company global exclusivity to specified products.
Non-Marketable Equity Security Investment

On August 8, 2018, the Company invested $3.0 million, including costs, in MBio Diagnostics, Inc. ("MBio"), in exchange for preferred stock, representing a 6.9% interest in MBio. The Company’s investment in MBio is a non-marketable equity security, recorded using the measurement alternative of cost minus impairment, if any, plus or minus changes resulting from qualifying observable price changes.

As part of the agreement, the Company entered into a Supply and License Agreement with MBio, which provides that MBio produce and commercialize products that will enhance the Company's diagnostic portfolio. As part of this agreement, the Company made an upfront payment to MBio of $1.0 million related to a worldwide exclusive license agreement over a 20-year period, recorded in both short and long-term other assets. In addition, the agreement provides for an additional contingent payment from Heska to MBio of $10.0 million, relating to the successful achievement of sales milestones. This potential future milestone payment has not yet been accrued as it is not deemed by the Company to be probable at this time.

Both parties in this arrangement are active participants and are exposed to significant risks and rewards dependent on the commercial success of the activities of the collaboration. The parties are actively working on developing and testing the product as well as funding the research and development. Heska classifies the

-13-

HESKA CORPORATION AND SUBSIDIARIES
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - (Continued)


amounts paid for MBio's research and development work within the CCA segment research and development operating expenses. Expense is recognized ratably when incurred and in accordance with the development plan.
5.    INCOME TAXES

Our total income tax benefit for our (loss) income before income taxes were as follows (in thousands):
 
 
Three Months Ended March 31,
 
 
2019
 
2018
(Loss) income before income taxes
 
$
(59
)
 
$
1,875

Total income tax benefit
 
(1,010
)
 
(280
)
    
There were cash refunds of $0.1 million for income taxes, net of payments, for the three months ended March 31, 2019, and there were $18 thousand in cash payments for income taxes, net of refunds, for the three months ended March 31, 2018. The Company’s tax benefit increased to $1.0 million for the three months ended March 31, 2019, compared to the tax benefit of $0.3 million for the three months ended March 31, 2018. The increase in tax benefits is due to an increase in stock-based compensation excess tax benefits recognized in our income statement. In the first quarter of 2019, the Company recognized $1.1 million in excess tax benefits related to employee share based compensation compared to $0.8 million recognized in the first quarter of 2018.
6.    LEASES

Lessee Accounting

The Company leases buildings, office equipment, and vehicles. The Company’s finance leases were not material as of March 31, 2019 and for the three-month period then ended. ROU assets arising from finance leases are included in Property and equipment, net in the accompanying Condensed Consolidated Balance Sheets. The current portion of the finance lease liabilities are included in Current portion of deferred revenue, and other and the non-current portion of the finance lease liabilities are included in Line of credit and other long term borrowings in the accompanying Condensed Consolidated Balance Sheets.

For the three months ended March 31, 2019, operating lease expense was $0.6 million, including immaterial variable lease costs.

Supplemental cash flow information related to the Company's operating leases for the three months ended March 31, 2019 was as follows (in thousands):

Cash paid for amounts included in the measurement of operating lease liabilities
$
444

ROU assets obtained in exchange for operating lease obligations
293


The following table presents the weighted average remaining lease term and weighted average discount rate related to the Company's operating leases as of March 31, 2019:

Weighted average remaining lease term
4.4 years

Weighted average discount rate
4.45
%


-14-

HESKA CORPORATION AND SUBSIDIARIES
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - (Continued)


The following table presents the maturity of the Company's operating lease liabilities as of March 31, 2019 (in thousands):
Remainder of 2019
$
1,396

2020
1,611

2021
1,453

2022
1,320

2023
1,766

Total operating lease payments
7,546

Less: imputed interest
731

Total operating lease liabilities
$
6,815


Lessor Accounting
 
In our CCA segment, primarily related to our Point of Care laboratory products, the Company enters into sales-type leases as part of our subscription agreements. The following table presents the maturity of the Company's undiscounted lease receivables as of March 31, 2019 (in thousands):

Year Ending December 31,
 
Remainder of 2019
$
2,409

2020
3,430

2021
3,364

2022
2,989

2023
2,147

Thereafter
1,501

 
$
15,840


7.    EARNINGS PER SHARE

Basic earnings per share ("EPS") is computed by dividing net income attributable to the Company by the weighted-average number of common shares outstanding during the period. The computation of diluted EPS is similar to the computation of basic EPS except that the numerator is increased to exclude charges that would not have been incurred, and the denominator is increased to include the number of additional common shares that would have been outstanding (using the if-converted and treasury stock methods), if securities containing potentially dilutive common shares (stock options and restricted stock units but excluding options to purchase fractional shares resulting from the Company's December 2010 1-for-10 reverse stock split) had been converted to common shares, and if such assumed conversion is dilutive.


-15-

HESKA CORPORATION AND SUBSIDIARIES
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - (Continued)


The following is a reconciliation of the weighted-average shares outstanding used in the calculation of basic and diluted EPS for the three months ended March 31, 2019 and 2018 (in thousands, except per share data):
 
Three Months Ended March 31,
 
2019
 
2018
Net income attributable to Heska Corporation
$
814

 
$
2,155

 
 
 
 
Basic weighted-average common shares outstanding
7,459

 
7,102

Assumed exercise of dilutive stock options and restricted shares
506

 
609

Diluted weighted-average common shares outstanding
$
7,965

 
$
7,711

 
 
 
 
Basic earnings per share attributable to Heska Corporation
$
0.11

 
$
0.30

Diluted earnings per share attributable to Heska Corporation
$
0.10

 
$
0.28


The following stock options and restricted shares were excluded from the computation of diluted EPS because they would have been anti-dilutive (in thousands):
 
Three Months Ended March 31,
 
2019
 
2018
Stock options
86

 
244

8.    GOODWILL AND OTHER INTANGIBLES

The following summarizes the change in goodwill during the three months ended March 31, 2019 (in thousands):
Carrying amount, December 31, 2018
$
26,679

Goodwill attributable to acquisitions (subject to change)
643

Foreign currency adjustments
(11
)
Carrying amount, March 31, 2019
$
27,311


Other intangibles consisted of the following (in thousands):
 
March 31, 2019
 
December 31, 2018
 
Gross Carrying Amount
 
Accumulated Amortization
 
Net Carrying Amount
 
Gross Carrying Amount
 
Accumulated Amortization
 
Net Carrying Amount
Developed technology
$
8,200

 
$
(205
)
 
$
7,995

 
$
8,200

 
$
—

 
$
8,200

Customer relationships and other
3,793

 
(1,865
)
 
1,928

 
3,303

 
(1,739
)
 
1,564

Total intangible assets
$
11,993

 
$
(2,070
)
 
$
9,923

 
$
11,503

 
$
(1,739
)
 
$
9,764


Amortization expense relating to other intangibles was as follows (in thousands):
 
Three Months Ended March 31,
 
2019
 
2018
Amortization expense
$
303

 
$
97


-16-

HESKA CORPORATION AND SUBSIDIARIES
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - (Continued)



Estimated amortization expense related to intangibles for each of the five years from 2019 (remaining) through 2023 and thereafter is as follows (in thousands):
Year Ending December 31,
 
2019 (remaining)
$
968

2020
1,284

2021
1,280

2022
1,262

2023
915

Thereafter
4,214

 
$
9,923

9.    PROPERTY AND EQUIPMENT, NET
Property and equipment, net, consisted of the following (in thousands):
 
March 31,
 
December 31,
 
2019
 
2018
Land
$
377

 
$
377

Building
2,978

 
2,978

Machinery and equipment
33,591

 
33,087

Office furniture and equipment
1,767

 
1,687

Computer hardware and software
4,725

 
4,704

Leasehold and building improvements
10,086

 
9,953

Construction in progress
947

 
1,274

 
54,471

 
54,060

Less accumulated depreciation
(38,960
)
 
(38,079
)
Total property and equipment, net
$
15,511

 
$
15,981

Depreciation expense was $1.0 million and $1.1 million for the three months ended March 31, 2019 and 2018, respectively.
The Company has subscription agreements whereby its instruments in inventory may be placed at a customer's location on a rental basis. The cost of these instruments is transferred to machinery and equipment and depreciated, typically over a 5 to 7 year period depending on the circumstance under which the instrument is placed with the customer. Our cost of instruments under operating leases as of March 31, 2019 and December 31, 2018, was $11.0 million and $10.8 million, respectively, before accumulated depreciation of $6.4 million and $6.1 million, respectively.

-17-

HESKA CORPORATION AND SUBSIDIARIES
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - (Continued)


10.    INVENTORIES, NET

Inventories, net, consisted of the following (in thousands):
 
 
March 31,
 
December 31,
 
 
2019
 
2018
Raw materials
 
$
16,626

 
$
15,000

Work in process
 
3,214

 
3,592

Finished goods
 
8,869

 
8,085

Allowance for excess or obsolete inventory
 
(1,321
)
 
(1,573
)
Total inventory, net
 
$
27,388

 
$
25,104


Inventories are measured on a first-in, first-out basis and stated at lower of cost or net realizable value.
11.    ACCRUED LIABILITIES
Accrued liabilities consisted of the following (in thousands):
 
March 31,
2019
 
December 31,
2018
Accrued settlement (see Note 14)
$
6,750

 
$
6,750

Accrued payroll and employee benefits
840

 
759

Accrued property taxes
232

 
632

Inventory in transit
1,281

 
327

Other
1,544

 
1,674

Total accrued liabilities
$
10,647

 
$
10,142

Other accrued liabilities consists of items that are individually less than 5% of total current liabilities.
12.    CAPITAL STOCK
Stock Option Plans
The fair value of each option grant was estimated on the date of grant using the Black-Scholes option-pricing model with the following weighted average assumptions for options granted in the three months ended March 31, 2019 and 2018.
 
Three Months Ended March 31,
 
2019
 
2018
Risk-free interest rate
2.45%
 
2.64%
Expected lives
4.7 years
 
4.9 years
Expected volatility
39%
 
40%
Expected dividend yield
0%
 
0%

-18-

HESKA CORPORATION AND SUBSIDIARIES
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - (Continued)


A summary of our stock option plans is as follows:
 
Three Months Ended March 31,
 
Year Ended December 31,
 
2019
 
2018
 
 
 
 
Options
 
Weighted Average Exercise Price
 
 
 
 
Options
 
Weighted Average Exercise Price
Outstanding at beginning of period
620,553

 
$
40.741

 
630,847

 
$
29.312

Granted at market
1,200

 
$
98.970

 
153,700

 
$
75.244

Forfeited
—

 
$
—

 
(18,978
)
 
$
53.010

Expired
—

 
$
—

 
(896
)
 
$
25.740

Exercised
(122,895
)
 
$
17.013

 
(144,120
)
 
$
65.414

Outstanding at end of period
498,858

 
$
46.727

 
620,553

 
$
40.741

Exercisable at end of period
319,523

 
$
31.026

 
386,176

 
$
21.214

The total estimated fair value of stock options granted during the three months ended March 31, 2019 and 2018 was computed to be approximately $43 thousand and $3.5 million, respectively. The amounts are amortized ratably over the vesting periods of the options. The weighted average estimated fair value of options granted during the three months ended March 31, 2019 and 2018 was computed to be approximately $36.18 and $26.69, respectively. The total intrinsic value of options exercised during the three months ended March 31, 2019 and 2018 was $9.9 million and $406 thousand, respectively. The cash proceeds from options exercised during the three months ended March 31, 2019 and 2018 was $84 thousand and $121 thousand, respectively.
The following table summarizes information about stock options outstanding and exercisable at March 31, 2019:
 
 
Options Outstanding
 
Options Exercisable
Exercise Prices
 
Number of
Options
Outstanding
at
March 31, 2019
 
Weighted
Average
Remaining
Contractual
Life in Years
 
Weighted
Average
Exercise
Price
 
Number of
Options
Exercisable
at
March 31, 2019
 
Weighted
Average
Exercise
Price
$ 4.50 - $ 7.36
 
101,502

 
3.65
 
$
6.807

 
101,502

 
$
6.807

$ 7.37 - $ 32.21
 
94,485

 
5.05
 
$
15.917

 
93,758

 
$
15.793

$ 32.22 - $ 62.50
 
61,104

 
6.84
 
$
39.783

 
44,672

 
$
39.693

$ 62.51 - $ 69.77
 
130,000

 
8.93
 
$
69.770

 
43,337

 
$
69.770

$ 69.78 - $ 108.25
 
111,767

 
8.20
 
$
86.020

 
36,254

 
$
81.236

$ 4.50 - $ 108.25
 
498,858

 
6.70
 
$
46.727

 
319,523

 
$
31.026

As of March 31, 2019, there was approximately $4.7 million in total unrecognized compensation cost related to outstanding stock options. That cost is expected to be recognized over a weighted average period of 1.62 years, with all cost to be recognized by the end of February 2023, assuming all options vest according to the vesting schedules in place at March 31, 2019. As of March 31, 2019, the aggregate intrinsic value of outstanding options was approximately $20.0 million and the aggregate intrinsic value of exercisable options was approximately $17.4 million.

-19-

HESKA CORPORATION AND SUBSIDIARIES
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - (Continued)


The Company issues new shares upon share option exercise, which may be netted or withheld to meet strike price or related tax obligations.
Employee Stock Purchase Plan (the "ESPP")

For the three months ended March 31, 2019 and 2018, we issued 2,583 and 3,127 shares under the ESPP, respectively.
For the three months ended March 31, 2019 and 2018, we estimated the fair values of stock purchase rights granted under the ESPP using the Black-Scholes pricing model. The weighted average assumptions used for the periods presented were as follows:
 
Three Months Ended March 31,
 
2019
 
2018
Risk-free interest rate
2.35%
 
1.03%
Expected lives
1.1 years
 
1.2 years
Expected volatility
40%
 
44%
Expected dividend yield
0%
 
0%
For the three months ended March 31, 2019 and 2018, the weighted-average fair value of the purchase rights granted was $18.97 and $14.28 per share, respectively.
Restricted Stock Issuance
We have granted non-vested restricted stock awards (“restricted stock”) to management and non-employee directors pursuant to the 1997 Plan. The restricted stock awards have varying vesting periods, but generally become fully vested between one and four years after the grant date, depending on the specific award, performance targets met for performance-based awards granted to management, and vesting periods for time based awards. Management performance-based awards are granted at the target amount of shares that may be earned. We valued the restricted stock awards related to service and/or company performance targets based on grant date fair value and expense over the period when achievement of those conditions is deemed probable. For restricted stock awards related to market conditions, we utilize a Monte Carlo simulation model to estimate grant date fair value and expense over the requisite period. We recognize forfeitures as they occur. There were no modifications that affected our accounting for restricted stock awards in the three months ended March 31, 2019 or 2018.
The following table summarizes restricted stock transactions for the three months ended March 31, 2019:
 
RSAs
 
Weighted-Average Grant Date Fair Value Per Award
Non-vested as of December 31, 2018
259,430

 
$
74.26

     Granted
117

 
77.52

     Vested
—

 
—

     Forfeited
—

 
—

Non-vested as of March 31, 2019
259,547

 
$
74.26


The weighted average grant date fair value of awards granted was $77.52 and $62.73 for the three months ended March 31, 2019 and 2018, respectively. Fair value of restricted stock vested was $0.0 and $4.2 million for the three months ended March 31, 2019 and 2018, respectively.

-20-

HESKA CORPORATION AND SUBSIDIARIES
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - (Continued)



As of March 31, 2019, there was approximately $2.5 million of total unrecognized compensation cost related to restricted stock with market and time vesting conditions. The Company expects to recognize this expense over a weighted average period of 1.4 years. As of March 31, 2019, we reviewed each of the underlying corporate performance targets and determined that approximately 167,000 of shares of common stock were related to company performance targets in which we did not deem achievement probable. No compensation expense had been recorded at any period prior to March 31, 2019.
Restrictions on the transfer of Company stock

The Company's Restated Certificate of Incorporation, as amended (the "Certificate of Incorporation"), places restrictions (the "Transfer Restrictions") on the transfer of the Company's stock that could adversely affect the Company's ability to utilize its domestic Federal Net Operating Loss Position. In particular, the Transfer Restrictions prevent the transfer of shares without the approval of the Company's Board of Directors if, as a consequence of such transfer, an individual, entity or groups of individuals or entities would become a 5-percent holder under Section 382 of the Internal Revenue Code of 1986, as amended, and the related Treasury regulations, and also prevents any existing 5-percent holder from increasing his or her ownership position in the Company without the approval of the Company's Board of Directors. Any transfer of shares in violation of the Transfer Restrictions (a "Transfer Violation") shall be void ab initio under the Certificate of Incorporation, and the Company's Board of Directors has procedures under the Certificate of Incorporation to remedy a Transfer Violation including requiring the shares causing such Transfer Violation to be sold and any profit resulting from such sale to be transferred to a charitable entity chosen by the Company's Board of Directors in specified circumstances.
13.    ACCUMULATED OTHER COMPREHENSIVE INCOME
Accumulated other comprehensive income (loss) consisted of the following (in thousands):
 
Minimum Pension Liability
 
Foreign Currency Translation
 
Total Accumulated Other Comprehensive Income
Balances at December 31, 2018
$
(419
)
 
$
696

 
$
277

Current period other comprehensive loss
—

 
(62
)
 
(62
)
Balances at March 31, 2019
$
(419
)
 
$
634

 
$
215

14.    COMMITMENTS AND CONTINGENCIES
Royalty Agreements
The Company holds certain rights to market and manufacture products developed or created under certain research, development, and licensing agreements with various entities. In connection with such agreements, the Company has agreed to pay the entities royalties on net product sales. In each of the three months ended March 31, 2019 and 2018, royalties of $0.1 million became payable under these agreements.
Warranties

The Company's current terms and conditions of sale include a limited warranty that its products and services will conform to published specifications at the time of shipment and a more extensive warranty related to certain of its products. The Company also sells a renewal warranty for certain of its products. The typical

-21-

HESKA CORPORATION AND SUBSIDIARIES
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - (Continued)


remedy for breach of warranty is to correct or replace any defective product, and if not possible or practical, the Company will accept the return of the defective product and refund the amount paid. Historically, the Company has incurred minimal warranty costs. The Company's warranty reserve was $0.2 million at both March 31, 2019 and December 31, 2018.

Litigation
From time to time, the Company may be involved in litigation relating to claims arising out of its operations. The Company records accruals for outstanding legal matters when it believes it is probable that a loss will be incurred, and the amount can be reasonably estimated.

On October 10, 2018, we reached an agreement in principle to settle the complaint that was filed against the Company by Shaun Fauley on March 12, 2015 in the U.S. District Court Northern District of Illinois alleging our transmittal of unauthorized faxes in violation of the federal Telephone Consumer Protection Act of 1991, as amended by the Junk Fax Prevention Act of 2005, as a class action (the "Fauley Complaint"). The settlement, which received the Court's approval on February 28, 2019 and was not subsequently appealed by a class member, required us to make available a total of $6.75 million to pay class members, as well as to pay attorneys' fees and expenses to legal counsel to the class. The Company recorded the loss provision in the third quarter of 2018 in connection with the settlement agreement and does not have insurance coverage for the Fauley Complaint. The payment in respect of the settlement was made in full on April 3, 2019, and all activity related to the Fauley Complaint has ceased.
As of March 31, 2019, the Company was not a party to any other legal proceedings that were expected, individually or in the aggregate, to have a material adverse effect on its business, financial condition, or operating results.

Off-Balance Sheet Commitments

Unconditional Purchase Obligations
The Company has contractual obligations with suppliers for unconditional annual minimum inventory purchases in the amounts of $12.2 million as of March 31, 2019.
15.    INTEREST AND OTHER INCOME, NET
Interest and other income, net, consisted of the following (in thousands):
 
Three Months Ended March 31,
 
2019
 
2018
Interest income
$
(92
)
 
$
(56
)
Interest expense
77

 
65

Other income, net
(1
)
 
(13
)
Total interest and other income, net
$
(16
)
 
$
(4
)
Cash paid for interest for the three months ended March 31, 2019 and 2018 was $56 thousand and $27 thousand, respectively.


-22-

HESKA CORPORATION AND SUBSIDIARIES
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - (Continued)


16.    CREDIT FACILITY

On July 27, 2017, and subsequently amended in May and December 2018, we entered into a Credit Agreement (the "Credit Agreement") with JPMorgan Chase Bank, N.A. ("Chase") which provides for a revolving credit facility up to $30.0 million (the "Credit Facility"). The Credit Facility provides us with the ability to borrow up to $30.0 million although the amount of the Credit Facility may be increased by an additional $20.0 million up to a total of $50.0 million subject to receipt of additional lender commitments and other conditions. Any interest on borrowings due is to be charged at either the (i) rate of interest per annum publicly announced from time to time by Chase as its prime rate in effect at its principal offices in New York City, subject to a floor, minus 1.65%, or (ii) the interest rate per annum equal to (a) LIBOR for the interest period in effect multiplied by (b) Chase's Statutory Reserve Rate (as defined in the Credit Agreement), plus 1.10% and payable monthly. There is an annual minimum interest charge of $60 thousand under the Credit Agreement. Chase holds first right of priority over all other liens, if any were to exist. Borrowings under the Credit Facility are subject to certain financial and non-financial covenants and are available for various corporate purposes, including general working capital, capital investments, and certain permitted acquisitions. Failure to comply with any of the covenants, representations or warranties could result in our being in default on the loan and could cause all outstanding amounts payable to Chase to become immediately due and payable or impact our ability to borrow under the agreement. The Credit Agreement also permits us to issue letters of credit, although there are currently none outstanding. The maturity date of the Credit Facility is July 27, 2020. The foregoing discussion of the Credit Facility is a summary only and is qualified in its entirety by reference to the full text of the Credit Agreement, a copy of which has been filed as an exhibit to the Company's Current Report on Form 8-K filed with the SEC on August 2, 2017, and the Facility Amendment, a copy of which has been filed as an exhibit to the Company's Current Report on Form 10-Q filed with the SEC on August 8, 2018, each of which are incorporated herein by reference.

At March 31, 2019, we had a $6.0 million line of credit outstanding under the Credit Facility and we were in compliance with all financial covenants. In April 2019, we used this Credit Facility to make a $6.75 million payment to settle all claims associated with the Fauley Complaint that is further discussed in Note 14 of this Form 10-Q.


17.    SEGMENT REPORTING
The Company is composed of two reportable segments, CCA and OVP. The CCA segment includes Point of Care diagnostic laboratory instruments and consumables, and Point of Care digital imaging diagnostic instruments and software services as well as single use diagnostic and other tests, pharmaceuticals and vaccines, primarily for canine and feline use. These products are sold directly by the Company as well as through independent third-party distributors and through other distribution relationships. CCA segment products manufactured at the Des Moines, Iowa production facility included in the OVP segment's assets are transferred at cost and are not recorded as revenue for the OVP segment. The OVP segment includes private label vaccine and pharmaceutical production, primarily for cattle, but also for other animals including small mammals. All OVP products are sold by third parties under third-party labels.


-23-

HESKA CORPORATION AND SUBSIDIARIES
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - (Continued)


Summarized financial information concerning the Company's reportable segments is shown in the following tables (in thousands):
Three Months Ended March 31, 2019
 
Core
Companion
Animal
 
Other Vaccines and Pharmaceuticals
 
 
 
Total
Total revenue
 
$
24,716

 
$
4,795

 
$
29,511

Operating loss
 
(51
)
 
(24
)
 
(75
)
Loss before income taxes
 
(35
)
 
(24
)
 
(59
)
Capital expenditures
 
44

 
190

 
234

Depreciation and amortization
 
947

 
318

 
1,265

Three Months Ended March 31, 2018
 
Core
Companion
Animal
 
Other Vaccines and Pharmaceuticals
 
 
 
Total
Total revenue
 
$
26,819

 
$
5,946

 
$
32,765

Operating income (loss)
 
1,923

 
(52
)
 
1,871

Income (loss) before income taxes
 
1,927

 
(52
)
 
1,875

Capital expenditures
 
57

 
318

 
375

Depreciation and amortization
 
908

 
288

 
1,196


Asset information by reportable segment as of March 31, 2019 is as follows (in thousands):
Three Months Ended March 31, 2019
 
Core
Companion
Animal
 
Other Vaccines and Pharmaceuticals
 
Total
Investments in unconsolidated affiliates
 
$
7,837

 
$
—

 
$
7,837

Total assets
 
138,076

 
24,704

 
162,780

Net assets
 
95,683

 
26,256

 
121,939


Asset information by reportable segment as of December 31, 2018 is as follows (in thousands):
Year Ended December 31, 2018
 
Core
Companion
Animal
 
Other Vaccines and Pharmaceuticals
 
Total
Investments in unconsolidated affiliates
 
$
8,018

 
$
—

 
$
8,018

Total assets
 
133,586

 
22,866

 
156,452

Net assets
 
96,129

 
26,280

 
122,409



-24-



Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
The following discussion and analysis of our financial condition and results of operations should be read in conjunction with the unaudited Condensed Consolidated Financial Statements and related Notes included in Part I Item 1 of this Form 10-Q.
This discussion contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Rule 175 promulgated thereunder, that involve risks and uncertainties. Such statements, which include statements concerning future revenue sources and concentration, international market expansion, gross profit margins, selling and marketing expenses, remaining minimum performance obligations, research and development expenses, general and administrative expenses, capital resources, additional financings or borrowings and additional losses, are subject to risks and uncertainties, including, but not limited to, those discussed in "Risk Factors" in Item 1A in Part I of our Annual Report on Form 10-K for the year ended December 31, 2018 that could cause actual results to differ materially from those projected. The Risk Factors and others described in the Company’s periodic and current reports filed with the SEC from time to time are not necessarily all of the important factors that could cause the Company’s actual results to differ materially from those projected. Other unknown or unpredictable factors could also harm the Company’s results. The forward-looking statements set forth in this Form 10-Q are as of the close of business on May 7, 2019 and we undertake no duty and do not intend to update this information, except as required by applicable laws. If we updated one or more forward looking statements, no inference should be drawn that we will make additional updates with respect to those or other forward-looking statements. All forward-looking statements attributable to us or persons acting on our behalf are expressly qualified in their entirety by the cautionary statements set forth above.
Overview
We sell advanced veterinary diagnostic and specialty products. Our offerings include Point of Care laboratory instruments and consumables, Point of Care digital imaging diagnostic products; vaccines; local and cloud-based data services; allergy testing and immunotherapy; and single-use offerings such as in-clinic diagnostic tests and heartworm preventive products. Our core focus is on supporting veterinarians in the canine and feline healthcare space.
Our business is composed of two reportable segments, CCA and OVP. The CCA segment includes, primarily for canine and feline use, Point of Care laboratory instruments and consumables; digital imaging diagnostic instruments, software and services; local and cloud-based data services; allergy testing and immunotherapy; and single use offerings such as in-clinic diagnostic tests and heartworm preventive products. The OVP segment includes private label vaccine and pharmaceutical production, primarily for cattle but also for other species including equine, porcine, avian, feline and canine. OVP products are sold by third parties under third party labels.
The CCA segment represented approximately 85% of our revenue for the three months ended March 31, 2019, and the OVP segment represented approximately 15% of our revenue for the three months ended March 31, 2019.
CCA Segment
Revenue from Point of Care laboratory represented 64.6% of CCA revenue for the three months ended March 31, 2019. Revenue from this area primarily involves placing an instrument under contract in the field and generating future revenue from testing consumables, such as cartridges and reagents, as that instrument is used. The majority of revenue from Point of Care laboratory results from the sales of such testing consumables to an installed base of instruments, followed by instrument sales and other revenue sources such

-25-



as service and repairs. Instruments placed under subscription agreements are considered operating or sales-type leases, depending on the duration and other factors of the underlying agreement. A loss of, or disruption in, the procurement of consumables we are selling to an installed base of instruments could substantially harm our business. All of our Point of Care laboratory and other non-imaging instruments and consumables are supplied by third parties, who typically own the product rights and supply the product to us under marketing and/or distribution agreements. In many cases, we have collaborated with a third party to adapt a human instrument for veterinary use. Major products in this area include our instruments for chemistry, hematology, blood gas, coagulation and immunodiagnostic testing and their affiliated operating consumables.
Point of Care imaging hardware, software and services represented 21.9% of CCA revenue for the three months ended March 31, 2019. Digital radiography is the largest product offering in this area, which also includes ultrasound and endoscopy instruments. Digital radiography solutions typically consist of a combination of hardware and software placed with a customer, often combined with an ongoing service and support contract. We sell our imaging solutions both in the U.S. and internationally. Our experience has been that most of the revenue is generated at the time of sale in this area, in contrast to the Point of Care diagnostic laboratory placements discussed above where ongoing consumable revenue is often a larger component of economic value as a given instrument is used.
Other CCA revenue, including single use diagnostic and other tests, pharmaceuticals and biologicals as well as research and development, licensing and royalty revenue, represented 13.5% of CCA revenue for the three months ended March 31, 2019. Since items in this area are often single use by their nature, our typical aim is to build customer satisfaction and loyalty for each product, generate repeat annual sales from existing customers and expand our customer base in the future. Products in this area are both supplied by third parties and provided by us. Major products and services in this area include heartworm diagnostic tests and preventives, and allergy test kits, allergy immunotherapy and testing.
We consider the CCA segment to be our core business and devote most of our management time and other resources to improving the prospects for this segment. Maintaining a continuing, reliable and economic supply of products we currently obtain from third parties is critical to our success in this area. Virtually all of our sales and marketing expenses occur in the CCA segment. The majority of our research and development spending is dedicated to this segment as well.
All of our CCA products are ultimately sold primarily to or through veterinarians. In many cases, veterinarians will mark up their costs to their customer. The acceptance of our products by veterinarians is critical to our success. CCA products are sold directly to end users by us as well as through distribution relationships, such as the sale of kits to conduct blood testing to third-party veterinary diagnostic laboratories and sales to independent third-party distributors. Revenue from direct sales and distribution relationships represented approximately 70% and 30%, respectively, of CCA revenue for the three months ended March 31, 2019.
OVP Segment
The OVP segment includes our approximately 160,000 square foot USDA and FDA licensed production facility in Des Moines, Iowa. We view this facility as an asset which could allow us to control our cost of goods on any pharmaceuticals and vaccines that we may commercialize in the future. We have increased integration of this facility with our operations elsewhere. For example, virtually all our U.S. inventory, excluding our imaging products, is now stored at this facility and related fulfillment logistics are managed there. CCA segment products manufactured at this facility are transferred at cost and are not recorded as revenue for our OVP segment. We view OVP reported revenue as revenue primarily to cover the overhead costs of the facility and to generate incremental cash flow to fund our CCA segment.

-26-



Historically, a significant portion of our OVP segment's revenue has been generated from the sale of certain bovine vaccines, which have been sold primarily under the Titanium® and MasterGuard® brands. We have an agreement with Eli Lilly and Company and its affiliates operating through Elanco for the production of these vaccines (the "Elanco Agreement"). Our OVP segment also produces vaccines and pharmaceuticals for other third parties.
Results of Operations
Our analysis presented below is organized to provide the information we believe will facilitate an understanding of our historical performance and relevant trends going forward.
The following tables set forth, for the periods indicated, certain data derived from our unaudited Condensed Consolidated Statements of Income (in thousands):
 
Three Months Ended March 31,
 
2019
 
2018
Revenue
$
29,511

 
$
32,765

Gross profit
12,543

 
13,307

Operating expenses
12,618

 
11,436

Operating (loss) income
(75
)
 
1,871

Interest and other income, net
(16
)
 
(4
)
(Loss) income before income taxes and equity in losses of unconsolidated affiliates
(59
)
 
1,875

Income tax benefit
(1,010
)
 
(280
)
Net income before equity in losses of unconsolidated affiliates
951

 
2,155

Equity in losses of unconsolidated affiliates
(181
)
 
—

Net income after equity in losses of unconsolidated affiliates
770

 
2,155

Net loss attributable to redeemable non-controlling interest
(44
)
 
—

Net income attributable to Heska Corporation
$
814

 
$
2,155


CCA Segment
 
Three Months Ended March 31,
 
Change
 
2019
 
2018
 
Dollar
 Change
 
%
 Change
Point of Care laboratory:
$
15,961

 
$
13,641

 
$
2,320

 
17.0
 %
      Consumables
12,317

 
10,821

 
1,496

 
13.8
 %
      Instruments
3,270

 
2,349

 
921

 
39.2
 %
      Other
374

 
471

 
(97
)
 
(20.6
)%
Point of Care imaging
5,410

 
5,972

 
(562
)
 
(9.4
)%
Other CCA revenue
3,345

 
7,206

 
(3,861
)
 
(53.6
)%
Total CCA revenue
$
24,716

 
$
26,819

 
$
(2,103
)
 
(7.8
)%
Percent of total revenue
83.8
%
 
81.9
%
 
 
 
 
Cost of revenue
12,622

 
14,069

 
(1,447
)
 
(10.3
)%
Gross profit
12,094

 
12,750

 
(656
)
 
(5.1
)%
Operating (loss) income
$
(51
)
 
$
1,923

 
$
(1,974
)
 
(102.7
)%

-27-




OVP Segment
 
Three Months Ended March 31,
 
Change
 
2019
 
2018
 
Dollar
 Change
 
%
 Change
Revenue
$
4,795

 
$
5,946

 
$
(1,151
)
 
(19.4
)%
Percent of total revenue
16.2
%
 
18.1
%
 
 
 
 
Cost of revenue
4,346

 
5,389

 
(1,043
)
 
(19.4
)%
Gross profit
449

 
557

 
(108
)
 
(19.4
)%
Operating loss
$
(24
)
 
$
(52
)
 
$
28

 
(53.8
)%
Revenue
Total revenue decreased 9.9% to $29.5 million in the three months ended March 31, 2019, compared to $32.8 million in the three months ended March 31, 2018.
CCA segment revenue decreased 7.8% to $24.7 million in the three months ended March 31, 2019, compared to $26.8 million in the three months ended March 31, 2018. The $2.1 million decrease was primarily driven by a $3.8 million decrease in contract manufactured heartworm preventative, Tri-Heart, revenue as a result of reduced customer demand. Additionally, Point of Care imaging contributed less revenue in the current quarter of $0.6 million. Offsetting these decreases were strong Point of Care laboratory consumables revenue increases of $1.5 million and an increase in instrument and other revenue of approximately $0.4 million, mostly driven by revenue resulting from sales-type lease placements. Also offsetting the decreases was higher levels of non-core, lower margin infusion pump sales of approximately $0.4 million in current period as compared to the prior year period.
OVP segment revenue decreased 19.4% to $4.8 million in the three months ended March 31, 2019, compared to $5.9 million in the three months ended March 31, 2018. The decrease is due to decreased volume of sales under our Elanco Agreement as well as other customer contracts.
Gross Profit
Gross profit decreased 5.7% to $12.5 million in the three months ended March 31, 2019, compared to $13.3 million in the three months ended March 31, 2018. Gross margin increased to 42.5% in the three months ended March 31, 2019 compared to 40.6% in the three months ended March 31, 2018. The decrease in gross profit was mainly driven by our lower Tri-Heart sales while the improvement in gross margin was related to favorable margins in Point of Care laboratory and imaging products.
Operating Expenses
Selling and marketing expenses increased 14.5% to $7.0 million in the three months ended March 31, 2019, compared to $6.1 million in the three months ended March 31, 2018. The increase was primarily driven by an increase in compensation, including stock-based compensation, benefits, and commissions expense, which is mostly related to our commercial team expansion. The increase is in line with management expectations as we continue to invest in the future growth of the Company.
Research and development expenses increased 103.9% to $1.4 million in the three months ended March 31, 2019, compared to $0.7 million in the three months ended March 31, 2018. The increase was primarily driven by spending on product development for urine and fecal diagnostics and enhanced immunodiagnostic

-28-



offerings. As we invest in future growth of the Company, the increased research and development expenses are consistent with managements spending initiatives.
General and administrative expenses decreased 8.8% to $4.2 million in the three months ended March 31, 2019, compared to $4.6 million in the three months ended March 31, 2018. The decrease was driven primarily by $0.2 million lower compensation cost as a result of prior year severance activities that were completed. Additionally, the period ended March 31, 2019 included $0.2 million less of corporate expenses.
Interest and Other Expense (Income), net
Interest and other expense (income), net, was $(16) thousand in the three months ended March 31, 2019, compared to $(4) thousand in the three months ended March 31, 2018. This increase in other income was driven primarily by an increase in other interest income, offset by foreign exchange losses related to our international expansion.
Income Tax Expense (Benefit)
In the three months ended March 31, 2019, we had a total income tax benefit of $1.0 million, including $1.1 million of domestic deferred income tax benefit and $45 thousand current income tax expense. In the three months ended March 31, 2018, we had a total income tax benefit of $0.3 million, including $0.3 million of domestic deferred income tax benefit and $17 thousand of current income tax expense. The increase in tax benefits is primarily due to an increase in stock-based compensation excess tax benefits recognized in our income statement. In the three months ended March 31, 2019, the Company recognized $1.1 million in excess tax benefits compared to $0.8 million recognized in the three months ended March 31, 2018.
Net Income Attributable to Heska Corporation
Net income attributable to Heska was $0.8 million for the three months ended March 31, 2019, compared to net income attributable to Heska of $2.2 million in the prior year period. The difference between this line item and "Net income after equity in losses of unconsolidated affiliates" is the net income or loss attributable to our minority interest in our French subsidiary, which we purchased in February 2019. Net income is lower in the three months ended March 31, 2019 as compared to the three months ended March 31, 2018 due to lower revenues and increased operating expenses as a result of our future growth initiatives.
Impact of Inflation
In recent years, inflation has not had a significant impact on our operations.

Liquidity, Capital Resources and Financial Condition
We believe that adequate liquidity and cash generation is important to the execution of our strategic initiatives. Our ability to fund our operations, acquisitions, capital expenditures, and product development efforts may depend on our ability to generate cash from operating activities, which is subject to future operating performance, as well as general economic, financial, competitive, legislative, regulatory, and other conditions, some of which may be beyond our control. Our primary sources of liquidity are our available cash, cash generated from current operations and availability under our credit facility noted below.

For the three months ended March 31, 2019, we had net income attributable to Heska Corporation of $0.8 million and net cash provided by operations of $0.7 million. At March 31, 2019, we had $9.1 million of cash and cash equivalents and working capital of $37.7 million.

-29-



On July 27, 2017, and subsequently amended in May and December of 2018, we entered into a Credit Agreement (the "Credit Agreement") with JPMorgan Chase Bank, N.A. ("Chase") which provides for a revolving credit facility up to $30.0 million (the "Credit Facility"). The Credit Facility provides us with the ability to borrow up to $30.0 million, although the amount of the Credit Facility may be increased by an additional $20.0 million up to a total of $50.0 million subject to receipt of additional lender commitments and other conditions. Any interest on borrowings due is to be charged at either the (i) rate of interest per annum publicly announced from time to time by Chase as its prime rate in effect at its principal offices in New York City, subject to a floor, minus 1.65%, or (ii) the interest rate per annum equal to (a) LIBOR for the interest period in effect multiplied by (b) Chase's Statutory Reserve Rate (as defined in the Credit Agreement), plus 1.10% and payable monthly. There is an annual minimum interest charge of $60 thousand under the Credit Agreement. Chase holds first right of priority over all other liens, if any were to exist. Borrowings under the Credit Facility are subject to certain financial and non-financial covenants and are available for various corporate purposes, including general working capital, capital investments, and certain permitted acquisitions. Failure to comply with any of the covenants, representations or warranties could result in our being in default on the loan and could cause all outstanding amounts payable to Chase to become immediately due and payable or impact our ability to borrow under the agreement. The Credit Agreement also permits us to issue letters of credit, although there are currently none outstanding. The maturity date of the Credit Facility is July 27, 2020. The foregoing discussion of the Credit Facility is a summary only and is qualified in its entirety by reference to the full text of the Credit Agreement, a copy of which has been filed as an exhibit to the Company's Current Report on Form 8-K filed with the SEC on August 2, 2017, and the Facility Amendment, a copy of which has been filed as an exhibit to the Company's Current Report on Form 10-Q filed with the SEC on August 8, 2018, each of which are incorporated herein by reference.
At March 31, 2019, we had a $6.0 million line of credit outstanding under the Credit Facility and were in compliance with all financial covenants. We used a portion of the funds then available under this Credit Facility to pay in full in April 2019 the amount required to be paid by the Company in respect of the settlement of the Fauley Complaint discussed in further detail under Note 14 - Commitments and Contingencies in our Condensed Consolidated Financial Statements included in Item 1 of this Form 10-Q.
A summary of our cash from operating, investing and financing activities is as follows (in thousands):
 
Three Months Ended March 31,
 
Change
 
2019
 
2018
 
Dollar
Change
 
%
Change
Net cash provided by operating activities
$
727

 
$
4,207

 
$
(3,480
)
 
(82.7
)%
Net cash used in investing activities
(458
)
 
(375
)
 
(83
)
 
22.1
 %
Net cash used in financing activities
(4,556
)
 
(1,409
)
 
(3,147
)
 
223.3
 %
Effect of currency translation on cash
(1
)
 
44

 
(45
)
 
(102.3
)%
(Decrease) increase in cash and cash equivalents
(4,288
)
 
2,467

 
(6,755
)
 
(273.8
)%
Cash and cash equivalents, beginning of the period
13,389

 
9,659

 
3,730

 
38.6
 %
Cash and cash equivalents, end of the period
$
9,101

 
$
12,126

 
$
(3,025
)
 
(24.9
)%
Net cash provided by operating activities was $0.7 million in the three months ended March 31, 2019, compared to net cash provided by operating activities of $4.2 million in the three months ended March 31, 2018, a decrease of approximately $3.5 million. Net cash provided by operating activities decreased due to significant working capital fluctuations such as cash used by inventory purchases of $3.1 million related to timing of purchases and lower sales; cash provided by accounts payable of $3.2 million; a $2.9 million increase in cash used by accrued liabilities, and a $1.3 million change in cash provided by deferred revenue

-30-



and other liabilities. Non-cash transactions had relatively no impact to cash provided by operating activities as the $0.8 million increase in our deferred tax benefit was offset by the $0.4 million impact of adopting ASC 842, Leases and a $0.1 million impact from increased stock-based compensation expense. In addition to these factors cash provided by operating activities was $1.4 million less in the current period due to decreased revenue in the quarter ended March 31, 2019 versus the quarter ended March 31, 2018.
Net cash used in investing activities was $0.5 million in the three months ended March 31, 2019, compared to net cash used in investing activities of $0.4 million in the three months ended March 31, 2018, an increase of approximately $0.1 million. The increase in cash used for investing activities was mainly driven by the $0.2 million acquisition in France.
Net cash used in financing activities was $4.6 million in the three months ended March 31, 2019, compared to net cash used in financing activities of $1.4 million in the three months ended March 31, 2018, an increase of approximately $3.1 million. The change was driven primarily by a $1.9 million use of cash related to the repurchase of common stock and a $1.5 million use of cash relating to debt repayments as part of the acquisition in France.
Our financial plan for 2019, including selling and marketing team expansion and product development initiatives, indicates that our available cash and cash equivalents, together with cash from operations and borrowings expected to be available under our Credit Facility, will be sufficient to fund our operations for the foreseeable future. Additionally, we are actively seeking acquisitions that are consistent with our strategic direction, which may require additional capital. Our actual results may differ from this plan and we may be required to consider alternative strategies. We may be required to raise additional capital in the future, even in the absence of any acquisitions. If necessary, we expect to raise these additional funds through the sale of equity securities or the issuance of debt. There is no guarantee that additional capital will be available from these sources on acceptable terms, if at all, and certain of these sources may require approval by existing lenders. See "Risk Factors" in Item 1A in Part I of our Annual Report on Form 10-K for the year ended December 31, 2018 for a discussion of some of the factors that affect our capital raising alternatives.

Effect of currency translation on cash
Net effect of foreign currency translations on cash changed $45 thousand to a $1 thousand negative impact in the three months ended March 31, 2019, compared to a $44 thousand positive impact in the three months ended March 31, 2018. These effects are related to changes in exchange rates of our foreign subsidiaries functional currencies and the U.S. dollar, the functional and reporting currency of Heska Corporation. Our foreign subsidiaries primary currencies are the Swiss Franc, Euro, Canadian dollar and Australian dollar.
Off-Balance Sheet Arrangements and Contractual Obligations
The Company has not entered into any transactions with unconsolidated entities whereby the Company has financial guarantees, subordinated retained interests, derivative instruments, or other contingent arrangements that expose the Company to material continuing risks, contingent liabilities, or any other obligation under a variable interest in an unconsolidated entity that provided financing, liquidity, market risk or credit risk support to the Company, or engages in leasing, hedging or research and development services with the Company.
Purchase Obligations
Purchase obligations represent contractual agreements to purchase goods or services that are legally binding; specify a fixed, minimum or range of quantities; specify a fixed, minimum, variable, or indexed price provision; and specify approximate timing of the transaction. As of March 31, 2019, the Company had

-31-



purchase obligations for inventory of $12.2 million and an approximate commitment of $1.0 million to purchase real estate from Optomed's minority interest holder within six months of the acquisition of the French company.
Critical Accounting Policies and Estimates
Our accounting policies are described in our audited Consolidated Financial Statements and Notes thereto contained in our Annual Report on Form 10-K for the year ended December 31, 2018 and other than the recently adopted accounting pronouncements described in Note 1 - Operations and Summary of Significant Accounting Policies in our Condensed Consolidated Financial Statements included in Item 1 of this Form 10-Q, have not changed significantly since such filing.

Item 3. Quantitative and Qualitative Disclosures about Market Risk

For quantitative and qualitative disclosures about market risk affecting us, see the section under the heading “Part II, Item 7A. Quantitative and Qualitative Disclosures About Market Risk” of our Annual Report on Form 10-K for the year ended December 31, 2018, which is incorporated by reference herein. As of the date of this Quarterly Report on Form 10-Q, there have been no material changes to the market risks described in our Annual Report on Form 10-K for the year ended December 31, 2018.
Item 4. Controls and Procedures
Evaluation of Disclosure Controls and Procedures
Our management, with the participation of our principal executive officer and our principal financial officer, evaluated the effectiveness of our disclosure controls and procedures, as defined by Rule 13a-15(e) of the Exchange Act, as of the end of the period covered by this Quarterly Report on Form 10-Q. Based on this evaluation, our principal executive officer and principal financial officer have concluded that our disclosure controls and procedures were effective to provide reasonable assurance that information we are required to disclose in reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC's rules and forms and that such information is accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate, to allow timely decisions regarding required disclosure.
Changes in Internal Control over Financial Reporting
There was no change in our internal control over financial reporting that occurred since our last fiscal year-end that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.


PART II. OTHER INFORMATION
Item 1.    Legal Proceedings
The information required by this item is incorporated by reference to Note 14 (Commitments and Contingencies) to the unaudited Condensed Consolidated Financial Statements included in Part 1, Item 1 of this Form 10-Q.

-32-



Item 1A.Risk Factors

For a discussion of our risk factors, see Item 1A. Risk Factors in Part I of our Annual Report on Form 10-K for the year ended December 31, 2018, which is incorporated herein by reference.
Item 2.    Unregistered Sales of Equity Securities and Use of Proceeds
The following table sets forth information about our purchases of our outstanding Public Common Stock during the quarter ended March 31, 2019.
Period
 
Total Number of Shares Purchased (1)
 
Average Price Paid per Share (1)
 
Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs
 
Approximate Dollar Value of Shares that May Yet be Purchased Under Plans or Programs
January 2019
 
16,243

 
$
97.66

 
—

 
$
—

February 2019
 
17,737

 
$
98.17

 
—

 
$
—

 
 
33,980

 
$
97.92

 
—

 
$
—

 
 
 
 
 
 
 
 
 
 (1) Shares of Public Common Stock we purchased between January 1, 2019 and March 31, 2019 were solely for the cancellation of shares of stock withheld for related tax obligations

Item 6.        Exhibits

 
Exhibit Number
 
 
Notes
 
 
Description of Document
 
 
 
 
Certification of Chief Executive Officer Pursuant to Rule 13a-14(a) and Rule 15d-14(a) of the Securities Exchange Act of 1934, as amended.
 
 
 
 
Certification of Chief Financial Officer Pursuant to Rule 13a-14(a) and Rule 15d-14(a) of the Securities Exchange Act of 1934, as amended.
 
 
*
 
Certification of Chief Executive Officer and Chief Financial Officer Pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
 
101.INS
 
 
 
XBRL Instance Document.
 
101.SCH
 
 
 
XBRL Taxonomy Extension Schema Document.
 
101.CAL
 
 
 
XBRL Taxonomy Extension Calculation Linkbase Document.
 
101.DEF
 
 
 
XBRL Taxonomy Extension Definition Linkbase Document.
 
101.PRE
 
 
 
XBRL Taxonomy Extension Presentation Linkbase Document.
 
101.LAB
 
 
 
XBRL Taxonomy Extension Label Linkbase Document.
Notes
 
*
Furnished and not filed herewith.



-33-



SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized on May 8, 2019.
 
 
HESKA CORPORATION
 
 
 
By:  /s/ KEVIN S. WILSON  
Kevin S. Wilson
Chief Executive Officer and President
(Principal Executive Officer)
 
By:  /s/ CATHERINE GRASSMAN                              
Catherine Grassman
Executive Vice President, Chief Financial Officer
(Principal Financial and Accounting Officer)
 

 


-34-
 EX-31.1 2 heska-03312019xex31x1.htm EXHIBIT 31.1 Exhibit
Exhibit 31.1
 
 
CERTIFICATION
 
I, Kevin S. Wilson, certify that:
 
1.
I have reviewed this quarterly report on Form 10-Q of Heska Corporation;
2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.
The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal controls over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a.
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b.
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; and
c.
Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d.
Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
5.
The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
a.
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
b.
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.
 
 
Dated: May 8, 2019
/s/ Kevin S. Wilson
 
KEVIN S. WILSON
 
Chief Executive Officer and President
 
(Principal Executive Officer)


 EX-31.2 3 heska-03312019xexx31x2.htm EXHIBIT 31.2 Exhibit
Exhibit 31.2
 
CERTIFICATION
 
I, Catherine Grassman, certify that:

1.
I have reviewed this quarterly report on Form 10-Q of Heska Corporation;
2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.
The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal controls over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a.
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b.
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; and
c.
Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d.
Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
5.
The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
a.
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
b.
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.
 
 
 
Dated: May 8, 2019
/s/ Catherine Grassman
 
CATHERINE GRASSMAN
 
Executive Vice President, Chief Financial Officer
 
(Principal Financial Officer)




 EX-32.1 4 heska-03312019xex32x1.htm EXHIBIT 32.1 Exhibit
Exhibit 32.1
 
CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER
PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
 
I, Kevin S. Wilson, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Quarterly Report of Heska Corporation on Form 10-Q for the quarter ended March 31, 2019 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that information contained in such Form 10-Q fairly presents in all material respects the financial condition and results of operations of Heska Corporation, to the best of my knowledge.
 

Dated: May 8, 2019
By:
/s/ Kevin S. Wilson
 
Name:
KEVIN S. WILSON
 
Title:
Chief Executive Officer and President
 
 
I, Catherine Grassman, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Quarterly Report of Heska Corporation on Form 10-Q for the quarter ended March 31, 2019 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that information contained in such Form 10-Q fairly presents in all material respects the financial condition and results of operations of Heska Corporation, to the best of my knowledge.
 
Dated: May 8, 2019
By:
/s/ Catherine Grassman
 
Name:
CATHERINE GRASSMAN
 
Title:
Executive Vice President, Chief Financial Officer
 
A signed original of this written statement required by Section 906 has been provided to Heska Corporation and will be retained by Heska Corporation and furnished to the Securities and Exchange Commission or its staff upon request.


 EX-101.INS 5 hska-20190331.xml XBRL INSTANCE DOCUMENT 0001038133 2019-01-01 2019-03-31 0001038133 2019-05-07 0001038133 2018-12-31 0001038133 2019-03-31 0001038133 us-gaap:CommonStockMember 2018-12-31 0001038133 us-gaap:CommonStockMember 2019-03-31 0001038133 hska:PublicCommonStockMember 2018-12-31 0001038133 hska:PublicCommonStockMember 2019-03-31 0001038133 2018-01-01 2018-03-31 0001038133 hska:OtherVaccinesPharmaceuticalsAndProductsMember 2019-01-01 2019-03-31 0001038133 hska:CoreCompanionAnimalHealthMember 2019-01-01 2019-03-31 0001038133 hska:CoreCompanionAnimalHealthMember 2018-01-01 2018-03-31 0001038133 hska:OtherVaccinesPharmaceuticalsAndProductsMember 2018-01-01 2018-03-31 0001038133 hska:CommonStockPreferredStockAndPublicStockMember 2018-12-31 0001038133 us-gaap:RetainedEarningsMember 2017-12-31 0001038133 hska:CommonStockPreferredStockAndPublicStockMember 2017-12-31 0001038133 srt:ScenarioPreviouslyReportedMember hska:CommonStockPreferredStockAndPublicStockMember 2017-12-31 0001038133 us-gaap:AdditionalPaidInCapitalMember 2018-01-01 2018-03-31 0001038133 us-gaap:AdditionalPaidInCapitalMember 2019-03-31 0001038133 us-gaap:ComprehensiveIncomeMember 2019-03-31 0001038133 hska:CommonStockPreferredStockAndPublicStockMember 2019-01-01 2019-03-31 0001038133 srt:ScenarioPreviouslyReportedMember us-gaap:AdditionalPaidInCapitalMember 2017-12-31 0001038133 us-gaap:ComprehensiveIncomeMember 2019-01-01 2019-03-31 0001038133 us-gaap:RetainedEarningsMember 2018-03-31 0001038133 us-gaap:AdditionalPaidInCapitalMember 2017-12-31 0001038133 us-gaap:ComprehensiveIncomeMember 2018-01-01 2018-03-31 0001038133 us-gaap:RetainedEarningsMember 2019-01-01 2019-03-31 0001038133 hska:CommonStockPreferredStockAndPublicStockMember 2018-03-31 0001038133 us-gaap:RetainedEarningsMember 2018-01-01 2018-03-31 0001038133 hska:CommonStockPreferredStockAndPublicStockMember 2019-03-31 0001038133 us-gaap:RetainedEarningsMember 2018-12-31 0001038133 2017-12-31 0001038133 us-gaap:RetainedEarningsMember 2019-03-31 0001038133 hska:CommonStockPreferredStockAndPublicStockMember 2018-01-01 2018-03-31 0001038133 srt:ScenarioPreviouslyReportedMember 2017-12-31 0001038133 srt:ScenarioPreviouslyReportedMember us-gaap:ComprehensiveIncomeMember 2017-12-31 0001038133 2018-03-31 0001038133 us-gaap:AdditionalPaidInCapitalMember 2018-03-31 0001038133 us-gaap:AdditionalPaidInCapitalMember 2019-01-01 2019-03-31 0001038133 us-gaap:AdditionalPaidInCapitalMember 2018-12-31 0001038133 us-gaap:ComprehensiveIncomeMember 2018-03-31 0001038133 us-gaap:ComprehensiveIncomeMember 2017-12-31 0001038133 us-gaap:ComprehensiveIncomeMember 2018-12-31 0001038133 srt:ScenarioPreviouslyReportedMember us-gaap:RetainedEarningsMember 2017-12-31 0001038133 us-gaap:AccountingStandardsUpdate201602Member 2019-01-01 0001038133 hska:LicenseResearchAndDevelopmentMember 2018-01-01 2018-03-31 0001038133 hska:ContractManufacturingContractsMember 2019-01-01 2019-03-31 0001038133 hska:LicenseResearchAndDevelopmentMember 2019-01-01 2019-03-31 0001038133 hska:ContractManufacturingContractsMember 2018-01-01 2018-03-31 0001038133 2022-01-01 2019-03-31 0001038133 2020-01-01 2019-03-31 0001038133 2024-01-01 2019-03-31 0001038133 2019-04-01 2019-03-31 0001038133 2021-01-01 2019-03-31 0001038133 2023-01-01 2019-03-31 0001038133 hska:PointOfCareLaboratoryRevenueSalesTypeLeasesMember 2018-01-01 2018-03-31 0001038133 hska:PointOfCareLaboratoryRevenueMember 2019-01-01 2019-03-31 0001038133 hska:PointOfCareLaboratoryRevenueConsumablesMember 2018-01-01 2018-03-31 0001038133 hska:PointOfCareImagingRevenueServiceRevenueMember 2019-01-01 2019-03-31 0001038133 hska:PointOfCareLaboratoryRevenueOutrightInstrumentSalesMember 2019-01-01 2019-03-31 0001038133 hska:PointOfCareLaboratoryRevenueOutrightInstrumentSalesMember 2018-01-01 2018-03-31 0001038133 hska:PointOfCareImagingRevenueOperatingTypeLeasesMember 2019-01-01 2019-03-31 0001038133 hska:OtherRevenueOtherPharmaceuticalsVaccinesAndDiagnosticTestsMember 2018-01-01 2018-03-31 0001038133 hska:OtherRevenueMember 2019-01-01 2019-03-31 0001038133 hska:PointOfCareImagingRevenueMember 2018-01-01 2018-03-31 0001038133 hska:PointOfCareImagingRevenueMember 2019-01-01 2019-03-31 0001038133 hska:PointOfCareLaboratoryRevenueConsumablesMember 2019-01-01 2019-03-31 0001038133 hska:PointOfCareImagingRevenueOutrightInstrumentSalesMember 2019-01-01 2019-03-31 0001038133 hska:PointOfCareImagingRevenueOperatingTypeLeasesMember 2018-01-01 2018-03-31 0001038133 hska:OtherRevenueMember 2018-01-01 2018-03-31 0001038133 hska:PointOfCareLaboratoryRevenueMember 2018-01-01 2018-03-31 0001038133 hska:OtherRevenueResearchAndDevelopmentLicenseAndRoyaltyRevenueMember 2018-01-01 2018-03-31 0001038133 hska:PointOfCareLaboratoryRevenueSalesTypeLeasesMember 2019-01-01 2019-03-31 0001038133 hska:PointOfCareLaboratoryRevenueOtherMember 2018-01-01 2018-03-31 0001038133 hska:PointOfCareLaboratoryRevenueOtherMember 2019-01-01 2019-03-31 0001038133 hska:PointOfCareImagingRevenueOutrightInstrumentSalesMember 2018-01-01 2018-03-31 0001038133 hska:OtherRevenueOtherPharmaceuticalsVaccinesAndDiagnosticTestsMember 2019-01-01 2019-03-31 0001038133 hska:PointOfCareImagingRevenueServiceRevenueMember 2018-01-01 2018-03-31 0001038133 hska:OtherRevenueResearchAndDevelopmentLicenseAndRoyaltyRevenueMember 2019-01-01 2019-03-31 0001038133 hska:CuattroLLCMember 2018-12-21 2018-12-21 0001038133 hska:OptomedMember 2019-02-22 0001038133 hska:OptomedMember 2019-02-22 0001038133 2018-12-21 0001038133 hska:HeskaImagingMember srt:AffiliatedEntityMember 2018-12-31 0001038133 hska:OptomedMember 2019-02-22 2019-02-22 0001038133 hska:CuattroLLCMember hska:HeskaImagingMember srt:AffiliatedEntityMember 2018-01-01 2018-03-31 0001038133 hska:CuattroLLCMember hska:HeskaImagingMember srt:AffiliatedEntityMember 2019-01-01 2019-03-31 0001038133 hska:MBioDiagnosticsInc.Member 2018-08-08 2018-08-08 0001038133 hska:GeneralFluidicsCorporationMember 2018-09-24 2018-09-24 0001038133 hska:GeneralFluidicsCorporationMember 2018-09-24 0001038133 hska:GeneralFluidicsCorporationMember 2018-09-24 2018-09-24 0001038133 hska:StockOptionsAndRestrictedUnitsMember 2019-01-01 2019-03-31 0001038133 hska:StockOptionsAndRestrictedUnitsMember 2018-01-01 2018-03-31 0001038133 2010-12-01 2010-12-31 0001038133 us-gaap:DevelopedTechnologyRightsMember 2018-12-31 0001038133 us-gaap:DevelopedTechnologyRightsMember 2019-03-31 0001038133 hska:CustomerRelationshipsAndOtherMember 2019-03-31 0001038133 hska:CustomerRelationshipsAndOtherMember 2018-12-31 0001038133 srt:MinimumMember hska:InventoryTransferredToMachineryAndEquipmentMember 2019-01-01 2019-03-31 0001038133 srt:MaximumMember hska:InventoryTransferredToMachineryAndEquipmentMember 2019-01-01 2019-03-31 0001038133 us-gaap:LandMember 2019-03-31 0001038133 us-gaap:BuildingMember 2018-12-31 0001038133 us-gaap:MachineryAndEquipmentMember 2019-03-31 0001038133 hska:LeaseholdandBuildingImprovementsMember 2018-12-31 0001038133 us-gaap:ConstructionInProgressMember 2018-12-31 0001038133 hska:OfficeFurnitureAndEquipmentMember 2018-12-31 0001038133 us-gaap:MachineryAndEquipmentMember 2018-12-31 0001038133 us-gaap:LandMember 2018-12-31 0001038133 hska:ComputerHardwareAndSoftwareMember 2019-03-31 0001038133 us-gaap:BuildingMember 2019-03-31 0001038133 us-gaap:ConstructionInProgressMember 2019-03-31 0001038133 hska:OfficeFurnitureAndEquipmentMember 2019-03-31 0001038133 hska:ComputerHardwareAndSoftwareMember 2018-12-31 0001038133 hska:LeaseholdandBuildingImprovementsMember 2019-03-31 0001038133 us-gaap:RestrictedStockMember 2019-01-01 2019-03-31 0001038133 us-gaap:RestrictedStockMember 2018-12-31 0001038133 us-gaap:RestrictedStockMember 2019-03-31 0001038133 us-gaap:EmployeeStockOptionMember 2018-01-01 2018-12-31 0001038133 us-gaap:EmployeeStockOptionMember 2018-12-31 0001038133 us-gaap:EmployeeStockOptionMember 2019-01-01 2019-03-31 0001038133 us-gaap:EmployeeStockOptionMember 2019-03-31 0001038133 us-gaap:EmployeeStockOptionMember 2017-12-31 0001038133 us-gaap:RestrictedStockMember 2018-01-01 2018-03-31 0001038133 us-gaap:EmployeeStockMember 2019-01-01 2019-03-31 0001038133 us-gaap:EmployeeStockMember 2018-01-01 2018-03-31 0001038133 srt:MinimumMember us-gaap:RestrictedStockMember 2019-01-01 2019-03-31 0001038133 srt:MaximumMember us-gaap:RestrictedStockMember 2019-01-01 2019-03-31 0001038133 us-gaap:EmployeeStockOptionMember 2018-01-01 2018-03-31 0001038133 hska:ExercisePriceRangeTwoMember 2019-03-31 0001038133 hska:ExercisePriceRangeOneMember 2019-03-31 0001038133 hska:ExercisePriceRangeFiveMember 2019-03-31 0001038133 hska:ExercisePriceRangeSixMember 2019-03-31 0001038133 hska:ExercisePriceRangeFourMember 2019-03-31 0001038133 hska:ExercisePriceRangeThreeMember 2019-03-31 0001038133 hska:ExercisePriceRangeFiveMember 2019-01-01 2019-03-31 0001038133 hska:ExercisePriceRangeOneMember 2019-01-01 2019-03-31 0001038133 hska:ExercisePriceRangeThreeMember 2019-01-01 2019-03-31 0001038133 hska:ExercisePriceRangeSixMember 2019-01-01 2019-03-31 0001038133 hska:ExercisePriceRangeFourMember 2019-01-01 2019-03-31 0001038133 hska:ExercisePriceRangeTwoMember 2019-01-01 2019-03-31 0001038133 us-gaap:AccumulatedTranslationAdjustmentMember 2019-01-01 2019-03-31 0001038133 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-03-31 0001038133 us-gaap:AccumulatedTranslationAdjustmentMember 2018-12-31 0001038133 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2018-12-31 0001038133 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2019-03-31 0001038133 us-gaap:AccumulatedTranslationAdjustmentMember 2019-03-31 0001038133 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-12-31 0001038133 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-01-01 2019-03-31 0001038133 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2019-01-01 2019-03-31 0001038133 2018-10-16 2018-10-16 0001038133 us-gaap:RevolvingCreditFacilityMember us-gaap:LineOfCreditMember 2017-07-27 0001038133 us-gaap:RevolvingCreditFacilityMember us-gaap:LineOfCreditMember us-gaap:LondonInterbankOfferedRateLIBORMember 2017-07-27 2017-07-27 0001038133 us-gaap:SubsequentEventMember 2019-04-01 2019-04-30 0001038133 us-gaap:RevolvingCreditFacilityMember us-gaap:LineOfCreditMember 2017-07-27 2017-07-27 0001038133 us-gaap:RevolvingCreditFacilityMember us-gaap:LineOfCreditMember 2019-03-31 0001038133 us-gaap:OperatingSegmentsMember hska:CoreCompanionAnimalHealthSegmentMember 2018-01-01 2018-03-31 0001038133 us-gaap:OperatingSegmentsMember hska:OtherVaccinesPharmaceuticalsandProductsSegmentMember 2018-01-01 2018-03-31 0001038133 us-gaap:OperatingSegmentsMember hska:OtherVaccinesPharmaceuticalsandProductsSegmentMember 2018-12-31 0001038133 us-gaap:OperatingSegmentsMember hska:CoreCompanionAnimalHealthSegmentMember 2018-12-31 0001038133 us-gaap:OperatingSegmentsMember hska:CoreCompanionAnimalHealthSegmentMember 2019-01-01 2019-03-31 0001038133 us-gaap:OperatingSegmentsMember hska:OtherVaccinesPharmaceuticalsandProductsSegmentMember 2019-01-01 2019-03-31 0001038133 us-gaap:OperatingSegmentsMember hska:OtherVaccinesPharmaceuticalsandProductsSegmentMember 2019-03-31 0001038133 us-gaap:OperatingSegmentsMember hska:CoreCompanionAnimalHealthSegmentMember 2019-03-31 iso4217:USD xbrli:shares hska:segment xbrli:pure iso4217:USD xbrli:shares false --12-31 Q1 2019 2019-03-31 10-Q 0001038133 7750652 Yes false Accelerated Filer Heska Corp false 54763 5400000 1000000 300000 400000 754000 668000 327000 1281000 20000000.0 50000000.0 60000 11908000 12615000 2155000 770000 3018000 3018000 10000000 1000000 P20Y 0.069 2800000 3000000 0.05 77000 77000 167000 P15Y 10000 191000 7469000 7746000 16454000 16202000 632000 232000 10142000 10647000 38079000 38960000 1100000 1000000 277000 215000 257034000 255150000 1064000 1064000 1186000 1186000 245000 259000 97000 303000 244000 86000 156452000 133586000 22866000 162780000 138076000 24704000 62407000 60536000 122409000 96129000 26280000 121939000 95683000 26256000 0.70 200000 200000 2500000 2500000 9659000 12126000 13389000 9101000 2467000 -4288000 0.01 0.01 0.01 0.01 0.01 10250000 10250000 10250000 10250000 7675692 0 7746602 0 7675692 0 7746602 0 0 0 2236000 752000 0 -44000 2236000 708000 900000 900000 3300000 3400000 9600000 9200000 7082000 6728000 700000 6 19458000 16968000 2634000 2634000 17000 45000 0.011 0.0165 -297000 -1055000 2526000 2704000 14121000 15176000 1196000 908000 288000 947000 318000 1265000 126000 0 226000 0 200000 0.30 0.11 0.28 0.10 44000 -1000 800000 1100000 759000 840000 P1Y7M13D P1Y4M26D 4700000 2500000 0.287 5000000 4819000 1739000 1739000 0 2070000 1865000 205000 4214000 968000 915000 1262000 1280000 1284000 11503000 3303000 8200000 11993000 3793000 8200000 9764000 1564000 8200000 9923000 1928000 7995000 4626000 4219000 26679000 27311000 643000 -11000 13307000 12543000 1875000 1927000 -52000 -35000 -24000 -59000 -280000 -1010000 18000 100000 -3265000 -110000 -1465000 -624000 2981000 39000 -1638000 -325000 -1000 0 -1026000 -226000 -2047000 1052000 233000 237000 -244000 -101000 -257000 151000 100000 100000 26679000 27311000 65000 77000 56000 92000 27000 56000 8085000 8869000 25104000 27388000 15000000 16626000 1573000 1321000 3592000 3214000 8018000 8018000 0 7837000 7837000 0 600000 7546000 1766000 1320000 1453000 1611000 1396000 731000 15840000 2147000 2989000 2409000 1501000 3364000 3430000 34043000 40841000 156452000 162780000 20363000 22790000 6000000 30000000.0 6031000 6026000 6750000 6750000 6750000 40000 40000 2989000 3225000 0.30 -1409000 -4556000 -375000 -458000 4207000 727000 2155000 2155000 814000 814000 0 181000 0 -44000 4000 16000 2 11436000 12618000 1871000 1923000 -52000 -51000 -24000 -75000 444000 6815000 6900000 1693000 5122000 0 -375000 6414000 6500000 0.0445 P4Y4M23D 1674000 1544000 4471000 4620000 7574000 7457000 81000 -62000 0 -62000 -62000 81000 81000 -62000 -62000 9764000 9923000 567000 175000 13000 1000 6750000 1571000 3480000 5100000 0 224000 375000 57000 318000 44000 190000 234000 0.01 0.01 2500000 2500000 0 0 0 0 0 0 288000 410000 0 -1486000 121000 84000 200000 200000 2155000 951000 54060000 4704000 9953000 1687000 2978000 1274000 377000 33087000 54471000 4725000 10086000 1767000 2978000 947000 377000 33591000 15981000 15511000 251000 227000 P7Y P5Y 6100000 6400000 10800000 11000000 12200000 0 662000 1700000 6000 670000 1366000 -134979000 -134165000 32765000 26819000 5946000 5791000 155000 7206000 7109000 97000 5972000 279000 5137000 556000 10821000 13641000 471000 811000 1538000 24716000 4795000 29511000 4666000 129000 3345000 3246000 99000 5410000 302000 4546000 562000 12317000 15961000 374000 1528000 1742000 87191000 18023000 21101000 17078000 13925000 10337000 6727000 P9M P1Y P1Y P1Y P1Y 32765000 26819000 5946000 24716000 4795000 29511000 293000 6140000 7033000 1064000 1186000 P4Y P1Y 0 0.00 117000 14.28 62.73 18.97 77.52 259430000 259547000 74.26 74.26 0 4200000 0 0.00 0 0 0 0 0.44 0.40 0.40 0.39 0.0103 0.0264 0.0235 0.0245 386176 319523 21.214 31.026 406000 9900000 17400000 896 0 18978 0 153700 1200 26.69 36.18 20000000 630847 620553 498858 3127 2583 65.414 17.013 25.740 0.000 53.010 0.000 75.244 98.970 69.78 62.51 4.50 4.40 32.22 7.37 36254 43337 101502 319523 44672 93758 111767 130000 101502 498858 61104 94485 108.25 69.77 7.36 108.25 62.50 32.21 P1Y2M18D P4Y10M24D P1Y1M6D P4Y8M6D 81.236 69.770 6.807 31.026 39.693 15.793 29.312 40.741 46.727 86.020 69.770 6.807 46.727 39.783 15.917 P8Y2M13D P8Y11M6D P3Y7M25D P6Y8M13D P6Y10M3D P5Y20D 7303000 7303000 7419000 7676000 7747000 3500000 43000 116000 71000 144120 122895 -1284000 1000 -1285000 0 -3070000 -3070000 122409000 121277000 103074000 100440000 73000 243598000 232000 -143463000 73000 243598000 232000 -140829000 105090000 74000 243377000 313000 -138674000 122409000 77000 -419000 277000 696000 257034000 277000 -134979000 121277000 77000 -419000 215000 634000 255150000 215000 -134165000 0.10 609000 506000 7711000 7965000 7102000 7459000 <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Interest and other income, net, consisted of the following (in thousands):</font></div><div style="line-height:120%;padding-top:4px;text-align:left;font-size:11pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:69%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;padding-left:24px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Three Months Ended March 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">2018</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Interest income</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">(92</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">(56</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Interest expense</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">77</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">65</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Other income, net</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">(1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">(13</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Total interest and other income, net</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">(16</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">(4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">)</font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">ACCRUED LIABILITIES</font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Accrued liabilities consisted of the following (in thousands):</font><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:57%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:19%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:19%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">March&#160;31, <br clear="none"/>2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">December&#160;31, <br clear="none"/>2018</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Accrued settlement (see Note 14)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">6,750</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">6,750</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Accrued payroll and employee benefits</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">840</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">759</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Accrued property taxes</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">232</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">632</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Inventory in transit</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">1,281</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">327</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Other</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">1,544</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">1,674</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Total accrued liabilities</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">10,647</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">10,142</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Other accrued liabilities consists of items that are individually less than </font><font style="font-family:inherit;font-size:11pt;">5%</font><font style="font-family:inherit;font-size:11pt;"> of total current liabilities.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">In the opinion of management, the accompanying unaudited Condensed Consolidated Financial Statements contain all adjustments, consisting of normal, recurring adjustments, necessary to present fairly the financial position of the Company as of </font><font style="font-family:inherit;font-size:11pt;">March&#160;31, 2019</font><font style="font-family:inherit;font-size:11pt;"> and </font><font style="font-family:inherit;font-size:11pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:11pt;">, the results of our operations, statements of stockholders' equity and cash flows for the </font><font style="font-family:inherit;font-size:11pt;">three</font><font style="font-family:inherit;font-size:11pt;"> months ended </font><font style="font-family:inherit;font-size:11pt;">March&#160;31, 2019</font><font style="font-family:inherit;font-size:11pt;"> and </font><font style="font-family:inherit;font-size:11pt;">2018</font><font style="font-family:inherit;font-size:11pt;">.</font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">The unaudited Condensed Consolidated Financial Statements included herein have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission ("SEC"). Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America ("GAAP") have been condensed or omitted pursuant to such rules and regulations. Our unaudited Condensed Consolidated Financial Statements include our accounts and the accounts of our wholly-owned subsidiaries since their respective dates of acquisitions. All intercompany accounts and transactions have been eliminated in consolidation. Where our ownership of a subsidiary is less than 100%, the non-controlling interest is reported on our Condensed Consolidated Balance Sheets. The non-controlling interest in our consolidated net income is reported as "Net loss attributable to redeemable non-controlling interest" on our Condensed Consolidated Statements of Income. These unaudited Condensed Consolidated Financial Statements should be read in conjunction with the audited Consolidated Financial Statements and Notes thereto contained in our Annual Report on Form&#160;10-K for the fiscal year ended </font><font style="font-family:inherit;font-size:11pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:11pt;"> and other financial information filed with the SEC.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">ACQUISITIONS AND RELATED PARTY ITEMS</font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-style:italic;">Optomed</font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">On February 22, 2019, Heska acquired </font><font style="font-family:inherit;font-size:11pt;">70%</font><font style="font-family:inherit;font-size:11pt;"> of the equity of Optomed, a French-based endoscopy company, in exchange for approximately </font><font style="font-family:inherit;font-size:11pt;">$0.2 million</font><font style="font-family:inherit;font-size:11pt;"> in cash and the assumption of approximately $1.5 million in debt. As part of the purchase, Heska entered into put options and call options on the remaining </font><font style="font-family:inherit;font-size:11pt;">30%</font><font style="font-family:inherit;font-size:11pt;"> minority interest. The written put options can be exercised based on the achievement of certain financial conditions over a specified period of time for a fixed amount. The options are not currently exercisable at the acquisition date or the reporting date. The estimated value of the non-controlling interest is inclusive of the probability weighted outcome of the options described herein. The Company is in process of finalizing its purchase price allocation. As part of the purchase agreement, Heska has committed to a purchase from the minority interest holder, within six months from the acquisition date, real estate in the amount of approximately </font><font style="font-family:inherit;font-size:11pt;">$1.0 million</font><font style="font-family:inherit;font-size:11pt;">, which is currently under lease by Optomed.</font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-style:italic;">Cuattro Veterinary Acquisitions</font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">In February 2013, the Company acquired a majority interest in Cuattro Veterinary USA, LLC, which was owned by Kevin S. Wilson, among other members. The subsidiary was subsequently renamed Heska Imaging US, LLC ("US Imaging"). The remaining minority position in US Imaging was subject to purchase by Heska under a performance-based put option which was exercised in March 2017. In May 2017, we purchased the remaining minority interest position in US Imaging.</font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">In May 2016, the Company closed a transaction to acquire Cuattro Veterinary, LLC ("International Imaging"), which was owned by Kevin S. Wilson, among other members. International Imaging is a provider to international markets of digital radiography technologies for veterinarians. As a leading provider of advanced veterinary diagnostic and specialty products, we made the acquisition in an effort to combine International Imaging's global reach with our domestic success in the imaging and laboratory markets in the United States.</font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">In June 2017, the Company consolidated its assets and liabilities in the US Imaging and International Imaging companies into Heska Imaging, LLC ("Heska Imaging"). Cuattro, LLC ("Cuattro") is owned by Kevin S. Wilson, the CEO and President of the Company in addition to Mrs. Wilson and trusts for the benefit of Mr. and Mrs. Wilson's children and family. Steven M. Asakowicz and Rodney A. Lippincott, members of Cuattro Veterinary USA, LLC and Cuattro International prior the acquisitions, each serve as Executive Vice President, Companion Animal Health Sales for the Company.</font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-style:italic;">Purchase Agreement for Certain Assets</font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">On December 21, 2018, the Company closed a transaction (the "Asset Acquisition") to acquire certain assets from Cuattro, all related to the CCA segment. Pursuant to the Asset Acquisition, dated November 26, 2018, the Company issued </font><font style="font-family:inherit;font-size:11pt;">54,763</font><font style="font-family:inherit;font-size:11pt;"> shares of the Company's common stock, </font><font style="font-family:inherit;font-size:11pt;">$0.01</font><font style="font-family:inherit;font-size:11pt;"> par value per share (the "Common Stock"), to Cuattro on the Closing Date, at an aggregate value equal to approximately </font><font style="font-family:inherit;font-size:11pt;">$5.4 million</font><font style="font-family:inherit;font-size:11pt;"> based on the adjusted closing price per share of the Common Stock as reported on the Nasdaq Stock Market on the Asset Acquisition agreement date. These shares were issued to Cuattro in a private placement in reliance upon an exemption from the registration requirements of the Securities Act pursuant to Section 4(a)(2) thereof and the safe harbor provided by Rule 506 of Regulation D promulgated thereunder. In addition to the Common Stock, the Company paid cash in the amount of </font><font style="font-family:inherit;font-size:11pt;">$2.8 million</font><font style="font-family:inherit;font-size:11pt;"> to Cuattro as part of the transaction. The total purchase price was determined based on a valuation report from an independent third party. Part of the Asset Acquisition was an agreement to terminate the supply and license agreement that Heska had been operating under since the acquisition of Cuattro Veterinary USA, LLC. </font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">The Company evaluated the acquisition of the purchased assets under ASC 805, </font><font style="font-family:inherit;font-size:11pt;font-style:italic;">Business Combinations</font><font style="font-family:inherit;font-size:11pt;"> and ASU 2017-01, </font><font style="font-family:inherit;font-size:11pt;font-style:italic;">Business Combinations (Topic 805)</font><font style="font-family:inherit;font-size:11pt;"> and concluded that as substantially all of the fair value of the gross assets acquired is concentrated in an identifiable group of similar assets, the transaction did not meet the requirements to be accounted for as a business combination and therefore was accounted for as an asset acquisition. Accordingly, the purchase price of the purchased assets was allocated entirely to an identifiable intangible asset. In addition to the software assets acquired, Cuattro is obligated, without further compensation, to assist the Company with the implementation of third-party image hosting platform and necessary data migration. </font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-style:italic;">Other Related Party Activities</font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Cuattro charged Heska Imaging </font><font style="font-family:inherit;font-size:11pt;">$6.0 thousand</font><font style="font-family:inherit;font-size:11pt;"> and </font><font style="font-family:inherit;font-size:11pt;">$1.7 million</font><font style="font-family:inherit;font-size:11pt;"> during </font><font style="font-family:inherit;font-size:11pt;">the three months ended March 31, 2019</font><font style="font-family:inherit;font-size:11pt;"> and </font><font style="font-family:inherit;font-size:11pt;">2018</font><font style="font-family:inherit;font-size:11pt;">, respectively. The charge in 2019 relates to minor inventory purchases as the Company transitions the digital imaging software assets away from Cuattro. The charge in 2018 was primarily for digital imaging products, pursuant to an underlying supply contract which was terminated in December 2018. </font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">The Company had no receivables from or payables to Cuattro as of </font><font style="font-family:inherit;font-size:11pt;">March&#160;31, 2019</font><font style="font-family:inherit;font-size:11pt;">. Heska Imaging owed Cuattro </font><font style="font-family:inherit;font-size:11pt;">$0.2 million</font><font style="font-family:inherit;font-size:11pt;"> as of </font><font style="font-family:inherit;font-size:11pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:11pt;">, which is reported in "Due to &#8211; related parties" on the Company's Condensed Consolidated Balance Sheets.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">COMMITMENTS AND CONTINGENCIES</font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-style:italic;">Royalty Agreements</font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">The Company holds certain rights to market and manufacture products developed or created under certain research, development, and licensing agreements with various entities. In connection with such agreements, the Company has agreed to pay the entities royalties on net product sales. In each of </font><font style="font-family:inherit;font-size:11pt;">the three months ended March 31, 2019</font><font style="font-family:inherit;font-size:11pt;"> and </font><font style="font-family:inherit;font-size:11pt;">2018</font><font style="font-family:inherit;font-size:11pt;">, royalties of </font><font style="font-family:inherit;font-size:11pt;">$0.1 million</font><font style="font-family:inherit;font-size:11pt;"> became payable under these agreements.</font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-style:italic;">Warranties</font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">The Company's current terms and conditions of sale include a limited warranty that its products and services will conform to published specifications at the time of shipment and a more extensive warranty related to certain of its products. The Company also sells a renewal warranty for certain of its products. The typical remedy for breach of warranty is to correct or replace any defective product, and if not possible or practical, the Company will accept the return of the defective product and refund the amount paid. Historically, the Company has incurred minimal warranty costs. The Company's warranty reserve was </font><font style="font-family:inherit;font-size:11pt;">$0.2 million</font><font style="font-family:inherit;font-size:11pt;"> at both </font><font style="font-family:inherit;font-size:11pt;">March&#160;31, 2019</font><font style="font-family:inherit;font-size:11pt;"> and </font><font style="font-family:inherit;font-size:11pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:11pt;">.</font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-style:italic;">Litigation</font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">From time to time, the Company may be involved in litigation relating to claims arising out of its operations. The Company records accruals for outstanding legal matters when it believes it is probable that a loss will be incurred, and the amount can be reasonably estimated.</font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">On October 10, 2018, we reached an agreement in principle to settle the complaint that was filed against the Company by Shaun Fauley on March 12, 2015 in the U.S. District Court Northern District of Illinois alleging our transmittal of unauthorized faxes in violation of the federal Telephone Consumer Protection Act of 1991, as amended by the Junk Fax Prevention Act of 2005, as a class action (the "Fauley Complaint"). The settlement, which received the Court's approval on February 28, 2019 and was not subsequently appealed by a class member, required us to make available a total of </font><font style="font-family:inherit;font-size:11pt;">$6.75 million</font><font style="font-family:inherit;font-size:11pt;"> to pay class members, as well as to pay attorneys' fees and expenses to legal counsel to the class. The Company recorded the loss provision in the third quarter of 2018 in connection with the settlement agreement and does not have insurance coverage for the Fauley Complaint. The payment in respect of the settlement was made in full on April 3, 2019, and all activity related to the Fauley Complaint has ceased. </font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">As of </font><font style="font-family:inherit;font-size:11pt;">March 31,</font><font style="font-family:inherit;font-size:11pt;"> </font><font style="font-family:inherit;font-size:11pt;">2019</font><font style="font-family:inherit;font-size:11pt;">, the Company was not a party to any other legal proceedings that were expected, individually or in the aggregate, to have a material adverse effect on its business, financial condition, or operating results.</font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Off-Balance Sheet Commitments</font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-style:italic;">Unconditional Purchase Obligations</font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">The Company has contractual obligations with suppliers for unconditional annual minimum inventory purchases in the amounts of </font><font style="font-family:inherit;font-size:11pt;">$12.2 million</font><font style="font-family:inherit;font-size:11pt;"> as of </font><font style="font-family:inherit;font-size:11pt;">March&#160;31, 2019</font><font style="font-family:inherit;font-size:11pt;">.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">ACCUMULATED OTHER COMPREHENSIVE INCOME </font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Accumulated other comprehensive income (loss) consisted of the following (in thousands):</font></div><div style="line-height:120%;padding-top:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td style="width:58%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Minimum Pension Liability</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Foreign Currency Translation</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Total Accumulated Other Comprehensive Income</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balances at December 31, 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(419</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">696</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">277</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Current period other comprehensive loss</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(62</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(62</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balances at March 31, 2019</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(419</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">634</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">215</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">CREDIT FACILITY</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">On July 27, 2017, and subsequently amended in May and December 2018, we entered into a Credit Agreement (the "Credit Agreement") with JPMorgan Chase Bank, N.A. ("Chase") which provides for a revolving credit facility up to </font><font style="font-family:inherit;font-size:11pt;">$30.0 million</font><font style="font-family:inherit;font-size:11pt;"> (the "Credit Facility"). The Credit Facility provides us with the ability to borrow up to </font><font style="font-family:inherit;font-size:11pt;">$30.0 million</font><font style="font-family:inherit;font-size:11pt;"> although the amount of the Credit Facility may be increased by an additional </font><font style="font-family:inherit;font-size:11pt;">$20.0 million</font><font style="font-family:inherit;font-size:11pt;"> up to a total of </font><font style="font-family:inherit;font-size:11pt;">$50.0 million</font><font style="font-family:inherit;font-size:11pt;"> subject to receipt of additional lender commitments and other conditions. Any interest on borrowings due is to be charged at either the (i) rate of interest per annum publicly announced from time to time by Chase as its prime rate in effect at its principal offices in New York City, subject to a floor, minus </font><font style="font-family:inherit;font-size:10pt;">1.65%</font><font style="font-family:inherit;font-size:11pt;">, or (ii) the interest rate per annum equal to (a) LIBOR for the interest period in effect multiplied by (b) Chase's Statutory Reserve Rate (as defined in the Credit Agreement), plus </font><font style="font-family:inherit;font-size:11pt;">1.10%</font><font style="font-family:inherit;font-size:11pt;"> and payable monthly. There is an annual minimum interest charge of </font><font style="font-family:inherit;font-size:11pt;">$60 thousand</font><font style="font-family:inherit;font-size:11pt;"> under the Credit Agreement. Chase holds first right of priority over all other liens, if any were to exist. Borrowings under the Credit Facility are subject to certain financial and non-financial covenants and are available for various corporate purposes, including general working capital, capital investments, and certain permitted acquisitions. Failure to comply with any of the covenants, representations or warranties could result in our being in default on the loan and could cause all outstanding amounts payable to Chase to become immediately due and payable or impact our ability to borrow under the agreement. The Credit Agreement also permits us to issue letters of credit, although there are currently none outstanding. The maturity date of the Credit Facility is July 27, 2020. The foregoing discussion of the Credit Facility is a summary only and is qualified in its entirety by reference to the full text of the Credit Agreement, a copy of which has been filed as an exhibit to the Company's Current Report on Form 8-K filed with the SEC on August 2, 2017, and the Facility Amendment, a copy of which has been filed as an exhibit to the Company's Current Report on Form 10-Q filed with the SEC on August 8, 2018, each of which are incorporated herein by reference. </font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">At </font><font style="font-family:inherit;font-size:11pt;">March&#160;31, 2019</font><font style="font-family:inherit;font-size:11pt;">, we had a </font><font style="font-family:inherit;font-size:11pt;">$6.0 million</font><font style="font-family:inherit;font-size:11pt;"> line of credit outstanding under the Credit Facility and we were in compliance with all financial covenants. In April 2019, we used this Credit Facility to make a </font><font style="font-family:inherit;font-size:11pt;">$6.75 million</font><font style="font-family:inherit;font-size:11pt;"> payment to settle all claims associated with the Fauley Complaint that is further discussed in Note 14 of this Form 10-Q.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">The following table summarizes our Core Companion Animal ("CCA") revenue (in thousands):</font></div><div style="line-height:120%;text-align:center;font-size:11pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:67%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Three Months Ended March 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">2018</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Point of Care laboratory revenue:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">15,961</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">13,641</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">&#160;&#160;&#160;&#160;Consumables</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">12,317</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">10,821</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">&#160;&#160;&#160;&#160;Sales-type leases</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">1,742</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">1,538</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">&#160;&#160;&#160;&#160;Outright instrument sales</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">1,528</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">811</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">&#160;&#160;&#160;&#160;Other</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">374</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">471</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Point of Care imaging revenue:</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">5,410</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">5,972</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">&#160;&#160;&#160;&#160;Outright instrument sales</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">4,546</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">5,137</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">&#160;&#160;&#160;&#160;Service revenue</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">562</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">556</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">&#160;&#160;&#160;&#160;Operating type leases and other</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">302</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">279</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Other CCA revenue:</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">3,345</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">7,206</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">&#160;&#160;&#160;&#160;Other pharmaceuticals, vaccines and diagnostic tests</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">3,246</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">7,109</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">&#160;&#160;&#160;&#160;Research and development, license and royalty revenue</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">99</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">97</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Total CCA revenue</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">24,716</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">26,819</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Revenue from our OVP segment consists of revenue generated from contract manufacturing agreements and from other license, research and development revenue. The following table summarizes our OVP revenue (in thousands): </font></div><div style="line-height:120%;padding-top:16px;text-align:center;font-size:11pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:65%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:15%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:15%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Three Months Ended March 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">2018</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Contract manufacturing</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">4,666</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">5,791</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">License, research and development</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">129</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">155</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Total OVP revenue</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">4,795</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">5,946</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">CAPITAL STOCK</font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-style:italic;">Stock Option Plans</font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">The fair value of each option grant was estimated on the date of grant using the Black-Scholes option-pricing model with the following weighted average assumptions for options granted in the </font><font style="font-family:inherit;font-size:11pt;">three</font><font style="font-family:inherit;font-size:11pt;"> months ended </font><font style="font-family:inherit;font-size:11pt;">March 31,</font><font style="font-family:inherit;font-size:11pt;"> </font><font style="font-family:inherit;font-size:11pt;">2019</font><font style="font-family:inherit;font-size:11pt;"> and </font><font style="font-family:inherit;font-size:11pt;">2018</font><font style="font-family:inherit;font-size:11pt;">.</font></div><div style="line-height:120%;padding-top:4px;text-align:left;font-size:11pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td style="width:67%;" rowspan="1" colspan="1"></td><td style="width:16%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:16%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;padding-left:24px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Three Months Ended March 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">2018</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Risk-free interest rate</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">2.45%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">2.64%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Expected lives</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">4.7 years</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">4.9 years</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Expected volatility</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">39%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">40%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Expected dividend yield</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">0%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">0%</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">A summary of our stock option plans is as follows:</font></div><div style="line-height:120%;padding-top:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="14" rowspan="1"></td></tr><tr><td style="width:49%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Three Months Ended March 31,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Year Ended December 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="padding-bottom:28px;text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">&#160;<br clear="none"/>&#160;<br clear="none"/>&#160;<br clear="none"/>Options</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Weighted Average Exercise Price</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="padding-bottom:28px;text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">&#160;<br clear="none"/>&#160;<br clear="none"/>&#160;<br clear="none"/>Options</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Weighted Average Exercise Price</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Outstanding at beginning of period</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">620,553</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">40.741</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">630,847</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">29.312</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Granted at market</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,200</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">98.970</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">153,700</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">75.244</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Forfeited</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(18,978</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">53.010</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Expired</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(896</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">25.740</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Exercised</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(122,895</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17.013</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(144,120</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">65.414</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Outstanding at end of period</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">498,858</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">46.727</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">620,553</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">40.741</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Exercisable at end of period</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">319,523</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">31.026</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">386,176</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">21.214</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">The total estimated fair value of stock options granted during </font><font style="font-family:inherit;font-size:11pt;">the three months ended March 31, 2019</font><font style="font-family:inherit;font-size:11pt;"> and </font><font style="font-family:inherit;font-size:11pt;">2018</font><font style="font-family:inherit;font-size:11pt;"> was computed to be approximately </font><font style="font-family:inherit;font-size:11pt;">$43 thousand</font><font style="font-family:inherit;font-size:11pt;"> and </font><font style="font-family:inherit;font-size:11pt;">$3.5 million</font><font style="font-family:inherit;font-size:11pt;">, respectively. The amounts are amortized ratably over the vesting periods of the options. The weighted average estimated fair value of options granted during </font><font style="font-family:inherit;font-size:11pt;">the three months ended March 31, 2019</font><font style="font-family:inherit;font-size:11pt;"> and </font><font style="font-family:inherit;font-size:11pt;">2018</font><font style="font-family:inherit;font-size:11pt;"> was computed to be approximately </font><font style="font-family:inherit;font-size:11pt;">$36.18</font><font style="font-family:inherit;font-size:11pt;"> and </font><font style="font-family:inherit;font-size:11pt;">$26.69</font><font style="font-family:inherit;font-size:11pt;">, respectively. The total intrinsic value of options exercised during </font><font style="font-family:inherit;font-size:11pt;">the three months ended March 31, 2019</font><font style="font-family:inherit;font-size:11pt;"> and </font><font style="font-family:inherit;font-size:11pt;">2018</font><font style="font-family:inherit;font-size:11pt;"> was </font><font style="font-family:inherit;font-size:11pt;">$9.9 million</font><font style="font-family:inherit;font-size:11pt;"> and </font><font style="font-family:inherit;font-size:11pt;">$406 thousand</font><font style="font-family:inherit;font-size:11pt;">, respectively. The cash proceeds from options exercised during </font><font style="font-family:inherit;font-size:11pt;">the three months ended March 31, 2019</font><font style="font-family:inherit;font-size:11pt;"> and </font><font style="font-family:inherit;font-size:11pt;">2018</font><font style="font-family:inherit;font-size:11pt;"> was </font><font style="font-family:inherit;font-size:11pt;">$84 thousand</font><font style="font-family:inherit;font-size:11pt;"> and </font><font style="font-family:inherit;font-size:11pt;">$121 thousand</font><font style="font-family:inherit;font-size:11pt;">, respectively.</font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">The following table summarizes information about stock options outstanding and exercisable at </font><font style="font-family:inherit;font-size:11pt;">March&#160;31, 2019</font><font style="font-family:inherit;font-size:11pt;">:</font><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="17" rowspan="1"></td></tr><tr><td style="width:25%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="8" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Options Outstanding</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Options Exercisable</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Exercise Prices</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Number of<br clear="none"/>Options<br clear="none"/>Outstanding<br clear="none"/>at<br clear="none"/>March 31, 2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Weighted</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Average</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Remaining</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Contractual</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Life in Years</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Weighted</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Average</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Exercise</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Price</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Number of<br clear="none"/>Options<br clear="none"/>Exercisable<br clear="none"/>at<br clear="none"/>March 31, 2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Weighted</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Average</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Exercise</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Price</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$ 4.50 - $ 7.36</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">101,502</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.65</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6.807</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">101,502</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6.807</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$ 7.37 - $ 32.21</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">94,485</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.05</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15.917</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">93,758</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15.793</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$ 32.22 - $ 62.50</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">61,104</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6.84</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">39.783</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">44,672</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">39.693</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$ 62.51 - $ 69.77</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">130,000</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8.93</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">69.770</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">43,337</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">69.770</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$ 69.78 - $ 108.25</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">111,767</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8.20</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">86.020</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">36,254</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">81.236</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$ 4.50 - $ 108.25</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">498,858</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6.70</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">46.727</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">319,523</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">31.026</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">As of </font><font style="font-family:inherit;font-size:11pt;">March&#160;31, 2019</font><font style="font-family:inherit;font-size:11pt;">, there was approximately </font><font style="font-family:inherit;font-size:11pt;">$4.7 million</font><font style="font-family:inherit;font-size:11pt;"> in total unrecognized compensation cost related to outstanding stock options. That cost is expected to be recognized over a weighted average period of </font><font style="font-family:inherit;font-size:11pt;">1.62</font><font style="font-family:inherit;font-size:11pt;"> years, with all cost to be recognized by the end of February 2023, assuming all options vest according to the vesting schedules in place at </font><font style="font-family:inherit;font-size:11pt;">March&#160;31, 2019</font><font style="font-family:inherit;font-size:11pt;">. As of </font><font style="font-family:inherit;font-size:11pt;">March&#160;31, 2019</font><font style="font-family:inherit;font-size:11pt;">, the aggregate intrinsic value of outstanding options was approximately </font><font style="font-family:inherit;font-size:11pt;">$20.0 million</font><font style="font-family:inherit;font-size:11pt;"> and the aggregate intrinsic value of exercisable options was approximately </font><font style="font-family:inherit;font-size:11pt;">$17.4 million</font><font style="font-family:inherit;font-size:11pt;">.</font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">The Company issues new shares upon share option exercise, which may be netted or withheld to meet strike price or related tax obligations.</font></div><div style="line-height:120%;padding-top:16px;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-style:italic;">Employee Stock Purchase Plan (the "ESPP")</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">For </font><font style="font-family:inherit;font-size:11pt;">the three months ended March 31, 2019</font><font style="font-family:inherit;font-size:11pt;"> and </font><font style="font-family:inherit;font-size:11pt;">2018</font><font style="font-family:inherit;font-size:11pt;">, we issued </font><font style="font-family:inherit;font-size:11pt;">2,583</font><font style="font-family:inherit;font-size:11pt;"> and </font><font style="font-family:inherit;font-size:11pt;">3,127</font><font style="font-family:inherit;font-size:11pt;"> shares under the ESPP, respectively.</font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">For the </font><font style="font-family:inherit;font-size:11pt;">three</font><font style="font-family:inherit;font-size:11pt;"> months ended </font><font style="font-family:inherit;font-size:11pt;">March&#160;31, 2019</font><font style="font-family:inherit;font-size:11pt;"> and </font><font style="font-family:inherit;font-size:11pt;">2018</font><font style="font-family:inherit;font-size:11pt;">, we estimated the fair values of stock purchase rights granted under the ESPP using the Black-Scholes pricing model. The weighted average assumptions used for the periods presented were as follows:</font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td style="width:67%;" rowspan="1" colspan="1"></td><td style="width:16%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:16%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;padding-left:24px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Three Months Ended March 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">2018</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Risk-free interest rate</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">2.35%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">1.03%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Expected lives</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">1.1 years</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">1.2 years</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Expected volatility</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">40%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">44%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Expected dividend yield</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">0%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">0%</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">For </font><font style="font-family:inherit;font-size:11pt;">the three months ended March 31, 2019</font><font style="font-family:inherit;font-size:11pt;"> and </font><font style="font-family:inherit;font-size:11pt;">2018</font><font style="font-family:inherit;font-size:11pt;">, the weighted-average fair value of the purchase rights granted was </font><font style="font-family:inherit;font-size:11pt;">$18.97</font><font style="font-family:inherit;font-size:11pt;"> and </font><font style="font-family:inherit;font-size:11pt;">$14.28</font><font style="font-family:inherit;font-size:11pt;"> per share, respectively.</font></div><div style="line-height:120%;padding-top:16px;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-style:italic;">Restricted Stock Issuance</font></div><div style="line-height:120%;padding-top:16px;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">We have granted non-vested restricted stock awards (&#8220;restricted stock&#8221;) to management and non-employee directors pursuant to the 1997 Plan. The restricted stock awards have varying vesting periods, but generally become fully vested between </font><font style="font-family:inherit;font-size:11pt;">one</font><font style="font-family:inherit;font-size:11pt;"> and </font><font style="font-family:inherit;font-size:11pt;">four</font><font style="font-family:inherit;font-size:11pt;"> years after the grant date, depending on the specific award, performance targets met for performance-based awards granted to management, and vesting periods for time based awards. Management performance-based awards are granted at the target amount of shares that may be earned. We valued the restricted stock awards related to service and/or company performance targets based on grant date fair value and expense over the period when achievement of those conditions is deemed probable. For restricted stock awards related to market conditions, we utilize a Monte Carlo simulation model to estimate grant date fair value and expense over the requisite period. We recognize forfeitures as they occur. There were no modifications that affected our accounting for restricted stock awards in the three months ended March 31, 2019 or 2018. </font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">The following table summarizes restricted stock transactions for </font><font style="font-family:inherit;font-size:11pt;">the three months ended March 31, 2019</font><font style="font-family:inherit;font-size:11pt;">:</font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="7" rowspan="1"></td></tr><tr><td style="width:65%;" rowspan="1" colspan="1"></td><td style="width:16%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:15%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">RSAs</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Weighted-Average Grant Date Fair Value Per Award</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Non-vested as of December 31, 2018</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">259,430</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">74.26</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;Granted</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">117</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">77.52</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;Vested</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;Forfeited</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Non-vested as of March 31, 2019</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">259,547</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">74.26</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">The weighted average grant date fair value of awards granted was&#160;</font><font style="font-family:inherit;font-size:11pt;">$77.52</font><font style="font-family:inherit;font-size:11pt;"> and&#160;</font><font style="font-family:inherit;font-size:11pt;">$62.73</font><font style="font-family:inherit;font-size:11pt;">&#160;for the three months ended March 31, 2019 and 2018, respectively. Fair value of restricted stock vested was&#160;</font><font style="font-family:inherit;font-size:11pt;">$0.0</font><font style="font-family:inherit;font-size:11pt;"> and&#160;</font><font style="font-family:inherit;font-size:11pt;">$4.2 million</font><font style="font-family:inherit;font-size:11pt;">&#160;for the three months ended March 31, 2019 and 2018, respectively.</font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">As of </font><font style="font-family:inherit;font-size:11pt;">March&#160;31, 2019</font><font style="font-family:inherit;font-size:11pt;">, there was approximately&#160;</font><font style="font-family:inherit;font-size:11pt;">$2.5 million</font><font style="font-family:inherit;font-size:11pt;">&#160;of total unrecognized compensation cost related to restricted stock with market and time vesting conditions. The Company expects to recognize this expense over a weighted average period of&#160;</font><font style="font-family:inherit;font-size:11pt;">1.4</font><font style="font-family:inherit;font-size:11pt;">&#160;years. As of March 31, 2019, we reviewed each of the underlying corporate performance targets and determined that approximately </font><font style="font-family:inherit;font-size:11pt;">167,000</font><font style="font-family:inherit;font-size:11pt;"> of shares of common stock were related to company performance targets in which we did not deem achievement probable. No compensation expense had been recorded at any period prior to March 31, 2019. </font></div><div style="line-height:120%;padding-top:16px;text-align:justify;text-indent:4px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-style:italic;">Restrictions on the transfer of Company stock</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">The Company's Restated Certificate of Incorporation, as amended (the "Certificate of Incorporation"), places restrictions (the "Transfer Restrictions") on the transfer of the Company's stock that could adversely affect the Company's ability to utilize its domestic Federal Net Operating Loss Position. In particular, the Transfer Restrictions prevent the transfer of shares without the approval of the Company's Board of Directors if, as a consequence of such transfer, an individual, entity or groups of individuals or entities would become a 5-percent holder under Section 382 of the Internal Revenue Code of 1986, as amended, and the related Treasury regulations, and also prevents any existing&#160;5-percent holder from increasing his or her ownership position in the Company without the approval of the Company's Board of Directors. Any transfer of shares in violation of the Transfer Restrictions (a "Transfer Violation") shall be void&#160;ab initio&#160;under the Certificate of Incorporation, and the Company's Board of Directors has procedures under the Certificate of Incorporation to remedy a Transfer Violation including requiring the shares causing such Transfer Violation to be sold and any profit resulting from such sale to be transferred to a charitable entity chosen by the Company's Board of Directors in specified circumstances.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">EARNINGS PER SHARE</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Basic earnings per share ("EPS") is computed by dividing net income attributable to the Company by the weighted-average number of common shares outstanding during the period. The computation of diluted EPS is similar to the computation of basic EPS except that the numerator is increased to exclude charges that would not have been incurred, and the denominator is increased to include the number of additional common shares that would have been outstanding (using the if-converted and treasury stock methods), if securities containing potentially dilutive common shares (stock options and restricted stock units but excluding options to purchase fractional shares resulting from the Company's December 2010 1-for-</font><font style="font-family:inherit;font-size:11pt;">10</font><font style="font-family:inherit;font-size:11pt;"> reverse stock split) had been converted to common shares, and if such assumed conversion is dilutive. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:10pt;">The </font><font style="font-family:inherit;font-size:11pt;">following is a reconciliation of the weighted-average shares outstanding used in the calculation of basic and diluted EPS for the </font><font style="font-family:inherit;font-size:11pt;">three</font><font style="font-family:inherit;font-size:11pt;"> months ended </font><font style="font-family:inherit;font-size:11pt;">March&#160;31, 2019</font><font style="font-family:inherit;font-size:11pt;"> and </font><font style="font-family:inherit;font-size:11pt;">2018</font><font style="font-family:inherit;font-size:11pt;"> (in thousands, except per share data):</font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:73%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Three Months Ended March 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">2018</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Net income attributable to Heska Corporation</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">814</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">2,155</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Basic weighted-average common shares outstanding</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">7,459</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">7,102</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Assumed exercise of dilutive stock options and restricted shares</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">506</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">609</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Diluted weighted-average common shares outstanding</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">7,965</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">7,711</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Basic earnings per share attributable to Heska Corporation</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">0.11</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">0.30</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Diluted earnings per share attributable to Heska Corporation</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">0.10</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">0.28</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">The following stock options and restricted shares were excluded from the computation of diluted EPS because they would have been anti-dilutive (in thousands):</font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="6" rowspan="1"></td></tr><tr><td style="width:73%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;padding-left:12px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Three Months Ended March 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">2018</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Stock options</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">86</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">244</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">INVESTMENTS IN UNCONSOLIDATED AFFILIATES</font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">The carrying values of investments in unconsolidated affiliates, categorized by type of investment, is as follows (in thousands):</font><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:69%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">March&#160;31, 2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">December&#160;31, 2018</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Equity method investment</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">4,819</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">5,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Non-marketable equity security investment</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">3,018</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">3,018</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">7,837</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">8,018</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-style:italic;">Equity Method Investment</font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">On September 24, 2018, we invested </font><font style="font-family:inherit;font-size:11pt;">$5.1 million</font><font style="font-family:inherit;font-size:11pt;">, including costs, in exchange for a </font><font style="font-family:inherit;font-size:11pt;">28.7%</font><font style="font-family:inherit;font-size:11pt;"> interest of a business as part of our product development strategy. The Company accounts for this investment using the equity method of accounting. Under the equity method, the carrying value of the investment is adjusted for the Company's proportionate share of the investee's reported earnings or losses with the corresponding share of earnings or losses reported as Equity in Losses of Unconsolidated Affiliates, listed below Net income before equity in losses of unconsolidated affiliates within the Condensed Consolidated Statements of Income. Additionally, the Company also entered into a </font><font style="font-family:inherit;font-size:11pt;">15</font><font style="font-family:inherit;font-size:11pt;">-year Manufacturing Supply Agreement, which grants the Company global exclusivity to specified products. </font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-style:italic;">Non-Marketable Equity Security Investment</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">On August 8, 2018, the Company invested </font><font style="font-family:inherit;font-size:11pt;">$3.0 million</font><font style="font-family:inherit;font-size:11pt;">, including costs, in MBio Diagnostics, Inc. ("MBio"), in exchange for preferred stock, representing a </font><font style="font-family:inherit;font-size:11pt;">6.9%</font><font style="font-family:inherit;font-size:11pt;"> interest in MBio. The Company&#8217;s investment in MBio is a non-marketable equity security, recorded using the measurement alternative of cost minus impairment, if any, plus or minus changes resulting from qualifying observable price changes. </font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">As part of the agreement, the Company entered into a Supply and License Agreement with MBio, which provides that MBio produce and commercialize products that will enhance the Company's diagnostic portfolio. As part of this agreement, the Company made an upfront payment to MBio of </font><font style="font-family:inherit;font-size:11pt;">$1.0 million</font><font style="font-family:inherit;font-size:11pt;"> related to a worldwide exclusive license agreement over a </font><font style="font-family:inherit;font-size:11pt;">20</font><font style="font-family:inherit;font-size:11pt;">-year period, recorded in both short and long-term other assets. In addition, the agreement provides for an additional contingent payment from Heska to MBio of </font><font style="font-family:inherit;font-size:11pt;">$10.0 million</font><font style="font-family:inherit;font-size:11pt;">, relating to the successful achievement of sales milestones. This potential future milestone payment has not yet been accrued as it is not deemed by the Company to be probable at this time.</font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Both parties in this arrangement are active participants and are exposed to significant risks and rewards dependent on the commercial success of the activities of the collaboration. The parties are actively working on developing and testing the product as well as funding the research and development. Heska classifies the amounts paid for MBio's research and development work within the CCA segment research and development operating expenses. Expense is recognized ratably when incurred and in accordance with the development plan.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">The carrying values of investments in unconsolidated affiliates, categorized by type of investment, is as follows (in thousands):</font><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:69%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">March&#160;31, 2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">December&#160;31, 2018</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Equity method investment</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">4,819</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">5,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Non-marketable equity security investment</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">3,018</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">3,018</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">7,837</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">8,018</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">The weighted average assumptions used for the periods presented were as follows:</font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td style="width:67%;" rowspan="1" colspan="1"></td><td style="width:16%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:16%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;padding-left:24px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Three Months Ended March 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">2018</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Risk-free interest rate</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">2.35%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">1.03%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Expected lives</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">1.1 years</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">1.2 years</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Expected volatility</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">40%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">44%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Expected dividend yield</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">0%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">0%</font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Amortization expense relating to other intangibles was as follows (in thousands):</font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:63%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:16%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:16%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;padding-left:12px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Three Months Ended March 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">2018</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Amortization expense</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">303</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">97</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">GOODWILL AND OTHER INTANGIBLES</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">The following summarizes the change in goodwill during </font><font style="font-family:inherit;font-size:11pt;">the three months ended March 31, 2019</font><font style="font-family:inherit;font-size:11pt;"> (in thousands):</font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td style="width:82%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:16%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Carrying amount, December 31, 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">26,679</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Goodwill attributable to acquisitions (subject to change)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">643</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Foreign currency adjustments</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">(11</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Carrying amount, March 31, 2019</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">27,311</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Other intangibles consisted of the following (in thousands):</font></div><div style="line-height:120%;text-align:center;font-size:11pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="24" rowspan="1"></td></tr><tr><td style="width:22%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;padding-left:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">March 31, 2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;padding-left:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December 31, 2018</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Gross Carrying Amount</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Accumulated Amortization</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Net Carrying Amount</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Gross Carrying Amount</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Accumulated Amortization</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Net Carrying Amount</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Developed technology</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">8,200</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">(205</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">7,995</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">8,200</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">8,200</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Customer relationships and other</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">3,793</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">(1,865</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">1,928</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">3,303</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">(1,739</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">1,564</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Total intangible assets</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">11,993</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">(2,070</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">9,923</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">11,503</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">(1,739</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">9,764</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Amortization expense relating to other intangibles was as follows (in thousands):</font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:63%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:16%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:16%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;padding-left:12px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Three Months Ended March 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">2018</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Amortization expense</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">303</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">97</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Estimated amortization expense related to intangibles for each of the five years from 2019 (remaining) through 2023 and thereafter is as follows (in thousands):</font></div><div style="line-height:120%;text-align:center;font-size:11pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td style="width:87%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Year Ending December 31,</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">2019 (remaining)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">968</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">2020</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">1,284</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">2021</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">1,280</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">2022</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">1,262</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">2023</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">915</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Thereafter</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">4,214</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">9,923</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">INCOME TAXES</font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Our total income tax benefit for our (loss) income before income taxes were as follows (in thousands):</font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td style="width:60%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:17%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:17%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;padding-left:12px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Three Months Ended March 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">2018</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">(Loss) income before income taxes</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">(59</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">1,875</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Total income tax benefit</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">(1,010</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">(280</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">)</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#160;&#160;&#160;&#160;</font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">There were cash refunds of </font><font style="font-family:inherit;font-size:11pt;">$0.1 million</font><font style="font-family:inherit;font-size:11pt;"> for income taxes, net of payments, for the </font><font style="font-family:inherit;font-size:11pt;">three</font><font style="font-family:inherit;font-size:11pt;"> months ended </font><font style="font-family:inherit;font-size:11pt;">March&#160;31, 2019</font><font style="font-family:inherit;font-size:11pt;">, and there were </font><font style="font-family:inherit;font-size:11pt;">$18 thousand</font><font style="font-family:inherit;font-size:11pt;"> in cash payments for income taxes, net of refunds, for the </font><font style="font-family:inherit;font-size:11pt;">three</font><font style="font-family:inherit;font-size:11pt;"> months ended </font><font style="font-family:inherit;font-size:11pt;">March&#160;31, 2018</font><font style="font-family:inherit;font-size:11pt;">. The Company&#8217;s tax benefit increased to </font><font style="font-family:Times New Roman;font-size:11pt;color:#000000;">$1.0 million</font><font style="font-family:inherit;font-size:11pt;"> for the </font><font style="font-family:inherit;font-size:11pt;">three</font><font style="font-family:inherit;font-size:11pt;"> months ended </font><font style="font-family:inherit;font-size:11pt;">March&#160;31, 2019</font><font style="font-family:inherit;font-size:11pt;">, compared to the tax benefit of </font><font style="font-family:Times New Roman;font-size:11pt;color:#000000;">$0.3 million</font><font style="font-family:inherit;font-size:11pt;"> for the </font><font style="font-family:inherit;font-size:11pt;">three</font><font style="font-family:inherit;font-size:11pt;"> months ended </font><font style="font-family:inherit;font-size:11pt;">March&#160;31, 2018</font><font style="font-family:inherit;font-size:11pt;">. The increase in tax benefits is due to an increase in stock-based compensation excess tax benefits recognized in our income statement. In the first quarter of 2019, the Company recognized </font><font style="font-family:inherit;font-size:11pt;">$1.1 million</font><font style="font-family:inherit;font-size:11pt;"> in excess tax benefits related to employee share based compensation compared to </font><font style="font-family:inherit;font-size:11pt;">$0.8 million</font><font style="font-family:inherit;font-size:11pt;"> recognized in the first quarter of 2018.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">INTEREST AND OTHER INCOME, NET </font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Interest and other income, net, consisted of the following (in thousands):</font></div><div style="line-height:120%;padding-top:4px;text-align:left;font-size:11pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:69%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;padding-left:24px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Three Months Ended March 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">2018</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Interest income</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">(92</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">(56</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Interest expense</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">77</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">65</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Other income, net</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">(1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">(13</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Total interest and other income, net</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">(16</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">(4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">)</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Cash paid for interest for </font><font style="font-family:inherit;font-size:11pt;">the three months ended March 31, 2019</font><font style="font-family:inherit;font-size:11pt;"> and </font><font style="font-family:inherit;font-size:11pt;">2018</font><font style="font-family:inherit;font-size:11pt;"> was </font><font style="font-family:inherit;font-size:11pt;">$56 thousand</font><font style="font-family:inherit;font-size:11pt;"> and </font><font style="font-family:inherit;font-size:11pt;">$27 thousand</font><font style="font-family:inherit;font-size:11pt;">, respectively.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">INVENTORIES, NET</font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Inventories, net, consisted of the following (in thousands):</font></div><div style="line-height:120%;text-align:center;font-size:11pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td style="width:66%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">March 31,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">December 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">2018</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Raw materials</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">16,626</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">15,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Work in process</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">3,214</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">3,592</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Finished goods</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">8,869</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">8,085</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Allowance for excess or obsolete inventory</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">(1,321</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">(1,573</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Total inventory, net</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">27,388</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">25,104</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Inventories are measured on a first-in, first-out basis and stated at lower of cost or net realizable value.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Supplemental cash flow information related to the Company's operating leases for the </font><font style="font-family:inherit;font-size:11pt;">three</font><font style="font-family:inherit;font-size:11pt;"> months ended </font><font style="font-family:inherit;font-size:11pt;">March&#160;31, 2019</font><font style="font-family:inherit;font-size:11pt;"> was as follows (in thousands):</font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:11pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td style="width:80%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:18%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Cash paid for amounts included in the measurement of operating lease liabilities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">444</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">ROU assets obtained in exchange for operating lease obligations</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">293</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">The following table presents the weighted average remaining lease term and weighted average discount rate related to the Company's operating leases as of </font><font style="font-family:inherit;font-size:11pt;">March&#160;31, 2019</font><font style="font-family:inherit;font-size:11pt;">: </font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:11pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3" rowspan="1"></td></tr><tr><td style="width:80%;" rowspan="1" colspan="1"></td><td style="width:19%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Weighted average remaining lease term</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">4.4 years</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Weighted average discount rate</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">4.45</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">%</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br clear="none"/></font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">The following table presents the maturity of the Company's operating lease liabilities as of </font><font style="font-family:inherit;font-size:11pt;">March&#160;31, 2019</font><font style="font-family:inherit;font-size:11pt;"> (in thousands):</font></div><div style="line-height:120%;text-align:center;font-size:11pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td style="width:80%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:18%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Remainder of 2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">1,396</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">2020</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">1,611</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">2021</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">1,453</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">2022</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">1,320</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">2023</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">1,766</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Total operating lease payments</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">7,546</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Less: imputed interest</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">731</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Total operating lease liabilities</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">6,815</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">LEASES</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;background-color:#ffffff;font-style:italic;">Lessee Accounting </font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;background-color:#ffffff;">The Company leases buildings, office equipment, and vehicles.</font><font style="font-family:inherit;font-size:11pt;"> </font><font style="font-family:inherit;font-size:11pt;">The Company&#8217;s finance leases were not material as of&#160;March&#160;31, 2019&#160;and for the three-month period then ended. ROU assets arising from finance leases are included in Property and equipment, net in the accompanying Condensed Consolidated Balance Sheets. The current portion of the finance lease liabilities are included in Current portion of deferred revenue, and other and the non-current portion of the finance lease liabilities are included in Line of credit and other long term borrowings in the accompanying Condensed Consolidated Balance Sheets. </font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">For the </font><font style="font-family:inherit;font-size:11pt;">three</font><font style="font-family:inherit;font-size:11pt;"> months ended </font><font style="font-family:inherit;font-size:11pt;">March&#160;31, 2019</font><font style="font-family:inherit;font-size:11pt;">, operating lease expense was </font><font style="font-family:inherit;font-size:11pt;">$0.6 million</font><font style="font-family:inherit;font-size:11pt;">, including immaterial variable lease costs. </font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Supplemental cash flow information related to the Company's operating leases for the </font><font style="font-family:inherit;font-size:11pt;">three</font><font style="font-family:inherit;font-size:11pt;"> months ended </font><font style="font-family:inherit;font-size:11pt;">March&#160;31, 2019</font><font style="font-family:inherit;font-size:11pt;"> was as follows (in thousands):</font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:11pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td style="width:80%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:18%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Cash paid for amounts included in the measurement of operating lease liabilities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">444</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">ROU assets obtained in exchange for operating lease obligations</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">293</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">The following table presents the weighted average remaining lease term and weighted average discount rate related to the Company's operating leases as of </font><font style="font-family:inherit;font-size:11pt;">March&#160;31, 2019</font><font style="font-family:inherit;font-size:11pt;">: </font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:11pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3" rowspan="1"></td></tr><tr><td style="width:80%;" rowspan="1" colspan="1"></td><td style="width:19%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Weighted average remaining lease term</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">4.4 years</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Weighted average discount rate</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">4.45</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">%</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">The following table presents the maturity of the Company's operating lease liabilities as of </font><font style="font-family:inherit;font-size:11pt;">March&#160;31, 2019</font><font style="font-family:inherit;font-size:11pt;"> (in thousands):</font></div><div style="line-height:120%;text-align:center;font-size:11pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td style="width:80%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:18%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Remainder of 2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">1,396</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">2020</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">1,611</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">2021</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">1,453</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">2022</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">1,320</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">2023</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">1,766</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Total operating lease payments</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">7,546</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Less: imputed interest</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">731</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Total operating lease liabilities</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">6,815</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-style:italic;">Lessor Accounting</font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-style:italic;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">In our CCA segment, primarily related to our Point of Care laboratory products, the Company enters into sales-type leases as part of our subscription agreements. The following table presents the maturity of the Company's undiscounted lease receivables as of </font><font style="font-family:inherit;font-size:11pt;">March&#160;31, 2019</font><font style="font-family:inherit;font-size:11pt;"> (in thousands):</font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:11pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td style="width:82%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:16%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Year Ending December 31,</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Remainder of 2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">2,409</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">2020</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">3,430</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">2021</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">3,364</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">2022</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">2,989</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">2023</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">2,147</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Thereafter</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">1,501</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">15,840</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">The following table presents the maturity of the Company's undiscounted lease receivables as of </font><font style="font-family:inherit;font-size:11pt;">March&#160;31, 2019</font><font style="font-family:inherit;font-size:11pt;"> (in thousands):</font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:11pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td style="width:82%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:16%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Year Ending December 31,</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Remainder of 2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">2,409</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">2020</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">3,430</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">2021</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">3,364</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">2022</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">2,989</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">2023</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">2,147</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Thereafter</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">1,501</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">15,840</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:16px;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-style:italic;">Adoption of New Accounting Pronouncements</font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Effective January 1, 2019, we adopted&#160;ASU 2018-07,&#160;</font><font style="font-family:inherit;font-size:11pt;font-style:italic;">Compensation &#8211; Stock Compensation (Topic 718)</font><font style="font-family:inherit;font-size:11pt;">, </font><font style="font-family:inherit;font-size:11pt;font-style:italic;">Improvements to Non-employee Share-Based Payment Accounting</font><font style="font-family:inherit;font-size:11pt;">.&#160;This ASU is intended to simplify aspects of share-based compensation issued to non-employees by making the guidance consistent with accounting for employee share-based compensation. Guidance related to the stock compensation granted to employees is followed for non-employees, including the measurement date, valuation approach and performance conditions. The expense is recognized in the same period as though cash were paid for the good or service, ratably over the service period. The adoption of this ASU did not have an impact on our consolidated financial statements but did have a minimal impact on our related disclosures.</font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Effective January 1, 2019, we adopted ASU 2018-02, </font><font style="font-family:inherit;font-size:11pt;font-style:italic;">Income Statement-Reporting Comprehensive Income (Topic 220): Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income</font><font style="font-family:inherit;font-size:11pt;">. The ASU permits companies to elect a reclassification of the disproportionate tax effects in accumulated other comprehensive income ("AOCI") caused by the Tax Cuts and Jobs Act of 2017 to retained earnings. As of March 31, 2019, the Company does not have any disproportionate income tax effects in AOCI to reclassify. However, if the Company did have disproportionate income tax effects in AOCI in the future, it would reclassify them to retained earnings.</font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">In February 2016, the FASB issued ASU 2016-02, </font><font style="font-family:inherit;font-size:11pt;font-style:italic;">Leases (</font><font style="font-family:inherit;font-size:11pt;">Topic 842</font><font style="font-family:inherit;font-size:11pt;font-style:italic;">)</font><font style="font-family:inherit;font-size:11pt;">, which supersedes ASC 840, </font><font style="font-family:inherit;font-size:11pt;font-style:italic;">Leases</font><font style="font-family:inherit;font-size:11pt;">. This update requires lessees to recognize a right-of-use (&#8220;ROU&#8221;) asset and a lease liability for all leases, including operating leases, with terms greater than 12 months on its balance sheet. The update also expands the required quantitative and qualitative disclosures by lessees and lessors about the amount, timing and uncertainty of cash flows arising from leases. The accounting for lessors does not fundamentally change except for changes to conform and align guidance to the lessee guidance as well as to the new revenue recognition guidance in ASU 2014-09, </font><font style="font-family:inherit;font-size:11pt;font-style:italic;">Revenue from Contracts with Customers (Topic 606)</font><font style="font-family:inherit;font-size:11pt;">. Subsequent to the issuance of Topic 842, the FASB clarified the guidance through several ASUs; hereinafter the collection of lease guidance is referred to as &#8220;ASC 842&#8221;.</font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">The Company adopted ASC 842 on January 1, 2019, using the modified retrospective approach for all lease arrangements at the beginning of the period of adoption. Results for reporting periods beginning January 1, 2019 are presented under ASC 842, while prior period amounts were not adjusted and continue to be reported in accordance with the Company&#8217;s historic accounting under ASC 840, </font><font style="font-family:inherit;font-size:11pt;font-style:italic;">Leases</font><font style="font-family:inherit;font-size:11pt;">. For leases that commenced before the effective date of ASC 842, the Company elected the permitted practical expedients to not reassess the following: (i) whether any expired or existing contracts contain leases; (ii) the lease classification for any expired or existing leases; and (iii) initial direct costs for any existing leases. The Company also elected to exclude leases with a term of 12 months or less from the recognized ROU assets and lease liabilities.</font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Adoption of the standard did not have a material net impact in our Condensed Consolidated Balance Sheets, Condensed Consolidated Statements of Income or Condensed Consolidated Statements of Cash Flows. The most significant impact was the recognition of ROU assets and lease liabilities for the operating leases, of which we are the lessee. As a result of the cumulative impact of adopting ASC 842, the Company recorded operating lease ROU assets of </font><font style="font-family:inherit;font-size:11pt;">$6.5 million</font><font style="font-family:inherit;font-size:11pt;"> and operating lease liabilities of </font><font style="font-family:inherit;font-size:11pt;">$6.9 million</font><font style="font-family:inherit;font-size:11pt;"> as of January 1, 2019, primarily related to building, vehicle, and office equipment leases, based on the present value of the future lease payments on the date of adoption. As a lessor, accounting for our subscription agreements will remain substantially unchanged. Refer to Note 6 for additional disclosures required by ASC 842. </font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">The Company determines if an arrangement is a lease at inception based on whether control of an identified asset is transferred. For leases where the Company is the lessee, ROU assets represent the Company&#8217;s right to use an underlying asset for the lease term and lease liabilities represent an obligation to make lease payments arising from the lease. ROU assets and lease liabilities are recognized at the lease commencement date based on the present value of lease payments over the lease term. As most of the Company&#8217;s leases do not provide an implicit interest rate, the Company uses its incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. The lease terms used to calculate the ROU asset and related lease liability include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. Lease expense for operating leases is recognized on a straight-line basis over the lease term as an operating expense while the expense for finance leases is recognized as amortization expense and interest expense. The Company has lease agreements which require payments for lease and non-lease components and has elected to account for these as a single lease component for our building and office equipment leases, but as separate components for our vehicle leases. </font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Our revenue under subscription agreements relates to both operating-type lease (&#8220;OTL&#8221;) arrangements or sales-type lease (&#8220;STL&#8221;) arrangements. Determination of an OTL or STL is primarily determined as a result of the length of the contract as compared to the estimated useful life of the instrument, among other factors. A STL results in earlier recognition of instrument revenue. The cost of the customer-leased instruments is removed from inventory and recognized in the Consolidated Statements of Income. There is no residual value taken into consideration as it does not meet our capitalization requirements. Instrument lease revenue for OTL agreements is recognized on a straight-line basis over the life of the lease and included with the predominant non-lease components in consumable revenue. The costs of customer-leased instruments are recorded within property and equipment in the accompanying Consolidated Balance Sheets and depreciated over the instrument&#8217;s estimated useful life. The depreciation expense is reflected in cost of revenue in the accompanying Consolidated Statements of Income. The OTLs and STLs are not cancellable until after an initial term and include an option to renew. </font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">For lease arrangements with lease and non-lease components where the Company is the lessor, the Company allocates the contracts transaction price to the lease and non-lease components on a relative standalone selling price basis using the Company&#8217;s best estimate of the standalone selling price of each distinct product or service in the contract. The primary method used to estimate standalone selling price is the price observed in standalone sales to customers of a prior period. Changes in these values can impact the amount of consideration allocated to each component of the contract. When prices in standalone sales are not available, we may use a cost-plus margin approach. Allocation of the transaction price is determined at the inception of the lease arrangement. The Company&#8217;s leases consist of leases with fixed and variable lease payments. For those leases with variable lease payments, the variable lease payment is typically based upon purchase of consumables used with the leased instruments and included in consumable revenue.</font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"> </font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-style:italic;">Accounting Pronouncements Not Yet Adopted</font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">In June 2016, the FASB issued ASU&#160;2016-13,</font><font style="font-family:inherit;font-size:11pt;font-style:italic;">&#160;Financial Instruments - Credit Losses (Topic 326)</font><font style="font-family:inherit;font-size:11pt;">, which requires that financial assets measured at amortized cost be presented at the net amount expected to be collected. The allowance for credit losses is a valuation account that is deducted from the amortized cost basis of the financial asset to present the net carrying value at the amount expected to be collected. The income statement reflects the measurement of credit losses for newly recognized financial assets, as well as the increases or decreases of expected credit losses that have taken place during the period. The measurement of expected credit losses is based upon historical experience, current conditions and reasonable and supportable forecasts that affect the collectability of the reported amount. In November 2018, the FASB issued ASU 2018-19,</font><font style="font-family:inherit;font-size:11pt;font-style:italic;"> Codification Improvements to Topic 326, Financial Instruments - Credit Losses</font><font style="font-family:inherit;font-size:11pt;">. This ASU clarifies that receivables from operating leases are accounted for using the lease guidance and not as financial instruments. The amendments in this update are</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:11pt;">effective for fiscal years beginning after December 15, 2019 and interim periods within those annual periods. Early adoption for fiscal year beginning after December 15, 2018 is permitted. We will adopt the provisions of this ASU in the first quarter of 2020. We are currently evaluating the effect of this update on our consolidated financial statements.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">LEASES</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;background-color:#ffffff;font-style:italic;">Lessee Accounting </font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;background-color:#ffffff;">The Company leases buildings, office equipment, and vehicles.</font><font style="font-family:inherit;font-size:11pt;"> </font><font style="font-family:inherit;font-size:11pt;">The Company&#8217;s finance leases were not material as of&#160;March&#160;31, 2019&#160;and for the three-month period then ended. ROU assets arising from finance leases are included in Property and equipment, net in the accompanying Condensed Consolidated Balance Sheets. The current portion of the finance lease liabilities are included in Current portion of deferred revenue, and other and the non-current portion of the finance lease liabilities are included in Line of credit and other long term borrowings in the accompanying Condensed Consolidated Balance Sheets. </font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">For the </font><font style="font-family:inherit;font-size:11pt;">three</font><font style="font-family:inherit;font-size:11pt;"> months ended </font><font style="font-family:inherit;font-size:11pt;">March&#160;31, 2019</font><font style="font-family:inherit;font-size:11pt;">, operating lease expense was </font><font style="font-family:inherit;font-size:11pt;">$0.6 million</font><font style="font-family:inherit;font-size:11pt;">, including immaterial variable lease costs. </font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Supplemental cash flow information related to the Company's operating leases for the </font><font style="font-family:inherit;font-size:11pt;">three</font><font style="font-family:inherit;font-size:11pt;"> months ended </font><font style="font-family:inherit;font-size:11pt;">March&#160;31, 2019</font><font style="font-family:inherit;font-size:11pt;"> was as follows (in thousands):</font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:11pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td style="width:80%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:18%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Cash paid for amounts included in the measurement of operating lease liabilities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">444</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">ROU assets obtained in exchange for operating lease obligations</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">293</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">The following table presents the weighted average remaining lease term and weighted average discount rate related to the Company's operating leases as of </font><font style="font-family:inherit;font-size:11pt;">March&#160;31, 2019</font><font style="font-family:inherit;font-size:11pt;">: </font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:11pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3" rowspan="1"></td></tr><tr><td style="width:80%;" rowspan="1" colspan="1"></td><td style="width:19%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Weighted average remaining lease term</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">4.4 years</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Weighted average discount rate</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">4.45</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">%</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">The following table presents the maturity of the Company's operating lease liabilities as of </font><font style="font-family:inherit;font-size:11pt;">March&#160;31, 2019</font><font style="font-family:inherit;font-size:11pt;"> (in thousands):</font></div><div style="line-height:120%;text-align:center;font-size:11pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td style="width:80%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:18%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Remainder of 2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">1,396</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">2020</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">1,611</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">2021</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">1,453</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">2022</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">1,320</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">2023</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">1,766</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Total operating lease payments</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">7,546</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Less: imputed interest</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">731</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Total operating lease liabilities</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">6,815</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-style:italic;">Lessor Accounting</font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-style:italic;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">In our CCA segment, primarily related to our Point of Care laboratory products, the Company enters into sales-type leases as part of our subscription agreements. The following table presents the maturity of the Company's undiscounted lease receivables as of </font><font style="font-family:inherit;font-size:11pt;">March&#160;31, 2019</font><font style="font-family:inherit;font-size:11pt;"> (in thousands):</font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:11pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td style="width:82%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:16%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Year Ending December 31,</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Remainder of 2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">2,409</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">2020</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">3,430</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">2021</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">3,364</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">2022</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">2,989</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">2023</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">2,147</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Thereafter</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">1,501</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">15,840</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">PROPERTY AND EQUIPMENT, NET</font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Property and equipment, net, consisted of the following (in thousands):</font><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:67%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">March 31,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">December 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">2018</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Land</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">377</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">377</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Building</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">2,978</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">2,978</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Machinery and equipment</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">33,591</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">33,087</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Office furniture and equipment</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">1,767</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">1,687</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Computer hardware and software</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">4,725</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">4,704</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Leasehold and building improvements</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">10,086</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">9,953</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Construction in progress</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">947</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">1,274</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">54,471</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">54,060</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Less accumulated depreciation </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">(38,960</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">(38,079</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Total property and equipment, net</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">15,511</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">15,981</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Depreciation expense was </font><font style="font-family:inherit;font-size:11pt;">$1.0 million</font><font style="font-family:inherit;font-size:11pt;"> and $</font><font style="font-family:inherit;font-size:11pt;">1.1 million</font><font style="font-family:inherit;font-size:11pt;"> for </font><font style="font-family:inherit;font-size:11pt;">the three months ended March 31, 2019</font><font style="font-family:inherit;font-size:11pt;"> and </font><font style="font-family:inherit;font-size:11pt;">2018</font><font style="font-family:inherit;font-size:11pt;">, respectively.</font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">The Company has subscription agreements whereby its instruments in inventory may be placed at a customer's location on a rental basis. The cost of these instruments is transferred to machinery and equipment and depreciated, typically over a </font><font style="font-family:inherit;font-size:11pt;">5</font><font style="font-family:inherit;font-size:11pt;"> to </font><font style="font-family:inherit;font-size:11pt;">7</font><font style="font-family:inherit;font-size:11pt;"> year period depending on the circumstance under which the instrument is placed with the customer. Our cost of instruments under operating leases as of </font><font style="font-family:inherit;font-size:11pt;">March&#160;31, 2019</font><font style="font-family:inherit;font-size:11pt;"> and </font><font style="font-family:inherit;font-size:11pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:11pt;">, was&#160;</font><font style="font-family:inherit;font-size:11pt;">$11.0 million</font><font style="font-family:inherit;font-size:11pt;">&#160;and&#160;</font><font style="font-family:inherit;font-size:11pt;">$10.8 million</font><font style="font-family:inherit;font-size:11pt;">, respectively, before accumulated depreciation of&#160;</font><font style="font-family:inherit;font-size:11pt;">$6.4 million</font><font style="font-family:inherit;font-size:11pt;">&#160;and&#160;</font><font style="font-family:inherit;font-size:11pt;">$6.1 million</font><font style="font-family:inherit;font-size:11pt;">, respectively.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Property and equipment, net, consisted of the following (in thousands):</font><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:67%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">March 31,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">December 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">2018</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Land</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">377</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">377</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Building</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">2,978</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">2,978</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Machinery and equipment</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">33,591</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">33,087</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Office furniture and equipment</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">1,767</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">1,687</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Computer hardware and software</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">4,725</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">4,704</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Leasehold and building improvements</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">10,086</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">9,953</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Construction in progress</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">947</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">1,274</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">54,471</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">54,060</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Less accumulated depreciation </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">(38,960</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">(38,079</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Total property and equipment, net</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">15,511</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">15,981</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Summarized financial information concerning the Company's reportable segments is shown in the following tables (in thousands):</font></div><div style="line-height:120%;padding-top:8px;text-align:center;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="13" rowspan="1"></td></tr><tr><td style="width:49%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Three Months Ended March 31, 2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Core<br clear="none"/>Companion<br clear="none"/>Animal</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Other Vaccines and Pharmaceuticals</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#160;<br clear="none"/>&#160;<br clear="none"/>Total</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total revenue</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">24,716</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,795</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">29,511</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Operating loss</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(51</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(24</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(75</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Loss before income taxes</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(35</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(24</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(59</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Capital expenditures</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">44</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">190</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">234</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Depreciation and amortization</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">947</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">318</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,265</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:8px;text-align:center;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="13" rowspan="1"></td></tr><tr><td style="width:49%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Three Months Ended March 31, 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Core<br clear="none"/>Companion<br clear="none"/>Animal</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Other Vaccines and Pharmaceuticals</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#160;<br clear="none"/>&#160;<br clear="none"/>Total</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total revenue</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">26,819</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,946</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">32,765</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Operating income (loss)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,923</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(52</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,871</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Income (loss) before income taxes</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,927</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(52</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,875</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Capital expenditures</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">57</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">318</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">375</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Depreciation and amortization</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">908</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">288</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,196</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">REVENUE</font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">We separate our goods and services among:</font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:11pt;padding-left:24px;"><font style="font-family:inherit;font-size:11pt;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Point of Care laboratory products including instruments, consumables and services;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:11pt;padding-left:24px;"><font style="font-family:inherit;font-size:11pt;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Point of Care imaging products including instruments, software and services;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:11pt;padding-left:24px;"><font style="font-family:inherit;font-size:11pt;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Single use pharmaceuticals, vaccines and diagnostic tests primarily related to companion animals; and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:11pt;padding-left:24px;"><font style="font-family:inherit;font-size:11pt;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Other vaccines and pharmaceuticals ("OVP").</font></div></td></tr></table><div style="line-height:120%;padding-top:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">The following table summarizes our Core Companion Animal ("CCA") revenue (in thousands):</font></div><div style="line-height:120%;text-align:center;font-size:11pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:67%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Three Months Ended March 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">2018</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Point of Care laboratory revenue:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">15,961</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">13,641</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">&#160;&#160;&#160;&#160;Consumables</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">12,317</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">10,821</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">&#160;&#160;&#160;&#160;Sales-type leases</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">1,742</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">1,538</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">&#160;&#160;&#160;&#160;Outright instrument sales</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">1,528</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">811</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">&#160;&#160;&#160;&#160;Other</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">374</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">471</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Point of Care imaging revenue:</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">5,410</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">5,972</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">&#160;&#160;&#160;&#160;Outright instrument sales</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">4,546</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">5,137</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">&#160;&#160;&#160;&#160;Service revenue</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">562</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">556</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">&#160;&#160;&#160;&#160;Operating type leases and other</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">302</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">279</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Other CCA revenue:</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">3,345</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">7,206</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">&#160;&#160;&#160;&#160;Other pharmaceuticals, vaccines and diagnostic tests</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">3,246</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">7,109</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">&#160;&#160;&#160;&#160;Research and development, license and royalty revenue</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">99</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">97</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Total CCA revenue</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">24,716</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">26,819</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Revenue from our OVP segment consists of revenue generated from contract manufacturing agreements and from other license, research and development revenue. The following table summarizes our OVP revenue (in thousands): </font></div><div style="line-height:120%;padding-top:16px;text-align:center;font-size:11pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:65%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:15%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:15%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Three Months Ended March 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">2018</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Contract manufacturing</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">4,666</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">5,791</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">License, research and development</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">129</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">155</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Total OVP revenue</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">4,795</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">5,946</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Remaining Performance Obligations</font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Remaining performance obligations represent the aggregate transaction price allocated to performance obligations with an original contract term greater than one year which are fully or partially unsatisfied at the end of the period. Remaining performance obligations include noncancelable purchase orders, the non-lease portion of minimum purchase commitments under long-term supply arrangements, extended warranty, service and other long-term contracts. Remaining performance obligations do not include revenue from contracts with customers with an original term of one year or less, revenue from long-term supply arrangements with no minimum purchase requirements, revenue expected from purchases made in excess of the minimum purchase requirements, or revenue from instruments leased to customers. While the remaining performance obligation disclosure is similar in concept to backlog, the definition of remaining performance obligations excludes leases and contracts that provide the customer with the right to cancel or terminate for convenience with no substantial penalty, even if historical experience indicates the likelihood of cancellation or termination is remote. Additionally, the Company has elected to exclude contracts with customers with an original term of one year or less from remaining performance obligations.</font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">As of&#160;</font><font style="font-family:inherit;font-size:11pt;">March&#160;31, 2019</font><font style="font-family:inherit;font-size:11pt;">, the aggregate amount of the transaction price allocated to remaining minimum performance obligations was approximately&#160;</font><font style="font-family:inherit;font-size:11pt;">$87.2 million</font><font style="font-family:inherit;font-size:11pt;">. As of </font><font style="font-family:inherit;font-size:11pt;">March&#160;31, 2019</font><font style="font-family:inherit;font-size:11pt;">, the Company expects to recognize revenue as follows (in thousands):</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td style="width:80%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:18%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Year Ending December 31,</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Revenue</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2019 (remaining)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18,023</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2020</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">21,101</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2021</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17,078</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2022</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13,925</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2023</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10,337</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Thereafter</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,727</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">87,191</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Contract Balances</font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">The timing of revenue recognition, billings and cash collections results in billed accounts receivable, unbilled receivables (contract assets) and deferred revenue, and customer deposits and billings in excess of revenue recognized (contract liabilities) on the Condensed Consolidated Balance Sheets. In addition, the Company defers certain costs incurred to obtain contracts (contract costs).</font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-style:italic;">Contract Receivables</font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Certain unbilled receivable balances related to long-term contracts for which we provide a free term to the customer but have recognized revenue are recorded in other current and other non-current assets. We have no further performance obligations related to these receivable balances and the collection of these balances occurs over the term of the underlying contract. The balances as of </font><font style="font-family:inherit;font-size:11pt;">March&#160;31, 2019</font><font style="font-family:inherit;font-size:11pt;"> were </font><font style="font-family:inherit;font-size:11pt;">$0.9 million</font><font style="font-family:inherit;font-size:11pt;"> and </font><font style="font-family:inherit;font-size:11pt;">$3.4 million</font><font style="font-family:inherit;font-size:11pt;"> for current and non-current assets, respectively, shown net of related unearned interest. The balances as of </font><font style="font-family:inherit;font-size:11pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:11pt;"> were </font><font style="font-family:inherit;font-size:11pt;">$0.9 million</font><font style="font-family:inherit;font-size:11pt;"> and </font><font style="font-family:inherit;font-size:11pt;">$3.3 million</font><font style="font-family:inherit;font-size:11pt;"> for current and non-current assets, respectively, shown net of related unearned interest. </font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-style:italic;">Contract Liabilities</font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">The Company receives cash payments from customers for licensing fees or other arrangements that extend for a specified term. These contract liabilities are classified as either current or long-term in the Condensed Consolidated Balance Sheets based on the timing of when the Company expects to recognize revenue. As of&#160;</font><font style="font-family:inherit;font-size:11pt;">March&#160;31, 2019</font><font style="font-family:inherit;font-size:11pt;">&#160;and </font><font style="font-family:inherit;font-size:11pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:11pt;">, contract liabilities were&#160;</font><font style="font-family:inherit;font-size:11pt;">$9.2 million</font><font style="font-family:inherit;font-size:11pt;">&#160;and&#160;</font><font style="font-family:inherit;font-size:11pt;">$9.6 million</font><font style="font-family:inherit;font-size:11pt;">, respectively, and are included within "Current portion of deferred revenue, and other" and "Deferred revenue, net of current portion" in the accompanying Condensed Consolidated Balance Sheets. The&#160;decrease&#160;in the contract liability balance during the </font><font style="font-family:inherit;font-size:11pt;">three</font><font style="font-family:inherit;font-size:11pt;">-month period ended&#160;</font><font style="font-family:inherit;font-size:11pt;">March&#160;31, 2019</font><font style="font-family:inherit;font-size:11pt;">&#160;is </font><font style="font-family:inherit;font-size:11pt;">$0.7 million</font><font style="font-family:inherit;font-size:11pt;"> of revenue recognized during the period, offset by </font><font style="font-family:inherit;font-size:11pt;">$0.4 million</font><font style="font-family:inherit;font-size:11pt;"> of additional deferred sales in </font><font style="font-family:inherit;font-size:11pt;">2019</font><font style="font-family:inherit;font-size:11pt;">. </font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-style:italic;">Contract Costs</font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">The Company capitalizes certain direct incremental costs incurred to obtain customer contracts, typically sales-related commissions, where the recognition period for the related revenue is greater than one year. Contract costs are classified as current or non-current, and are included in "Other current assets" and "Other non-current assets" in the Condensed Consolidated Balance Sheets based on the timing of when the Company expects to recognize the expense. Contract costs are generally amortized into selling and marketing expense with a certain percentage recognized immediately based upon placement of the instrument with the remainder recognized on a straight-line basis (which is consistent with the transfer of control for the related goods or services) over the average term of the underlying contracts, approximately </font><font style="font-family:inherit;font-size:11pt;">6</font><font style="font-family:inherit;font-size:11pt;"> years. Management assesses these costs for impairment at least quarterly on a portfolio basis and as &#8220;triggering&#8221; events occur that indicate it is more-likely-than-not that an impairment exists. The balance of contract costs as of&#160;</font><font style="font-family:inherit;font-size:11pt;">March&#160;31, 2019</font><font style="font-family:inherit;font-size:11pt;">&#160;and </font><font style="font-family:inherit;font-size:11pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:11pt;"> was </font><font style="font-family:inherit;font-size:11pt;">$2.5 million</font><font style="font-family:inherit;font-size:11pt;"> and </font><font style="font-family:inherit;font-size:11pt;">$2.5 million</font><font style="font-family:inherit;font-size:11pt;">, respectively. Amortization expense for the </font><font style="font-family:inherit;font-size:11pt;">three</font><font style="font-family:inherit;font-size:11pt;">-month period ended&#160;</font><font style="font-family:inherit;font-size:11pt;">March&#160;31, 2019</font><font style="font-family:inherit;font-size:11pt;"> was approximately </font><font style="font-family:inherit;font-size:11pt;">$0.2 million</font><font style="font-family:inherit;font-size:11pt;">, offset by approximately </font><font style="font-family:inherit;font-size:11pt;">$0.3 million</font><font style="font-family:inherit;font-size:11pt;"> of additional contract costs capitalized. </font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Contract liabilities are reported on the accompanying Condensed Consolidated Balance Sheets on a contract-by-contract basis whereas contract costs are calculated and reported on a portfolio basis.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">As of </font><font style="font-family:inherit;font-size:11pt;">March&#160;31, 2019</font><font style="font-family:inherit;font-size:11pt;">, the Company expects to recognize revenue as follows (in thousands):</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td style="width:80%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:18%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Year Ending December 31,</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Revenue</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2019 (remaining)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18,023</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2020</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">21,101</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2021</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17,078</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2022</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13,925</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2023</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10,337</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Thereafter</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,727</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">87,191</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Accrued liabilities consisted of the following (in thousands):</font><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:57%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:19%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:19%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">March&#160;31, <br clear="none"/>2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">December&#160;31, <br clear="none"/>2018</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Accrued settlement (see Note 14)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">6,750</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">6,750</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Accrued payroll and employee benefits</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">840</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">759</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Accrued property taxes</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">232</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">632</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Inventory in transit</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">1,281</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">327</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Other</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">1,544</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">1,674</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Total accrued liabilities</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">10,647</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">10,142</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Accumulated other comprehensive income (loss) consisted of the following (in thousands):</font></div><div style="line-height:120%;padding-top:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td style="width:58%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Minimum Pension Liability</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Foreign Currency Translation</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Total Accumulated Other Comprehensive Income</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balances at December 31, 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(419</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">696</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">277</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Current period other comprehensive loss</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(62</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(62</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balances at March 31, 2019</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(419</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">634</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">215</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">The following stock options and restricted shares were excluded from the computation of diluted EPS because they would have been anti-dilutive (in thousands):</font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="6" rowspan="1"></td></tr><tr><td style="width:73%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;padding-left:12px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Three Months Ended March 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">2018</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Stock options</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">86</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">244</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Our total income tax benefit for our (loss) income before income taxes were as follows (in thousands):</font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td style="width:60%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:17%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:17%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;padding-left:12px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Three Months Ended March 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">2018</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">(Loss) income before income taxes</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">(59</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">1,875</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Total income tax benefit</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">(1,010</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">(280</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">)</font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:10pt;">The </font><font style="font-family:inherit;font-size:11pt;">following is a reconciliation of the weighted-average shares outstanding used in the calculation of basic and diluted EPS for the </font><font style="font-family:inherit;font-size:11pt;">three</font><font style="font-family:inherit;font-size:11pt;"> months ended </font><font style="font-family:inherit;font-size:11pt;">March&#160;31, 2019</font><font style="font-family:inherit;font-size:11pt;"> and </font><font style="font-family:inherit;font-size:11pt;">2018</font><font style="font-family:inherit;font-size:11pt;"> (in thousands, except per share data):</font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:73%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Three Months Ended March 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">2018</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Net income attributable to Heska Corporation</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">814</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">2,155</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Basic weighted-average common shares outstanding</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">7,459</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">7,102</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Assumed exercise of dilutive stock options and restricted shares</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">506</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">609</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Diluted weighted-average common shares outstanding</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">7,965</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">7,711</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Basic earnings per share attributable to Heska Corporation</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">0.11</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">0.30</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Diluted earnings per share attributable to Heska Corporation</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">0.10</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">0.28</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Other intangibles consisted of the following (in thousands):</font></div><div style="line-height:120%;text-align:center;font-size:11pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="24" rowspan="1"></td></tr><tr><td style="width:22%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;padding-left:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">March 31, 2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;padding-left:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December 31, 2018</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Gross Carrying Amount</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Accumulated Amortization</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Net Carrying Amount</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Gross Carrying Amount</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Accumulated Amortization</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Net Carrying Amount</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Developed technology</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">8,200</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">(205</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">7,995</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">8,200</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">8,200</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Customer relationships and other</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">3,793</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">(1,865</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">1,928</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">3,303</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">(1,739</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">1,564</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Total intangible assets</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">11,993</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">(2,070</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">9,923</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">11,503</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">(1,739</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">9,764</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br clear="none"/></font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">The following summarizes the change in goodwill during </font><font style="font-family:inherit;font-size:11pt;">the three months ended March 31, 2019</font><font style="font-family:inherit;font-size:11pt;"> (in thousands):</font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td style="width:82%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:16%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Carrying amount, December 31, 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">26,679</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Goodwill attributable to acquisitions (subject to change)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">643</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Foreign currency adjustments</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">(11</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Carrying amount, March 31, 2019</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">27,311</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Inventories, net, consisted of the following (in thousands):</font></div><div style="line-height:120%;text-align:center;font-size:11pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td style="width:66%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">March 31,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">December 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">2018</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Raw materials</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">16,626</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">15,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Work in process</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">3,214</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">3,592</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Finished goods</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">8,869</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">8,085</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Allowance for excess or obsolete inventory</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">(1,321</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">(1,573</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Total inventory, net</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">27,388</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">25,104</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Asset information by reportable segment as of </font><font style="font-family:inherit;font-size:11pt;">March&#160;31, 2019</font><font style="font-family:inherit;font-size:11pt;"> is as follows (in thousands):</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="13" rowspan="1"></td></tr><tr><td style="width:49%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Three Months Ended March 31, 2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Core</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Companion</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Animal</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Other Vaccines and Pharmaceuticals</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Investments in unconsolidated affiliates</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,837</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,837</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">138,076</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">24,704</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">162,780</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net assets</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">95,683</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">26,256</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">121,939</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Asset information by reportable segment as of </font><font style="font-family:inherit;font-size:11pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:11pt;"> is as follows (in thousands):</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="13" rowspan="1"></td></tr><tr><td style="width:49%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Year Ended December 31, 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Core</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Companion</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Animal</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Other Vaccines and Pharmaceuticals</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Investments in unconsolidated affiliates</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,018</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,018</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">133,586</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">22,866</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">156,452</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net assets</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">96,129</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">26,280</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">122,409</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br clear="none"/></font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">The following table summarizes information about stock options outstanding and exercisable at </font><font style="font-family:inherit;font-size:11pt;">March&#160;31, 2019</font><font style="font-family:inherit;font-size:11pt;">:</font><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="17" rowspan="1"></td></tr><tr><td style="width:25%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="8" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Options Outstanding</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Options Exercisable</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Exercise Prices</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Number of<br clear="none"/>Options<br clear="none"/>Outstanding<br clear="none"/>at<br clear="none"/>March 31, 2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Weighted</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Average</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Remaining</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Contractual</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Life in Years</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Weighted</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Average</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Exercise</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Price</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Number of<br clear="none"/>Options<br clear="none"/>Exercisable<br clear="none"/>at<br clear="none"/>March 31, 2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Weighted</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Average</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Exercise</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Price</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$ 4.50 - $ 7.36</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">101,502</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.65</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6.807</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">101,502</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6.807</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$ 7.37 - $ 32.21</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">94,485</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.05</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15.917</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">93,758</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15.793</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$ 32.22 - $ 62.50</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">61,104</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6.84</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">39.783</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">44,672</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">39.693</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$ 62.51 - $ 69.77</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">130,000</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8.93</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">69.770</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">43,337</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">69.770</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$ 69.78 - $ 108.25</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">111,767</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8.20</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">86.020</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">36,254</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">81.236</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$ 4.50 - $ 108.25</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">498,858</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6.70</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">46.727</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">319,523</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">31.026</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">A summary of our stock option plans is as follows:</font></div><div style="line-height:120%;padding-top:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="14" rowspan="1"></td></tr><tr><td style="width:49%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Three Months Ended March 31,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Year Ended December 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="padding-bottom:28px;text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">&#160;<br clear="none"/>&#160;<br clear="none"/>&#160;<br clear="none"/>Options</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Weighted Average Exercise Price</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="padding-bottom:28px;text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">&#160;<br clear="none"/>&#160;<br clear="none"/>&#160;<br clear="none"/>Options</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Weighted Average Exercise Price</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Outstanding at beginning of period</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">620,553</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">40.741</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">630,847</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">29.312</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Granted at market</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,200</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">98.970</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">153,700</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">75.244</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Forfeited</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(18,978</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">53.010</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Expired</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(896</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">25.740</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Exercised</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(122,895</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17.013</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(144,120</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">65.414</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Outstanding at end of period</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">498,858</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">46.727</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">620,553</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">40.741</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Exercisable at end of period</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">319,523</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">31.026</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">386,176</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">21.214</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">The fair value of each option grant was estimated on the date of grant using the Black-Scholes option-pricing model with the following weighted average assumptions for options granted in the </font><font style="font-family:inherit;font-size:11pt;">three</font><font style="font-family:inherit;font-size:11pt;"> months ended </font><font style="font-family:inherit;font-size:11pt;">March 31,</font><font style="font-family:inherit;font-size:11pt;"> </font><font style="font-family:inherit;font-size:11pt;">2019</font><font style="font-family:inherit;font-size:11pt;"> and </font><font style="font-family:inherit;font-size:11pt;">2018</font><font style="font-family:inherit;font-size:11pt;">.</font></div><div style="line-height:120%;padding-top:4px;text-align:left;font-size:11pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td style="width:67%;" rowspan="1" colspan="1"></td><td style="width:16%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:16%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;padding-left:24px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Three Months Ended March 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">2018</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Risk-free interest rate</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">2.45%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">2.64%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Expected lives</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">4.7 years</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">4.9 years</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Expected volatility</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">39%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">40%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Expected dividend yield</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">0%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">0%</font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Estimated amortization expense related to intangibles for each of the five years from 2019 (remaining) through 2023 and thereafter is as follows (in thousands):</font></div><div style="line-height:120%;text-align:center;font-size:11pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td style="width:87%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Year Ending December 31,</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">2019 (remaining)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">968</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">2020</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">1,284</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">2021</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">1,280</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">2022</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">1,262</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">2023</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">915</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Thereafter</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">4,214</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">9,923</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">SEGMENT REPORTING</font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">The Company is composed of </font><font style="font-family:inherit;font-size:11pt;">two</font><font style="font-family:inherit;font-size:11pt;"> reportable segments, CCA and OVP. The CCA segment includes Point of Care diagnostic laboratory instruments and consumables, and Point of Care digital imaging diagnostic instruments and software services as well as single use diagnostic and other tests, pharmaceuticals and vaccines, primarily for canine and feline use. These products are sold directly by the Company as well as through independent third-party distributors and through other distribution relationships. CCA segment products manufactured at the Des Moines, Iowa production facility included in the OVP segment's assets are transferred at cost and are not recorded as revenue for the OVP segment. The OVP segment includes private label vaccine and pharmaceutical production, primarily for cattle, but also for other animals including small mammals. All OVP products are sold by third parties under third-party labels.</font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Summarized financial information concerning the Company's reportable segments is shown in the following tables (in thousands):</font></div><div style="line-height:120%;padding-top:8px;text-align:center;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="13" rowspan="1"></td></tr><tr><td style="width:49%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Three Months Ended March 31, 2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Core<br clear="none"/>Companion<br clear="none"/>Animal</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Other Vaccines and Pharmaceuticals</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#160;<br clear="none"/>&#160;<br clear="none"/>Total</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total revenue</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">24,716</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,795</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">29,511</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Operating loss</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(51</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(24</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(75</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Loss before income taxes</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(35</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(24</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(59</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Capital expenditures</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">44</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">190</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">234</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Depreciation and amortization</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">947</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">318</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,265</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:8px;text-align:center;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="13" rowspan="1"></td></tr><tr><td style="width:49%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Three Months Ended March 31, 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Core<br clear="none"/>Companion<br clear="none"/>Animal</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Other Vaccines and Pharmaceuticals</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#160;<br clear="none"/>&#160;<br clear="none"/>Total</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total revenue</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">26,819</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,946</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">32,765</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Operating income (loss)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,923</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(52</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,871</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Income (loss) before income taxes</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,927</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(52</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,875</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Capital expenditures</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">57</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">318</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">375</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Depreciation and amortization</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">908</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">288</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,196</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Asset information by reportable segment as of </font><font style="font-family:inherit;font-size:11pt;">March&#160;31, 2019</font><font style="font-family:inherit;font-size:11pt;"> is as follows (in thousands):</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="13" rowspan="1"></td></tr><tr><td style="width:49%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Three Months Ended March 31, 2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Core</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Companion</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Animal</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Other Vaccines and Pharmaceuticals</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Investments in unconsolidated affiliates</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,837</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,837</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">138,076</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">24,704</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">162,780</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net assets</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">95,683</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">26,256</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">121,939</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Asset information by reportable segment as of </font><font style="font-family:inherit;font-size:11pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:11pt;"> is as follows (in thousands):</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="13" rowspan="1"></td></tr><tr><td style="width:49%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Year Ended December 31, 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Core</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Companion</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Animal</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Other Vaccines and Pharmaceuticals</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Investments in unconsolidated affiliates</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,018</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,018</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">133,586</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">22,866</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">156,452</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net assets</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">96,129</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">26,280</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">122,409</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Heska Corporation and its wholly-owned subsidiaries ("Heska", the "Company", "we" or "our") sell veterinary and animal health diagnostic and specialty products. Our offerings include Point of Care diagnostic laboratory instruments and supplies; digital imaging diagnostic products, software and services; vaccines; local and cloud-based data services; allergy testing and immunotherapy; and single-use offerings such as in-clinic diagnostic tests and heartworm preventive products. Our core focus is on supporting veterinarians in the canine and feline healthcare space.</font></div><div style="line-height:120%;padding-top:16px;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-style:italic;">Basis of Presentation and Consolidation</font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">In the opinion of management, the accompanying unaudited Condensed Consolidated Financial Statements contain all adjustments, consisting of normal, recurring adjustments, necessary to present fairly the financial position of the Company as of </font><font style="font-family:inherit;font-size:11pt;">March&#160;31, 2019</font><font style="font-family:inherit;font-size:11pt;"> and </font><font style="font-family:inherit;font-size:11pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:11pt;">, the results of our operations, statements of stockholders' equity and cash flows for the </font><font style="font-family:inherit;font-size:11pt;">three</font><font style="font-family:inherit;font-size:11pt;"> months ended </font><font style="font-family:inherit;font-size:11pt;">March&#160;31, 2019</font><font style="font-family:inherit;font-size:11pt;"> and </font><font style="font-family:inherit;font-size:11pt;">2018</font><font style="font-family:inherit;font-size:11pt;">.</font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">The unaudited Condensed Consolidated Financial Statements included herein have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission ("SEC"). Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America ("GAAP") have been condensed or omitted pursuant to such rules and regulations. Our unaudited Condensed Consolidated Financial Statements include our accounts and the accounts of our wholly-owned subsidiaries since their respective dates of acquisitions. All intercompany accounts and transactions have been eliminated in consolidation. Where our ownership of a subsidiary is less than 100%, the non-controlling interest is reported on our Condensed Consolidated Balance Sheets. The non-controlling interest in our consolidated net income is reported as "Net loss attributable to redeemable non-controlling interest" on our Condensed Consolidated Statements of Income. These unaudited Condensed Consolidated Financial Statements should be read in conjunction with the audited Consolidated Financial Statements and Notes thereto contained in our Annual Report on Form&#160;10-K for the fiscal year ended </font><font style="font-family:inherit;font-size:11pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:11pt;"> and other financial information filed with the SEC.</font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-style:italic;">Reclassification</font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">To maintain consistency and comparability, certain amounts in the financial statements have been reclassified to conform to current year presentation.</font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-style:italic;">Use of Estimates</font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates are required when establishing the allowance for doubtful accounts and the net realizable value of inventory; determining future costs associated with warranties provided; determining the period over which our obligations are fulfilled under agreements to license product rights and/or technology rights; evaluating long-lived and intangible assets and investments for estimated useful lives and impairment; estimating the useful lives of instruments under leasing arrangements; determining the allocation of purchase price under purchase accounting; estimating the expense associated with the granting of stock; determining the need for, and the amount of a valuation allowance on deferred tax assets; and determining the value of the non-controlling interest in a business combination.</font></div><div style="line-height:120%;padding-top:16px;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-style:italic;">Critical Accounting Policies</font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Our accounting policies are described in our audited Consolidated Financial Statements and Notes thereto contained in our Annual Report on Form 10-K for the year ended December&#160;31, </font><font style="font-family:inherit;font-size:11pt;">2018</font><font style="font-family:inherit;font-size:11pt;"> and other than the recently adopted accounting pronouncements described below, have not changed significantly since such filing.</font></div><div style="line-height:120%;padding-top:16px;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-style:italic;">Adoption of New Accounting Pronouncements</font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Effective January 1, 2019, we adopted&#160;ASU 2018-07,&#160;</font><font style="font-family:inherit;font-size:11pt;font-style:italic;">Compensation &#8211; Stock Compensation (Topic 718)</font><font style="font-family:inherit;font-size:11pt;">, </font><font style="font-family:inherit;font-size:11pt;font-style:italic;">Improvements to Non-employee Share-Based Payment Accounting</font><font style="font-family:inherit;font-size:11pt;">.&#160;This ASU is intended to simplify aspects of share-based compensation issued to non-employees by making the guidance consistent with accounting for employee share-based compensation. Guidance related to the stock compensation granted to employees is followed for non-employees, including the measurement date, valuation approach and performance conditions. The expense is recognized in the same period as though cash were paid for the good or service, ratably over the service period. The adoption of this ASU did not have an impact on our consolidated financial statements but did have a minimal impact on our related disclosures.</font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Effective January 1, 2019, we adopted ASU 2018-02, </font><font style="font-family:inherit;font-size:11pt;font-style:italic;">Income Statement-Reporting Comprehensive Income (Topic 220): Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income</font><font style="font-family:inherit;font-size:11pt;">. The ASU permits companies to elect a reclassification of the disproportionate tax effects in accumulated other comprehensive income ("AOCI") caused by the Tax Cuts and Jobs Act of 2017 to retained earnings. As of March 31, 2019, the Company does not have any disproportionate income tax effects in AOCI to reclassify. However, if the Company did have disproportionate income tax effects in AOCI in the future, it would reclassify them to retained earnings.</font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">In February 2016, the FASB issued ASU 2016-02, </font><font style="font-family:inherit;font-size:11pt;font-style:italic;">Leases (</font><font style="font-family:inherit;font-size:11pt;">Topic 842</font><font style="font-family:inherit;font-size:11pt;font-style:italic;">)</font><font style="font-family:inherit;font-size:11pt;">, which supersedes ASC 840, </font><font style="font-family:inherit;font-size:11pt;font-style:italic;">Leases</font><font style="font-family:inherit;font-size:11pt;">. This update requires lessees to recognize a right-of-use (&#8220;ROU&#8221;) asset and a lease liability for all leases, including operating leases, with terms greater than 12 months on its balance sheet. The update also expands the required quantitative and qualitative disclosures by lessees and lessors about the amount, timing and uncertainty of cash flows arising from leases. The accounting for lessors does not fundamentally change except for changes to conform and align guidance to the lessee guidance as well as to the new revenue recognition guidance in ASU 2014-09, </font><font style="font-family:inherit;font-size:11pt;font-style:italic;">Revenue from Contracts with Customers (Topic 606)</font><font style="font-family:inherit;font-size:11pt;">. Subsequent to the issuance of Topic 842, the FASB clarified the guidance through several ASUs; hereinafter the collection of lease guidance is referred to as &#8220;ASC 842&#8221;.</font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">The Company adopted ASC 842 on January 1, 2019, using the modified retrospective approach for all lease arrangements at the beginning of the period of adoption. Results for reporting periods beginning January 1, 2019 are presented under ASC 842, while prior period amounts were not adjusted and continue to be reported in accordance with the Company&#8217;s historic accounting under ASC 840, </font><font style="font-family:inherit;font-size:11pt;font-style:italic;">Leases</font><font style="font-family:inherit;font-size:11pt;">. For leases that commenced before the effective date of ASC 842, the Company elected the permitted practical expedients to not reassess the following: (i) whether any expired or existing contracts contain leases; (ii) the lease classification for any expired or existing leases; and (iii) initial direct costs for any existing leases. The Company also elected to exclude leases with a term of 12 months or less from the recognized ROU assets and lease liabilities.</font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Adoption of the standard did not have a material net impact in our Condensed Consolidated Balance Sheets, Condensed Consolidated Statements of Income or Condensed Consolidated Statements of Cash Flows. The most significant impact was the recognition of ROU assets and lease liabilities for the operating leases, of which we are the lessee. As a result of the cumulative impact of adopting ASC 842, the Company recorded operating lease ROU assets of </font><font style="font-family:inherit;font-size:11pt;">$6.5 million</font><font style="font-family:inherit;font-size:11pt;"> and operating lease liabilities of </font><font style="font-family:inherit;font-size:11pt;">$6.9 million</font><font style="font-family:inherit;font-size:11pt;"> as of January 1, 2019, primarily related to building, vehicle, and office equipment leases, based on the present value of the future lease payments on the date of adoption. As a lessor, accounting for our subscription agreements will remain substantially unchanged. Refer to Note 6 for additional disclosures required by ASC 842. </font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">The Company determines if an arrangement is a lease at inception based on whether control of an identified asset is transferred. For leases where the Company is the lessee, ROU assets represent the Company&#8217;s right to use an underlying asset for the lease term and lease liabilities represent an obligation to make lease payments arising from the lease. ROU assets and lease liabilities are recognized at the lease commencement date based on the present value of lease payments over the lease term. As most of the Company&#8217;s leases do not provide an implicit interest rate, the Company uses its incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. The lease terms used to calculate the ROU asset and related lease liability include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. Lease expense for operating leases is recognized on a straight-line basis over the lease term as an operating expense while the expense for finance leases is recognized as amortization expense and interest expense. The Company has lease agreements which require payments for lease and non-lease components and has elected to account for these as a single lease component for our building and office equipment leases, but as separate components for our vehicle leases. </font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Our revenue under subscription agreements relates to both operating-type lease (&#8220;OTL&#8221;) arrangements or sales-type lease (&#8220;STL&#8221;) arrangements. Determination of an OTL or STL is primarily determined as a result of the length of the contract as compared to the estimated useful life of the instrument, among other factors. A STL results in earlier recognition of instrument revenue. The cost of the customer-leased instruments is removed from inventory and recognized in the Consolidated Statements of Income. There is no residual value taken into consideration as it does not meet our capitalization requirements. Instrument lease revenue for OTL agreements is recognized on a straight-line basis over the life of the lease and included with the predominant non-lease components in consumable revenue. The costs of customer-leased instruments are recorded within property and equipment in the accompanying Consolidated Balance Sheets and depreciated over the instrument&#8217;s estimated useful life. The depreciation expense is reflected in cost of revenue in the accompanying Consolidated Statements of Income. The OTLs and STLs are not cancellable until after an initial term and include an option to renew. </font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">For lease arrangements with lease and non-lease components where the Company is the lessor, the Company allocates the contracts transaction price to the lease and non-lease components on a relative standalone selling price basis using the Company&#8217;s best estimate of the standalone selling price of each distinct product or service in the contract. The primary method used to estimate standalone selling price is the price observed in standalone sales to customers of a prior period. Changes in these values can impact the amount of consideration allocated to each component of the contract. When prices in standalone sales are not available, we may use a cost-plus margin approach. Allocation of the transaction price is determined at the inception of the lease arrangement. The Company&#8217;s leases consist of leases with fixed and variable lease payments. For those leases with variable lease payments, the variable lease payment is typically based upon purchase of consumables used with the leased instruments and included in consumable revenue.</font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"> </font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-style:italic;">Accounting Pronouncements Not Yet Adopted</font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">In June 2016, the FASB issued ASU&#160;2016-13,</font><font style="font-family:inherit;font-size:11pt;font-style:italic;">&#160;Financial Instruments - Credit Losses (Topic 326)</font><font style="font-family:inherit;font-size:11pt;">, which requires that financial assets measured at amortized cost be presented at the net amount expected to be collected. The allowance for credit losses is a valuation account that is deducted from the amortized cost basis of the financial asset to present the net carrying value at the amount expected to be collected. The income statement reflects the measurement of credit losses for newly recognized financial assets, as well as the increases or decreases of expected credit losses that have taken place during the period. The measurement of expected credit losses is based upon historical experience, current conditions and reasonable and supportable forecasts that affect the collectability of the reported amount. In November 2018, the FASB issued ASU 2018-19,</font><font style="font-family:inherit;font-size:11pt;font-style:italic;"> Codification Improvements to Topic 326, Financial Instruments - Credit Losses</font><font style="font-family:inherit;font-size:11pt;">. This ASU clarifies that receivables from operating leases are accounted for using the lease guidance and not as financial instruments. The amendments in this update are</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:11pt;">effective for fiscal years beginning after December 15, 2019 and interim periods within those annual periods. Early adoption for fiscal year beginning after December 15, 2018 is permitted. We will adopt the provisions of this ASU in the first quarter of 2020. We are currently evaluating the effect of this update on our consolidated financial statements.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates are required when establishing the allowance for doubtful accounts and the net realizable value of inventory; determining future costs associated with warranties provided; determining the period over which our obligations are fulfilled under agreements to license product rights and/or technology rights; evaluating long-lived and intangible assets and investments for estimated useful lives and impairment; estimating the useful lives of instruments under leasing arrangements; determining the allocation of purchase price under purchase accounting; estimating the expense associated with the granting of stock; determining the need for, and the amount of a valuation allowance on deferred tax assets; and determining the value of the non-controlling interest in a business combination.</font></div></div> EX-101.SCH 6 hska-20190331.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 2116100 - Disclosure - ACCRUED LIABILITIES link:presentationLink link:calculationLink link:definitionLink 2416402 - Disclosure - ACCRUED LIABILITIES (Details) link:presentationLink link:calculationLink link:definitionLink 2316301 - Disclosure - ACCRUED LIABILITIES (Tables) link:presentationLink link:calculationLink link:definitionLink 2119100 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE INCOME link:presentationLink link:calculationLink link:definitionLink 2419402 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE INCOME (Details) link:presentationLink link:calculationLink link:definitionLink 2319301 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE INCOME (Tables) link:presentationLink link:calculationLink link:definitionLink 2104100 - Disclosure - ACQUISITION AND RELATED PARTY ITEMS link:presentationLink link:calculationLink link:definitionLink 2404401 - Disclosure - ACQUISITION AND RELATED PARTY ITEMS (Details) link:presentationLink link:calculationLink link:definitionLink 2118100 - Disclosure - CAPITAL STOCK link:presentationLink link:calculationLink link:definitionLink 2418405 - Disclosure - CAPITAL STOCK CAPITAL STOCK - RESTRICTED STOCK (Details) link:presentationLink link:calculationLink link:definitionLink 2418404 - Disclosure - CAPITAL STOCK - EXERCISE PRICE (Details) link:presentationLink link:calculationLink link:definitionLink 2418403 - Disclosure - CAPITAL STOCK - NARRATIVE (Details) link:presentationLink link:calculationLink link:definitionLink 2418402 - Disclosure - CAPITAL STOCK - OPTION ACTIVITY (Details) link:presentationLink link:calculationLink link:definitionLink 2318301 - Disclosure - CAPITAL STOCK (Tables) link:presentationLink link:calculationLink link:definitionLink 2121100 - Disclosure - COMMITMENTS AND CONTINGENCIES link:presentationLink link:calculationLink link:definitionLink 2421401 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details) link:presentationLink link:calculationLink link:definitionLink 1001000 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS link:presentationLink link:calculationLink link:definitionLink 1001501 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 1005000 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS link:presentationLink link:calculationLink link:definitionLink 1003000 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME link:presentationLink link:calculationLink link:definitionLink 1003000 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME link:presentationLink link:calculationLink link:definitionLink 1002000 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF INCOME link:presentationLink link:calculationLink link:definitionLink 1004000 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY link:presentationLink link:calculationLink link:definitionLink 2123100 - Disclosure - CREDIT FACILITY link:presentationLink link:calculationLink link:definitionLink 2423401 - Disclosure - CREDIT FACILITY (Details) link:presentationLink link:calculationLink link:definitionLink 0001000 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 2109100 - Disclosure - EARNINGS PER SHARE link:presentationLink link:calculationLink link:definitionLink 2409402 - Disclosure - EARNINGS PER SHARE (Details) link:presentationLink link:calculationLink link:definitionLink 2309301 - Disclosure - EARNINGS PER SHARE (Tables) link:presentationLink link:calculationLink link:definitionLink 2111100 - Disclosure - GOODWILL AND OTHER INTANGIBLES link:presentationLink link:calculationLink link:definitionLink 2411402 - Disclosure - GOODWILL AND OTHER INTANGIBLES (Details) link:presentationLink link:calculationLink link:definitionLink 2411402 - Disclosure - GOODWILL AND OTHER INTANGIBLES (Details) link:presentationLink link:calculationLink link:definitionLink 2311301 - Disclosure - GOODWILL AND OTHER INTANGIBLES (Tables) link:presentationLink link:calculationLink link:definitionLink 2107100 - Disclosure - INCOME TAXES link:presentationLink link:calculationLink link:definitionLink 2407402 - Disclosure - INCOME TAXES (Details) link:presentationLink link:calculationLink link:definitionLink 2307301 - Disclosure - INCOME TAXES (Tables) link:presentationLink link:calculationLink link:definitionLink 2122100 - Disclosure - INTEREST AND OTHER EXPENSE, NET link:presentationLink link:calculationLink link:definitionLink 2422402 - Disclosure - INTEREST AND OTHER EXPENSE, NET (Details) link:presentationLink link:calculationLink link:definitionLink 2322301 - Disclosure - INTEREST AND OTHER EXPENSE, NET (Tables) link:presentationLink link:calculationLink link:definitionLink 2114100 - Disclosure - INVENTORIES, NET link:presentationLink link:calculationLink link:definitionLink 2414402 - Disclosure - INVENTORIES, NET (Details) link:presentationLink link:calculationLink link:definitionLink 2314301 - Disclosure - INVENTORIES, NET (Tables) link:presentationLink link:calculationLink link:definitionLink 2105100 - Disclosure - INVESTMENTS IN UNCONSOLIDATED AFFILIATES link:presentationLink link:calculationLink link:definitionLink 2405402 - Disclosure - INVESTMENTS IN UNCONSOLIDATED AFFILIATES (Details) link:presentationLink link:calculationLink link:definitionLink 2305301 - Disclosure - INVESTMENTS IN UNCONSOLIDATED AFFILIATES (Tables) link:presentationLink link:calculationLink link:definitionLink 2108100 - Disclosure - LEASES link:presentationLink link:calculationLink link:definitionLink 2408402 - Disclosure - LEASES - LESEE ACCOUNTING (Details) link:presentationLink link:calculationLink link:definitionLink 2408402 - Disclosure - LEASES - LESEE ACCOUNTING (Details) link:presentationLink link:calculationLink link:definitionLink 2408403 - Disclosure - LEASES - LESSOR ACCOUNTING (Details) link:presentationLink link:calculationLink link:definitionLink 2308301 - Disclosure - LEASES (Tables) link:presentationLink link:calculationLink link:definitionLink 2101100 - Disclosure - OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES link:presentationLink link:calculationLink link:definitionLink 2401402 - Disclosure - OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) link:presentationLink link:calculationLink link:definitionLink 2201201 - Disclosure - OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) link:presentationLink link:calculationLink link:definitionLink 2112100 - Disclosure - PROPERTY AND EQUIPMENT link:presentationLink link:calculationLink link:definitionLink 2412402 - Disclosure - PROPERTY AND EQUIPMENT (Details) link:presentationLink link:calculationLink link:definitionLink 2312301 - Disclosure - PROPERTY AND EQUIPMENT (Tables) link:presentationLink link:calculationLink link:definitionLink 2103100 - Disclosure - REVENUE link:presentationLink link:calculationLink link:definitionLink 2403402 - Disclosure - REVENUE (Details) link:presentationLink link:calculationLink link:definitionLink 2403403 - Disclosure - REVENUE - Performance Obligations (Details) link:presentationLink link:calculationLink link:definitionLink 2303301 - Disclosure - REVENUE (Tables) link:presentationLink link:calculationLink link:definitionLink 2124100 - Disclosure - SEGMENT REPORTING link:presentationLink link:calculationLink link:definitionLink 2424403 - Disclosure - SEGMENT REPORTING (Details) link:presentationLink link:calculationLink link:definitionLink 2424402 - Disclosure - SEGMENT REPORTING - NARRATIVE (Details) link:presentationLink link:calculationLink link:definitionLink 2324301 - Disclosure - SEGMENT REPORTING (Tables) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 7 hska-20190331_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 8 hska-20190331_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 9 hska-20190331_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Disclosure of Compensation Related Costs, Share-based Payments [Abstract] Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Award Type [Axis] Award Type [Axis] Equity Award [Domain] Equity Award [Domain] Employee Stock Option Employee Stock Option [Member] Employee Stock Employee Stock [Member] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Risk-free interest rate (as a percent) Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate Expected lives (in years) Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term Expected volatility (as a percent) Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate Expected dividend rate (as a percent) Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward] Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward] Outstanding at beginning of period Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number Granted at market Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures Forfeited Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period Expired Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period Exercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period Outstanding at end of period Exercisable at end of period Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract] Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract] Outstanding at beginning of period (in dollars per share) Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Exercise Price Granted at market (in dollars per share) Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Forfeited (in dollars per share) Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price Expired (in dollars per share) Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price Exercised (in dollars per share) Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Outstanding at ending of period (in dollars per share) Exercisable at end of period (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price Segment Reporting [Abstract] SEGMENT REPORTING Segment Reporting Disclosure [Text Block] Revenue from Contract with Customer [Abstract] Revenue, Initial Application Period Cumulative Effect Transition [Table] Revenue, Initial Application Period Cumulative Effect Transition [Table] Product and Service [Axis] Product and Service [Axis] Product and Service [Domain] Product and Service [Domain] Core companion animal Core Companion Animal Health [Member] Core Companion Animal Health [Member] Point of Care laboratory revenue: Point Of Care Laboratory Revenue [Member] Point Of Care Laboratory Revenue [Member] Consumables Point Of Care Laboratory Revenue, Consumables [Member] Point Of Care Laboratory Revenue, Consumables [Member] Sales-type leases Point Of Care Laboratory Revenue, Sales-Type Leases [Member] Point Of Care Laboratory Revenue, Sales-Type Leases [Member] Outright instrument sales Point Of Care Laboratory Revenue, Outright Instrument Sales [Member] Point Of Care Laboratory Revenue, Outright Instrument Sales [Member] Other Point Of Care Laboratory Revenue, Other [Member] Point Of Care Laboratory Revenue, Other [Member] Point of Care imaging revenue: Point Of Care Imaging Revenue [Member] Point Of Care Imaging Revenue [Member] Outright instrument sales Point Of Care Imaging Revenue, Outright Instrument Sales [Member] Point Of Care Imaging Revenue, Outright Instrument Sales [Member] Service revenue Point Of Care Imaging Revenue, Service Revenue [Member] Point Of Care Imaging Revenue, Service Revenue [Member] Operating type leases and other Point Of Care Imaging Revenue, Operating Type Leases [Member] Point Of Care Imaging Revenue, Operating Type Leases [Member] Other CCA revenue: Other Revenue [Member] Other Revenue [Member] Other pharmaceuticals, vaccines and diagnostic tests Other Revenue, Other Pharmaceuticals, Vaccines And Diagnostic Tests [Member] Other Revenue, Other Pharmaceuticals, Vaccines And Diagnostic Tests [Member] Research and development, license and royalty revenue Other Revenue, Research And Development, License And Royalty Revenue [Member] Other Revenue, Research And Development, License And Royalty Revenue [Member] Other vaccines and pharmaceuticals Other Vaccines, Pharmaceuticals And Products [Member] Other Vaccines, Pharmaceuticals And Products [Member] Contract manufacturing Contract Manufacturing Contracts [Member] Contract Manufacturing Contracts [Member] License, research and development License, Research And Development [Member] License, Research And Development [Member] Revenue, Initial Application Period Cumulative Effect Transition [Line Items] Revenue, Initial Application Period Cumulative Effect Transition [Line Items] Total revenue, net Revenue from Contract with Customer, Including Assessed Tax Contract receivables, current Contract with Customer, Asset, Net, Current Contract receivables, noncurrent Contract with Customer, Asset, Net, Noncurrent Current portion of deferred revenue, and other Contract with Customer, Liability, Current Contract liabilities, revenue recognized Contract with Customer, Liability, Revenue Recognized Contract liabilities, increase due to additional deferred sales Contract with Customer, Liability, Increase Due To Additional Deferred Sales Contract with Customer, Liability, Increase Due To Additional Deferred Sales Average term of underlying contracts Contract with Customer, Timing of Satisfaction of Performance Obligation and Payment Capitalized contract costs Capitalized Contract Cost, Net Capitalized contract costs, amortization Capitalized Contract Cost, Amortization Capitalized contract costs during the period Capitalized Contract Costs During The Period Capitalized Contract Costs During The Period Comprehensive Income (Loss), Net of Tax, Attributable to Parent [Abstract] Net income after equity in losses from unconsolidated affiliates Net Income (Loss) Attributable Before Nonredeemable Noncontrolling Interest Income Net Income (Loss) Attributable Before Nonredeemable Noncontrolling Interest Income Other comprehensive income (loss): Other Comprehensive Income (Loss), Net of Tax [Abstract] Foreign currency translation Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax Comprehensive income Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest Comprehensive loss attributable to redeemable non-controlling interest Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest Comprehensive income attributable to Heska Corporation Comprehensive Income (Loss), Net of Tax, Attributable to Parent Inventory Disclosure [Abstract] Schedule of inventory Schedule of Inventory, Current [Table Text Block] REVENUE Revenue from Contract with Customer [Text Block] Restricted Stock Restricted Stock [Member] Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] Non-vested balance (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number Granted (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period Vested (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period Forfeited (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period Non-vested balance (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract] Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract] Non-vested balance (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Granted (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Vested (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value Forfeited (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value Non-vested balance (in dollars per share) Leases [Abstract] Lessor, Operating Lease, Payments, Fiscal Year Maturity [Abstract] Lessor, Operating Lease, Payments, Fiscal Year Maturity [Abstract] Remainder of 2019 Lessor, Operating Lease, Payments to be Received, Remainder of Fiscal Year 2020 Lessor, Operating Lease, Payments to be Received, Two Years 2021 Lessor, Operating Lease, Payments to be Received, Three Years 2022 Lessor, Operating Lease, Payments to be Received, Four Years 2023 Lessor, Operating Lease, Payments to be Received, Five Years Thereafter Lessor, Operating Lease, Payments to be Received, Thereafter Lessor, Operating Lease, Payments to be Received Lessor, Operating Lease, Payments to be Received Operating lease expense Lease, Cost Cash paid for amounts included in the measurement of operating lease liabilities Operating Lease, Expense ROU assets obtained in exchange for operating lease obligations Right-of-Use Asset Obtained in Exchange for Operating Lease Liability Weighted average remaining lease term Operating Lease, Weighted Average Remaining Lease Term Weighted average discount rate Operating Lease, Weighted Average Discount Rate, Percent Operating Lease Liabilities, Payments Due [Abstract] Operating Lease Liabilities, Payments Due [Abstract] Remainder of 2019 Lessee, Operating Lease, Liability, Payments, Remainder of Fiscal Year 2020 Lessee, Operating Lease, Liability, Payments, Due Year Two 2021 Lessee, Operating Lease, Liability, Payments, Due Year Three 2022 Lessee, Operating Lease, Liability, Payments, Due Year Four 2023 Lessee, Operating Lease, Liability, Payments, Due Year Five Total operating lease payments Lessee, Operating Lease, Liability, Payments, Due Less: imputed interest Lessee, Operating Lease, Liability, Undiscounted Excess Amount Total operating lease liabilities Operating Lease, Liability Payables and Accruals [Abstract] Accrued settlement Estimated Litigation Liability, Current Accrued payroll and employee benefits Employee-related Liabilities, Current Accrued property taxes Accrual for Taxes Other than Income Taxes, Current Inventory in transit Inventory In Transit Inventory In Transit Other Other Accrued Liabilities, Current Total accrued liabilities Accrued Liabilities, Current Percentage of total current liabilities Percentage Of Total Liabilities, Current Percentage Of Total Liabilities, Current Other Income and Expenses [Abstract] Interest income Interest Income, Deposits with Financial Institutions Interest expense Interest Expense Other, net Other Nonoperating Income (Expense) Total interest and other income, net Nonoperating Income (Expense) Cash paid for interest Interest Paid, Including Capitalized Interest, Operating and Investing Activities Statement of Stockholders' Equity [Abstract] Statement [Table] Statement [Table] Equity Components [Axis] Equity Components [Axis] Equity Component [Domain] Equity Component [Domain] Traditional Common Stock Common Stock, Preferred Stock And Public Stock [Member] Common Stock, Preferred Stock And Public Stock [Member] Additional Paid-in Capital Additional Paid-in Capital [Member] Accumulated Other Comprehensive Income (Loss) Comprehensive Income [Member] Accumulated Deficit Retained Earnings [Member] Restatement [Axis] Restatement [Axis] Restatement [Domain] Restatement [Domain] Previously Reported Previously Reported [Member] Statement [Line Items] Statement [Line Items] Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity [Roll Forward] Beginning balance Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest Beginning balance (in shares) Shares, Outstanding Adoption of accounting standards Cumulative Effect of New Accounting Principle in Period of Adoption Net income after equity in losses of unconsolidated affiliates Net Income (Loss) Attributable to Parent Issuance of common stock, net of shares withheld for employee taxes Stock Issued During Period, Value, Employee Stock Purchase Plan Issuance of common stock, net of shares withheld for employee taxes (in shares) Stock Issued During Period, Shares, Employee Stock Purchase Plans Stock-based compensation Adjustments to Additional Paid in Capital, Share-based Compensation, Requisite Service Period Recognition Other comprehensive income (loss) Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, before Tax Ending balance Ending balance (in shares) Reconciliation of Other Significant Reconciling Items from Segments to Consolidated [Table] Reconciliation of Other Significant Reconciling Items from Segments to Consolidated [Table] Consolidation Items [Axis] Consolidation Items [Axis] Consolidation Items [Domain] Consolidation Items [Domain] Operating Segments Operating Segments [Member] Segments [Axis] Segments [Axis] Segments [Domain] Segments [Domain] Core Companion Animal Health Core Companion Animal Health Segment [Member] CCA segment Other Vaccines, Pharmaceuticals and Products Other Vaccines Pharmaceuticals and Products Segment [Member] OVP member Segment Reporting, Other Significant Reconciling Item [Line Items] Segment Reporting, Other Significant Reconciling Item [Line Items] Total revenue Revenues Operating income (loss) Operating Income (Loss) Income before income taxes Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest Capital expenditures Payments to Acquire Property, Plant, and Equipment Depreciation and amortization Depreciation, Depletion and Amortization, Nonproduction Investments in unconsolidated affiliates Investments Assets Assets Net Assets Net Assets Goodwill and Intangible Assets Disclosure [Abstract] Schedule of changes in goodwill Schedule of Goodwill [Table Text Block] Schedule of other intangible assets Schedule of Finite-Lived Intangible Assets [Table Text Block] Schedule of amortization expense on intangible assets Finite-lived Intangible Assets Amortization Expense [Table Text Block] Schedule of estimated future amortization expense Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block] Statement of Financial Position [Abstract] ASSETS Assets [Abstract] Current assets: Assets, Current [Abstract] Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value Accounts receivable, net of allowance for doubtful accounts of $259 and $245, respectively Accounts Receivable, Net, Current Inventories, net Inventory, Net Net investment in leases, current, net of allowance for doubtful accounts of $40 and $40, respectively Loans and Leases Receivable, Net of Deferred Income Other current assets Other Assets, Current Total current assets Assets, Current Property and equipment, net Property, Plant and Equipment, Net Operating lease right-of-use assets Operating Lease, Right-of-Use Asset Goodwill Intangible Assets, Net (Including Goodwill) Other intangible assets, net Other Intangible Assets, Net Deferred tax asset, net Deferred Tax Assets, Net Net investment in leases, non-current Loans And Leases Receivable, Net Of Deferred Income, Noncurrent Loans and Leases Receivable, Net of Deferred Income, Noncurrent Other non-current assets Other Assets, Noncurrent Total assets LIABILITIES, MEZZANINE EQUITY AND STOCKHOLDERS' EQUITY Liabilities and Equity [Abstract] Liabilities Liabilities [Abstract] Current liabilities: Liabilities, Current [Abstract] Accounts payable Accounts Payable, Current Due to – related parties Due to Related Parties, Current Accrued liabilities Current operating lease liability Operating Lease, Liability, Current Current portion of deferred revenue, and other Deferred Revenue, Current Total current liabilities Liabilities, Current Deferred revenue, net of current portion Contract with Customer, Liability, Noncurrent Line of credit and other long-term borrowings Line of Credit, Current Non-current operating lease liability Operating Lease, Liability, Noncurrent Other liabilities Other Liabilities, Noncurrent Total liabilities Liabilities Commitments and contingencies Commitments and Contingencies Redeemable non-controlling interest and mezzanine equity Redeemable Noncontrolling Interest, Equity, Carrying Amount Stockholders' equity: Stockholders' Equity Attributable to Parent [Abstract] Preferred stock, $.01 par value, 2,500,000 shares authorized, none issued or outstanding Preferred Stock, Value, Issued Common stock, $.01 par value, 10,250,000 and 10,250,000 shares authorized, respectively, none issued or outstanding Common Stock, Value, Issued Public common stock, $.01 par value, 10,250,000 and 10,250,000 shares authorized, 7,746,602 and 7,675,692 shares issued and outstanding, respectively Public Common Stock, Value, Issued Public Common Stock, Value, Issued Additional paid-in capital Additional Paid in Capital Accumulated other comprehensive income Accumulated Other Comprehensive Income (Loss), Net of Tax Accumulated deficit Retained Earnings (Accumulated Deficit) Total stockholders' equity Stockholders' Equity Attributable to Parent Total liabilities, mezzanine equity and stockholders' equity Liabilities and Equity Range [Axis] Range [Axis] Range [Domain] Range [Domain] Minimum Minimum [Member] Maximum Maximum [Member] Fair value of stock options granted during period Stock Granted, Value, Share-based Compensation, Gross Weighted average grant date fair value Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value Intrinsic value of options exercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value Proceeds from stock options exercised Proceeds from Stock Options Exercised Total unrecognized compensation expense related to outstanding stock options Employee Service Share-based Compensation, Nonvested Awards, Compensation Not yet Recognized, Stock Options Period for recognition of unrecognized compensation expense Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition Intrinsic value of options outstanding Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value Shares issued during period Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period Weighted average purchase price of shares purchased (in dollars per share) Award vesting period Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period Fair value of stock vested Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value Performance shares, nonprobable performance targets (in shares) Share-Based Compensation Arrangement By Share-based Payment Award, Equity Instruments Other Than Options, Performance Shares, Nonprobable Achievement Share-Based Compensation Arrangement By Share-based Payment Award, Equity Instruments Other Than Options, Performance Shares, Nonprobable Achievement LEASES, LESSEE Lessee, Operating Leases [Text Block] LEASES, LESSOR Lessor, Operating Leases [Text Block] ACCRUED LIABILITIES Accounts Payable and Accrued Liabilities Disclosure [Text Block] Equity Method Investments and Joint Ventures [Abstract] Carrying values of investments in unconsolidated entities Equity Method Investments [Table Text Block] Commitments and Contingencies Disclosure [Abstract] Increase in royalties payable Increase (Decrease) in Royalties Payable Warranty reserve Standard and Extended Product Warranty Accrual Litigation settlement, amount Litigation Settlement, Amount Awarded to Other Party Unconditional annual minimum inventory purchases Purchase Commitment, Remaining Minimum Amount Committed Disaggregation of Revenue Disaggregation of Revenue [Table Text Block] Schedule of Timing of Revenue Expected to be Recognized Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table Text Block] Accounting Policies [Abstract] OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Significant Accounting Policies [Text Block] INVENTORIES, NET Inventory Disclosure [Text Block] Income Tax Disclosure [Abstract] INCOME TAXES Income Tax Disclosure [Text Block] Schedule of components of income tax expense Schedule of Components of Income Tax Expense (Benefit) [Table Text Block] Schedule of accrued liabilities Schedule of Accrued Liabilities [Table Text Block] Equity [Abstract] Schedule of accumulated other comprehensive income (loss) Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block] Earnings Per Share [Abstract] Reverse stock split conversion ratio Stockholders' Equity Note, Stock Split, Conversion Ratio Basic weighted-average common shares outstanding (in shares) Weighted Average Number of Shares Outstanding, Basic Assumed exercise of dilutive stock options and restricted shares Weighted Average Number Diluted Shares Outstanding Adjustment Diluted weighted-average common shares outstanding Weighted Average Number of Shares Outstanding, Diluted Basic earnings per share attributable to Heska Corporation (in dollars per share) Earnings Per Share, Basic Diluted earnings per share attributable to Heska Corporation (in dollars per share) Earnings Per Share, Diluted Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Antidilutive Securities [Axis] Antidilutive Securities [Axis] Antidilutive Securities, Name [Domain] Antidilutive Securities, Name [Domain] Stock Options And Restricted Units Stock Options And Restricted Units [Member] Stock Options And Restricted Units [Member] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Stock options and restricted units excluded from computation of earnings per share Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Property, Plant and Equipment [Abstract] PROPERTY AND EQUIPMENT Property, Plant and Equipment Disclosure [Text Block] Number of reportable segments Number of Reportable Segments Reconciliation of basic and diluted earnings per share Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Schedule of antidilutive securities excluded from computation of earnings per share Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Schedule of weighted average valuation assumptions Schedule of Share-based Payment Award, Employee Stock Purchase Plan, Valuation Assumptions [Table Text Block] Schedule of stock options plans Share-based Compensation, Stock Options, Activity [Table Text Block] Schedule of shares authorized under stock options plans by exercise price Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range [Table Text Block] Schedule of pricing models Fair Value Option, Disclosures [Table Text Block] EARNINGS PER SHARE Earnings Per Share [Text Block] Business Combinations and Related Party Disclosures [Abstract] Business Combinations and Related Party Disclosures [Abstract] ACQUISITION AND RELATED PARTY ITEMS Business Combination Disclosure [Text Block] ACCUMULATED OTHER COMPREHENSIVE INCOME Comprehensive Income (Loss) Note [Text Block] Debt Disclosure [Abstract] CREDIT FACILITY Debt Disclosure [Text Block] Schedule of property and equipment Property, Plant and Equipment [Table Text Block] Remaining performance obligation Revenue, Remaining Performance Obligation, Amount Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table] Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table] Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis] Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis] Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] Expected timing of satisfaction Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period Basis of Presentation and Consolidation Basis of Accounting, Policy [Policy Text Block] Use of Estimates Use of Estimates, Policy [Policy Text Block] Recent Accounting Pronouncements New Accounting Pronouncements, Policy [Policy Text Block] Schedule of interest expense (income) and other income, net Interest Expense (Income) and Other Income, Net [Table Text Block] Interest Expense (Income) and Other Income, Net Schedule of Error Corrections and Prior Period Adjustment Restatement [Table] Schedule of Error Corrections and Prior Period Adjustment Restatement [Table] Adjustments for New Accounting Pronouncements [Axis] Adjustments for New Accounting Pronouncements [Axis] Type of Adoption [Domain] Type of Adoption [Domain] ASU 2016-02 Accounting Standards Update 2016-02 [Member] Error Corrections and Prior Period Adjustments Restatement [Line Items] Error Corrections and Prior Period Adjustments Restatement [Line Items] Accumulated Other Comprehensive Income (Loss) [Table] Accumulated Other Comprehensive Income (Loss) [Table] Total Accumulated Other Comprehensive Income AOCI Attributable to Parent [Member] Minimum Pension Liability Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member] Foreign Currency Translation Accumulated Foreign Currency Adjustment Attributable to Parent [Member] Accumulated Other Comprehensive Income (Loss) [Line Items] Accumulated Other Comprehensive Income (Loss) [Line Items] Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward] AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward] Current period other comprehensive loss Other Comprehensive Income (Loss), Net of Tax Schedule of Equity Method Investments [Table] Schedule of Equity Method Investments [Table] Investment, Name [Axis] Investment, Name [Axis] Investment, Name [Domain] Investment, Name [Domain] General Fluidics Corporation General Fluidics Corporation [Member] General Fluidics Corporation [Member] MBio Diagnostics, Inc. MBio Diagnostics, Inc. [Member] MBio Diagnostics, Inc. [Member] Counterparty Name [Axis] Counterparty Name [Axis] Counterparty Name [Domain] Counterparty Name [Domain] Schedule of Equity Method Investments [Line Items] Schedule of Equity Method Investments [Line Items] Investments in unconsolidated affiliates Equity Method Investments Non-marketable equity security investment Non-Marketable Equity Security Investment Non-Marketable Equity Security Investment Investments Payments to acquire equity method investments Payments to Acquire Equity Method Investments Ownership percentage Equity Method Investment, Ownership Percentage Supply commitment term Supply Commitment, Term Supply Commitment, Term Payments to acquire non-marketable securities Payments To Acquire Non-Marketable Securities Payments To Acquire Non-Marketable Securities Non-Marketable equity security investment, ownership percentage Non-Marketable Equity Security Investment, Ownership Percentage Non-Marketable Equity Security Investment, Ownership Percentage Intangible asset acquired Non-Marketable Equity Security Investment, Intangible Assets Acquired Non-Marketable Equity Security Investment, Intangible Assets Acquired Intangible assets acquired, useful life Non-Marketable Equity Security Investment, Intangible Assets Acquired, Useful Life Non-Marketable Equity Security Investment, Intangible Assets Acquired, Useful Life Contingent consideration on milestones Non-Marketable Equity Security Investment, Consideration Transferred, Contingent Consideration Amount Non-Marketable Equity Security Investment, Consideration Transferred, Contingent Consideration Amount COMMITMENTS AND CONTINGENCIES Commitments and Contingencies Disclosure [Text Block] GOOWILL AND OTHER INTANGIBLES Goodwill and Intangible Assets Disclosure [Text Block] Document And Entity Information Entity Registrant Name Entity Registrant Name Entity Central Index Key Entity Central Index Key Document Type Document Type Document Period End Date Document Period End Date Amendment Flag Amendment Flag Current Fiscal Year End Date Current Fiscal Year End Date Entity Current Reporting Status Entity Current Reporting Status Entity Filer Category Entity Filer Category Document Fiscal Period Focus Document Fiscal Period Focus Document Fiscal Year Focus Document Fiscal Year Focus Entity Small Business Entity Small Business Entity Emerging Growth Company Entity Emerging Growth Company Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Income Statement [Abstract] Revenue: Revenues [Abstract] Cost of revenue Cost of Revenue Gross profit Gross Profit Operating expenses: Operating Expenses [Abstract] Selling and marketing Selling and Marketing Expense Research and development Research and Development Expense General and administrative General and Administrative Expense Total operating expenses Operating Expenses Operating (loss) income Interest and other income, net (Loss) income before income taxes and equity in losses of unconsolidated affiliates Income tax (benefit) expense: Income Tax Expense (Benefit), Intraperiod Tax Allocation [Abstract] Current income tax expense Current Income Tax Expense (Benefit) Deferred income tax benefit Deferred Income Tax Expense (Benefit) Total income tax benefit Income Tax Expense (Benefit) Net income before equity in losses of unconsolidated affiliates Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Equity in losses of unconsolidated affiliates Net Income (Loss) Attributable to Nonredeemable Noncontrolling Interest Net income after equity in losses of unconsolidated affiliates Net loss attributable to redeemable non-controlling interest Net Income (Loss) Attributable to Redeemable Noncontrolling Interest Net income attributable to Heska Corporation Earnings Per Share [Abstract] Weighted average outstanding shares used to compute basic earnings per share attributable to Heska Corporation (in shares) Weighted average outstanding shares used to compute diluted earnings per share attributable to Heska Corporation (in shares) INVESTMENTS IN UNCONSOLIDATED AFFILIATES Equity Method Investments and Joint Ventures Disclosure [Text Block] Statement of Cash Flows [Abstract] CASH FLOWS FROM OPERATING ACTIVITIES: Net Cash Provided by (Used in) Operating Activities [Abstract] Adjustments to reconcile net income to cash provided by operating activities: Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Non-cash impact of operating leases Operating Lease, Payments Deferred income tax benefit Stock-based compensation Share-based Compensation Other losses Unrealized (gain) loss on foreign currency translation Unrealized gain loss on foreign currency transactions Changes in operating assets and liabilities (net of the effect of acquisitions): Increase (Decrease) in Operating Capital [Abstract] Accounts receivable Increase (Decrease) in Accounts Receivable Inventories Increase (Decrease) in Inventories Due from related parties Increase (Decrease) in Due from Related Parties Lease receivable, current Increase (Decrease) in Leasing Receivables Other current assets Increase (Decrease) in Other Operating Assets Accounts payable Increase (Decrease) in Accounts Payable, Trade Due to related parties Increase (Decrease) in Due to Related Parties Accrued liabilities and other Increase (Decrease) in Accrued Liabilities Lease receivable, non-current Increase (Decrease) In Leasing Receivable, Noncurrent Increase (Decrease) In Leasing Receivable, Noncurrent Other non-current assets Increase (Decrease) in Other Noncurrent Assets Deferred revenue and other Increase (Decrease) in Contract with Customer, Liability Net cash provided by operating activities Net Cash Provided by (Used in) Operating Activities CASH FLOWS FROM INVESTING ACTIVITIES: Net Cash Provided by (Used in) Investing Activities [Abstract] Investment in subsidiary, net of cash acquired Payments to Acquire Investments Purchases of property and equipment Net cash used in investing activities Net Cash Provided by (Used in) Investing Activities CASH FLOWS FROM FINANCING ACTIVITIES: Net Cash Provided by (Used in) Financing Activities [Abstract] Proceeds from issuance of common stock Proceeds from Issuance of Common Stock Repurchase of common stock Payments for Repurchase of Common Stock Distributions to non-controlling interest members Distribution Made to Limited Liability Company (LLC) Member, Cash Distributions Paid Repayments of other debt Proceeds from (Repayments of) Debt Net cash used in financing activities Net Cash Provided by (Used in) Financing Activities NET EFFECT OF EXCHANGE RATE CHANGES ON CASH Effect of Exchange Rate on Cash and Cash Equivalents NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS Cash and Cash Equivalents, Period Increase (Decrease) CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD CASH AND CASH EQUIVALENTS, END OF PERIOD SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION: Supplemental Cash Flow Information [Abstract] Non-cash transfers of equipment between inventory and property and equipment, net Property, Plant and Equipment, Transfers and Changes Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range [Table] Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range [Table] Exercise Price Range [Axis] Exercise Price Range [Axis] Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Domain] Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Domain] $ 4.50 - $ 7.36 Exercise Price Range One [Member] Exercise Price Range One [Member] $ 7.37 - $ 32.21 Exercise Price Range Two [Member] Exercise Price Range Two [Member] $ 32.22 - $ 62.50 Exercise Price Range Three [Member] Exercise Price Range Three [Member] $ 62.51 - $ 69.77 Exercise Price Range Four [Member] Exercise Price Range Four [Member] $ 69.78 - $ 108.25 Exercise Price Range Five [Member] Exercise Price Range Five [Member] $ 4.50 - $ 108.25 Exercise Price Range Six [Member] Exercise Price Range Six Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items] Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items] Number of Options Outstanding at March 31, 2019 Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Number of Outstanding Options Weighted Average Remaining Contractual Life in Years Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Remaining Contractual Term Weighted Average Exercise Price Number of Options Exercisable at March 31, 2019 Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Number of Exercisable Options Weighted Average Exercise Price Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Exercisable Options, Weighted Average Exercise Price Exercise price range, lower (in dollars per share) Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Lower Range Limit Exercise price range, upper (in dollars per share) Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Upper Range Limit Reconciliation of other significant reconciling items from segments to consolidated Reconciliation of Other Significant Reconciling Items from Segments to Consolidated [Table Text Block] Schedule of revenue from external customers and long-lived assets, by geographical areas Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas [Table Text Block] Additional lease information Lease, Cost [Table Text Block] Schedule of maturity of operating leases Lessee, Operating Lease, Liability, Maturity [Table Text Block] Lessor, maturity of undiscounted lease receivables Lessor, Operating Lease, Payments to be Received, Maturity [Table Text Block] Class of Stock [Axis] Class of Stock [Axis] Class of Stock [Domain] Class of Stock [Domain] Traditional Common Stock Common Stock [Member] Public Common Stock Public Common Stock [Member] Public Common Stock [Member] Allowance for doubtful accounts Allowance for Doubtful Accounts Receivable Leases, allowance for doubtful accounts Loans and Leases Receivable, Allowance Preferred stock, par value (in dollars per share) Preferred Stock, Par or Stated Value Per Share Preferred stock, shares authorized Preferred Stock, Shares Authorized Preferred stock, shares issued Preferred Stock, Shares Issued Preferred stock, shares outstanding Preferred Stock, Shares Outstanding Common stock, par value (in dollars per share) Common Stock, Par or Stated Value Per Share Common stock, shares authorized Common Stock, Shares Authorized Common stock, shares issued Common Stock, Shares, Issued Common stock, shares outstanding Common Stock, Shares, Outstanding Schedule of Long-term Debt Instruments [Table] Schedule of Long-term Debt Instruments [Table] Long-term Debt, Type [Axis] Long-term Debt, Type [Domain] Long-term Debt, Type [Domain] Line of Credit Line of Credit [Member] Credit Facility [Axis] Credit Facility [Axis] Credit Facility [Domain] Credit Facility [Domain] Revolving Credit Facility Revolving Credit Facility [Member] Variable Rate [Axis] Variable Rate [Axis] Variable Rate [Domain] Variable Rate [Domain] London Interbank Offered Rate (LIBOR) London Interbank Offered Rate (LIBOR) [Member] Subsequent Event Type [Axis] Subsequent Event Type [Axis] Subsequent Event Type [Domain] Subsequent Event Type [Domain] Subsequent Event Subsequent Event [Member] Debt Instrument [Line Items] Debt Instrument [Line Items] Maximum borrowing capacity Line of Credit Facility, Maximum Borrowing Capacity Additional maximum borrowing capacity increase Line Of Credit Facility, Contingent Increase In Maximum Borrowing Capacity Line Of Credit Facility, Contingent Increase In Maximum Borrowing Capacity Contingent maximum borrowing capacity Line of Credit Facility, Contingent Maximum Borrowing Capacity Line of Credit Facility, Contingent Maximum Borrowing Capacity Basis spread on variable rate Debt Instrument, Basis Spread on Variable Rate Minimum annual interest charge Line of Credit Facility, Minimum Annual Interest Charge Line of Credit Facility, Minimum Annual Interest Charge Long-term line of credit Long-term Line of Credit Payments for legal settlements Payments for Legal Settlements Raw materials Inventory, Raw Materials, Gross Work in process Inventory, Work in Process, Gross Finished goods Inventory, Finished Goods, Gross Allowance for excess or obsolete inventory Inventory Valuation Reserves Total inventory, net Goodwill [Roll Forward] Goodwill [Roll Forward] Carrying amount, December 31, 2018 Goodwill Goodwill, Acquired During Period Goodwill, Acquired During Period Foreign currency adjustments Goodwill, Foreign Currency Translation Gain (Loss) Carrying amount, March 31, 2019 Schedule of Finite-Lived Intangible Assets [Table] Schedule of Finite-Lived Intangible Assets [Table] Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets, Major Class Name [Domain] Finite-Lived Intangible Assets, Major Class Name [Domain] Developed technology Developed Technology Rights [Member] Customer relationships and other Customer Relationships And Other [Member] Customer Relationships And Other [Member] Finite-Lived Intangible Assets [Line Items] Finite-Lived Intangible Assets [Line Items] Finite-Lived Intangible Assets, Net [Abstract] Finite-Lived Intangible Assets, Net [Abstract] Gross carrying amount Finite-Lived Intangible Assets, Gross Accumulated amortization Finite-Lived Intangible Assets, Accumulated Amortization Net carrying amount Finite-Lived Intangible Assets, Net Amortization expense Amortization of Intangible Assets Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract] Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract] 2019 (remaining) Finite-Lived Intangible Assets, Amortization Expense, Remainder of Fiscal Year 2020 Finite-Lived Intangible Assets, Amortization Expense, Year Two 2021 Finite-Lived Intangible Assets, Amortization Expense, Year Three 2022 Finite-Lived Intangible Assets, Amortization Expense, Year Four 2023 Finite-Lived Intangible Assets, Amortization Expense, Year Five Thereafter Finite-Lived Intangible Assets, Amortization Expense, after Year Five INTEREST AND OTHER EXPENSE, NET Interest and Other Income [Text Block] Schedule of Business Acquisitions, by Acquisition [Table] Schedule of Business Acquisitions, by Acquisition [Table] Business Acquisition [Axis] Business Acquisition [Axis] Business Acquisition, Acquiree [Domain] Business Acquisition, Acquiree [Domain] Optomed Optomed [Member] Optomed [Member] Cuattro, LLC Cuattro, LLC [Member] Cuattro, LLC [Member] Legal Entity [Axis] Legal Entity [Axis] Entity [Domain] Entity [Domain] Heska Imaging Heska Imaging [Member] Heska Imaging [Member] Related Party [Axis] Related Party [Axis] Related Party [Domain] Related Party [Domain] Affiliated Entity Affiliated Entity [Member] Business Acquisition [Line Items] Business Acquisition [Line Items] Percentage of voting interest acquired Business Acquisition, Percentage of Voting Interests Acquired Cash consideration transferred Business Combination, Consideration Transferred Minority interest Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners Committed purchase amount Business Combination, Contingent Consideration To Be Transferred Business Combination, Contingent Consideration To Be Transferred Equity transferred as consideration for asset acquisition (in shares) Asset Acquisition, Consideration Transferred, Equity Instruments Issued Or Issuable Asset Acquisition, Consideration Transferred, Equity Instruments Issued Or Issuable Equity transferred as consideration for asset acquisition, value Asset Acquisition, Consideration Transferred, Equity Issued, Value Asset Acquisition, Consideration Transferred, Equity Issued, Value Payments for asset acquisitions Payments For Asset Acquisitions Payments For Asset Acquisitions Related party - amount of transaction Related Party Transaction, Amounts of Transaction Due to related parties Due to Related Parties Total income tax benefit Cash paid for income taxes Income Taxes Paid Excess tax benefits related to employee share-based compensation Effective Income Tax Rate Reconciliation, Share-based Compensation, Excess Tax Benefit, Amount CAPITAL STOCK Disclosure of Compensation Related Costs, Share-based Payments [Text Block] Property, Plant and Equipment [Table] Property, Plant and Equipment [Table] Property, Plant and Equipment, Type [Axis] Property, Plant and Equipment, Type [Axis] Property, Plant and Equipment, Type [Domain] Property, Plant and Equipment, Type [Domain] Land Land [Member] Building Building [Member] Machinery and equipment Machinery and Equipment [Member] Office furniture and equipment Office Furniture And Equipment [Member] Office Furniture And Equipment [Member] Computer hardware and software Computer Hardware And Software [Member] Computer Hardware And Software [Member] Leasehold and building improvements Leasehold and Building Improvements [Member] Leasehold and Building Improvements [Member] Construction in progress Construction in Progress [Member] Machinery and equipment Inventory Transferred To Machinery And Equipment [Member] Inventory Transferred To Machinery And Equipment [Member] Property, Plant and Equipment [Line Items] Property, Plant and Equipment [Line Items] Property and equipment, gross Property, Plant and Equipment, Gross Less accumulated depreciation Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Total property and equipment, net Depreciation and amortization Accumulated Depreciation, Depletion and Amortization, Property, Plant and Equipment, Period Increase (Decrease) Property plant and equipment, useful life Property, Plant and Equipment, Useful Life Operating leases, gross Property Subject to or Available for Operating Lease, Gross Operating leases, accumulated depreciation Property Subject to or Available for Operating Lease, Accumulated Depreciation EX-101.PRE 10 hska-20190331_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT GRAPHIC 11 heskalogowhtbkgd07.jpg begin 644 heskalogowhtbkgd07.jpg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htm IDEA: XBRL DOCUMENT v3.19.1
Document and Entity Information - shares
 3 Months Ended
Mar. 31, 2019
May 07, 2019
Document And Entity Information    
Entity Registrant Name Heska Corp  
Entity Central Index Key 0001038133  
Document Type 10-Q  
Document Period End Date Mar. 31, 2019  
Amendment Flag false  
Current Fiscal Year End Date --12-31  
Entity Current Reporting Status Yes  
Entity Filer Category Accelerated Filer  
Document Fiscal Period Focus Q1  
Document Fiscal Year Focus 2019  
Entity Small Business false  
Entity Emerging Growth Company false  
Entity Common Stock, Shares Outstanding   7,750,652
XML 13 R2.htm IDEA: XBRL DOCUMENT v3.19.1
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Mar. 31, 2019
Dec. 31, 2018
Current assets:    
Cash and cash equivalents $ 9,101 $ 13,389
Accounts receivable, net of allowance for doubtful accounts of $259 and $245, respectively 16,202 16,454
Inventories, net 27,388 25,104
Net investment in leases, current, net of allowance for doubtful accounts of $40 and $40, respectively 3,225 2,989
Other current assets 4,620 4,471
Total current assets 60,536 62,407
Property and equipment, net 15,511 15,981
Operating lease right-of-use assets 6,414  
Goodwill 27,311 26,679
Other intangible assets, net 9,923 9,764
Deferred tax asset, net 15,176 14,121
Net investment in leases, non-current 12,615 11,908
Investments in unconsolidated affiliates 7,837 8,018
Other non-current assets 7,457 7,574
Total assets 162,780 156,452
Current liabilities:    
Accounts payable 7,746 7,469
Due to – related parties 0 226
Accrued liabilities 10,647 10,142
Current operating lease liability 1,693  
Current portion of deferred revenue, and other 2,704 2,526
Total current liabilities 22,790 20,363
Deferred revenue, net of current portion 6,728 7,082
Line of credit and other long-term borrowings 6,026 6,031
Non-current operating lease liability 5,122  
Other liabilities 175 567
Total liabilities 40,841 34,043
Commitments and contingencies
Redeemable non-controlling interest and mezzanine equity 662 0
Stockholders' equity:    
Preferred stock, $.01 par value, 2,500,000 shares authorized, none issued or outstanding 0 0
Common stock, $.01 par value, 10,250,000 and 10,250,000 shares authorized, respectively, none issued or outstanding 0 0
Public common stock, $.01 par value, 10,250,000 and 10,250,000 shares authorized, 7,746,602 and 7,675,692 shares issued and outstanding, respectively 77 77
Additional paid-in capital 255,150 257,034
Accumulated other comprehensive income 215 277
Accumulated deficit (134,165) (134,979)
Total stockholders' equity 121,277 122,409
Total liabilities, mezzanine equity and stockholders' equity $ 162,780 $ 156,452
XML 14 R3.htm IDEA: XBRL DOCUMENT v3.19.1
CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($)
$ in Thousands
Mar. 31, 2019
Dec. 31, 2018
Allowance for doubtful accounts $ 259 $ 245
Leases, allowance for doubtful accounts $ 40 $ 40
Preferred stock, par value (in dollars per share) $ 0.01 $ 0.01
Preferred stock, shares authorized 2,500,000 2,500,000
Preferred stock, shares issued 0 0
Preferred stock, shares outstanding 0 0
Traditional Common Stock    
Common stock, par value (in dollars per share) $ 0.01 $ 0.01
Common stock, shares authorized 10,250,000 10,250,000
Common stock, shares issued 0 0
Common stock, shares outstanding 0 0
Public Common Stock    
Common stock, par value (in dollars per share) $ 0.01 $ 0.01
Common stock, shares authorized 10,250,000 10,250,000
Common stock, shares issued 7,746,602 7,675,692
Common stock, shares outstanding 7,746,602 7,675,692
XML 15 R4.htm IDEA: XBRL DOCUMENT v3.19.1
CONDENSED CONSOLIDATED STATEMENTS OF INCOME - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Revenue:    
Total revenue, net $ 29,511 $ 32,765
Cost of revenue 16,968 19,458
Gross profit 12,543 13,307
Operating expenses:    
Selling and marketing 7,033 6,140
Research and development 1,366 670
General and administrative 4,219 4,626
Total operating expenses 12,618 11,436
Operating (loss) income (75) 1,871
Interest and other income, net (16) (4)
(Loss) income before income taxes and equity in losses of unconsolidated affiliates (59) 1,875
Income tax (benefit) expense:    
Current income tax expense 45 17
Deferred income tax benefit (1,055) (297)
Total income tax benefit (1,010) (280)
Net income before equity in losses of unconsolidated affiliates 951 2,155
Equity in losses of unconsolidated affiliates (181) 0
Net income after equity in losses of unconsolidated affiliates 770 2,155
Net loss attributable to redeemable non-controlling interest (44) 0
Net income attributable to Heska Corporation $ 814 $ 2,155
Earnings Per Share [Abstract]    
Basic earnings per share attributable to Heska Corporation (in dollars per share) $ 0.11 $ 0.30
Diluted earnings per share attributable to Heska Corporation (in dollars per share) $ 0.10 $ 0.28
Weighted average outstanding shares used to compute basic earnings per share attributable to Heska Corporation (in shares) 7,459 7,102
Weighted average outstanding shares used to compute diluted earnings per share attributable to Heska Corporation (in shares) 7,965 7,711
Core companion animal    
Revenue:    
Total revenue, net $ 24,716 $ 26,819
Other vaccines and pharmaceuticals    
Revenue:    
Total revenue, net $ 4,795 $ 5,946
XML 16 R5.htm IDEA: XBRL DOCUMENT v3.19.1
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Comprehensive Income (Loss), Net of Tax, Attributable to Parent [Abstract]    
Net income after equity in losses from unconsolidated affiliates $ 770 $ 2,155
Other comprehensive income (loss):    
Foreign currency translation (62) 81
Comprehensive income 708 2,236
Comprehensive loss attributable to redeemable non-controlling interest (44) 0
Comprehensive income attributable to Heska Corporation $ 752 $ 2,236
XML 17 R6.htm IDEA: XBRL DOCUMENT v3.19.1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Previously Reported
Traditional Common Stock
Traditional Common Stock
Previously Reported
Additional Paid-in Capital
Additional Paid-in Capital
Previously Reported
Accumulated Other Comprehensive Income (Loss)
Accumulated Other Comprehensive Income (Loss)
Previously Reported
Accumulated Deficit
Accumulated Deficit
Previously Reported
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Adoption of accounting standards $ 2,634               $ 2,634  
Beginning balance at Dec. 31, 2017 103,074 $ 100,440 $ 73 $ 73 $ 243,598 $ 243,598 $ 232 $ 232 (140,829) $ (143,463)
Beginning balance (in shares) at Dec. 31, 2017     7,303 7,303            
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Net income after equity in losses of unconsolidated affiliates 2,155               2,155  
Issuance of common stock, net of shares withheld for employee taxes (1,284)   $ 1   (1,285)          
Issuance of common stock, net of shares withheld for employee taxes (in shares)     116              
Stock-based compensation 1,064       1,064          
Other comprehensive income (loss) 81           81      
Ending balance at Mar. 31, 2018 105,090   $ 74   243,377   313   (138,674)  
Ending balance (in shares) at Mar. 31, 2018     7,419              
Beginning balance at Dec. 31, 2018 122,409   $ 77   257,034   277   (134,979)  
Beginning balance (in shares) at Dec. 31, 2018     7,676              
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Net income after equity in losses of unconsolidated affiliates 814               814  
Issuance of common stock, net of shares withheld for employee taxes (3,070)   $ 0   (3,070)          
Issuance of common stock, net of shares withheld for employee taxes (in shares)     71              
Stock-based compensation 1,186       1,186          
Other comprehensive income (loss) (62)           (62)      
Ending balance at Mar. 31, 2019 $ 121,277   $ 77   $ 255,150   $ 215   $ (134,165)  
Ending balance (in shares) at Mar. 31, 2019     7,747              
XML 18 R7.htm IDEA: XBRL DOCUMENT v3.19.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2019
Mar. 31, 2018
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net income after equity in losses from unconsolidated affiliates $ 770 $ 2,155
Adjustments to reconcile net income to cash provided by operating activities:    
Depreciation and amortization 1,265 1,196
Non-cash impact of operating leases 375 0
Deferred income tax benefit (1,055) (297)
Stock-based compensation 1,186 1,064
Other losses 191 10
Changes in operating assets and liabilities (net of the effect of acquisitions):    
Accounts receivable 624 1,465
Inventories (1,052) 2,047
Due from related parties 0 1
Lease receivable, current (237) (233)
Other current assets (151) 257
Accounts payable (110) (3,265)
Due to related parties (226) (1,026)
Accrued liabilities and other 39 2,981
Lease receivable, non-current (668) (754)
Other non-current assets 101 244
Deferred revenue and other (325) (1,638)
Net cash provided by operating activities 727 4,207
CASH FLOWS FROM INVESTING ACTIVITIES:    
Investment in subsidiary, net of cash acquired (224) 0
Purchases of property and equipment (234) (375)
Net cash used in investing activities (458) (375)
CASH FLOWS FROM FINANCING ACTIVITIES:    
Proceeds from issuance of common stock 410 288
Repurchase of common stock (3,480) (1,571)
Distributions to non-controlling interest members 0 (126)
Repayments of other debt (1,486) 0
Net cash used in financing activities (4,556) (1,409)
NET EFFECT OF EXCHANGE RATE CHANGES ON CASH (1) 44
NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS (4,288) 2,467
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD 13,389 9,659
CASH AND CASH EQUIVALENTS, END OF PERIOD 9,101 12,126
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:    
Non-cash transfers of equipment between inventory and property and equipment, net $ 227 $ 251
XML 19 R8.htm IDEA: XBRL DOCUMENT v3.19.1
OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
 3 Months Ended
Mar. 31, 2019
Accounting Policies [Abstract]  
OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Heska Corporation and its wholly-owned subsidiaries ("Heska", the "Company", "we" or "our") sell veterinary and animal health diagnostic and specialty products. Our offerings include Point of Care diagnostic laboratory instruments and supplies; digital imaging diagnostic products, software and services; vaccines; local and cloud-based data services; allergy testing and immunotherapy; and single-use offerings such as in-clinic diagnostic tests and heartworm preventive products. Our core focus is on supporting veterinarians in the canine and feline healthcare space.
Basis of Presentation and Consolidation
In the opinion of management, the accompanying unaudited Condensed Consolidated Financial Statements contain all adjustments, consisting of normal, recurring adjustments, necessary to present fairly the financial position of the Company as of March 31, 2019 and December 31, 2018, the results of our operations, statements of stockholders' equity and cash flows for the three months ended March 31, 2019 and 2018.
The unaudited Condensed Consolidated Financial Statements included herein have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission ("SEC"). Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America ("GAAP") have been condensed or omitted pursuant to such rules and regulations. Our unaudited Condensed Consolidated Financial Statements include our accounts and the accounts of our wholly-owned subsidiaries since their respective dates of acquisitions. All intercompany accounts and transactions have been eliminated in consolidation. Where our ownership of a subsidiary is less than 100%, the non-controlling interest is reported on our Condensed Consolidated Balance Sheets. The non-controlling interest in our consolidated net income is reported as "Net loss attributable to redeemable non-controlling interest" on our Condensed Consolidated Statements of Income. These unaudited Condensed Consolidated Financial Statements should be read in conjunction with the audited Consolidated Financial Statements and Notes thereto contained in our Annual Report on Form 10-K for the fiscal year ended December 31, 2018 and other financial information filed with the SEC.
Reclassification
To maintain consistency and comparability, certain amounts in the financial statements have been reclassified to conform to current year presentation.
Use of Estimates
The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates are required when establishing the allowance for doubtful accounts and the net realizable value of inventory; determining future costs associated with warranties provided; determining the period over which our obligations are fulfilled under agreements to license product rights and/or technology rights; evaluating long-lived and intangible assets and investments for estimated useful lives and impairment; estimating the useful lives of instruments under leasing arrangements; determining the allocation of purchase price under purchase accounting; estimating the expense associated with the granting of stock; determining the need for, and the amount of a valuation allowance on deferred tax assets; and determining the value of the non-controlling interest in a business combination.
Critical Accounting Policies
Our accounting policies are described in our audited Consolidated Financial Statements and Notes thereto contained in our Annual Report on Form 10-K for the year ended December 31, 2018 and other than the recently adopted accounting pronouncements described below, have not changed significantly since such filing.
Adoption of New Accounting Pronouncements

Effective January 1, 2019, we adopted ASU 2018-07, Compensation – Stock Compensation (Topic 718), Improvements to Non-employee Share-Based Payment Accounting. This ASU is intended to simplify aspects of share-based compensation issued to non-employees by making the guidance consistent with accounting for employee share-based compensation. Guidance related to the stock compensation granted to employees is followed for non-employees, including the measurement date, valuation approach and performance conditions. The expense is recognized in the same period as though cash were paid for the good or service, ratably over the service period. The adoption of this ASU did not have an impact on our consolidated financial statements but did have a minimal impact on our related disclosures.

Effective January 1, 2019, we adopted ASU 2018-02, Income Statement-Reporting Comprehensive Income (Topic 220): Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income. The ASU permits companies to elect a reclassification of the disproportionate tax effects in accumulated other comprehensive income ("AOCI") caused by the Tax Cuts and Jobs Act of 2017 to retained earnings. As of March 31, 2019, the Company does not have any disproportionate income tax effects in AOCI to reclassify. However, if the Company did have disproportionate income tax effects in AOCI in the future, it would reclassify them to retained earnings.

In February 2016, the FASB issued ASU 2016-02, Leases (Topic 842), which supersedes ASC 840, Leases. This update requires lessees to recognize a right-of-use (“ROU”) asset and a lease liability for all leases, including operating leases, with terms greater than 12 months on its balance sheet. The update also expands the required quantitative and qualitative disclosures by lessees and lessors about the amount, timing and uncertainty of cash flows arising from leases. The accounting for lessors does not fundamentally change except for changes to conform and align guidance to the lessee guidance as well as to the new revenue recognition guidance in ASU 2014-09, Revenue from Contracts with Customers (Topic 606). Subsequent to the issuance of Topic 842, the FASB clarified the guidance through several ASUs; hereinafter the collection of lease guidance is referred to as “ASC 842”.

The Company adopted ASC 842 on January 1, 2019, using the modified retrospective approach for all lease arrangements at the beginning of the period of adoption. Results for reporting periods beginning January 1, 2019 are presented under ASC 842, while prior period amounts were not adjusted and continue to be reported in accordance with the Company’s historic accounting under ASC 840, Leases. For leases that commenced before the effective date of ASC 842, the Company elected the permitted practical expedients to not reassess the following: (i) whether any expired or existing contracts contain leases; (ii) the lease classification for any expired or existing leases; and (iii) initial direct costs for any existing leases. The Company also elected to exclude leases with a term of 12 months or less from the recognized ROU assets and lease liabilities.

Adoption of the standard did not have a material net impact in our Condensed Consolidated Balance Sheets, Condensed Consolidated Statements of Income or Condensed Consolidated Statements of Cash Flows. The most significant impact was the recognition of ROU assets and lease liabilities for the operating leases, of which we are the lessee. As a result of the cumulative impact of adopting ASC 842, the Company recorded operating lease ROU assets of $6.5 million and operating lease liabilities of $6.9 million as of January 1, 2019, primarily related to building, vehicle, and office equipment leases, based on the present value of the future lease payments on the date of adoption. As a lessor, accounting for our subscription agreements will remain substantially unchanged. Refer to Note 6 for additional disclosures required by ASC 842.
The Company determines if an arrangement is a lease at inception based on whether control of an identified asset is transferred. For leases where the Company is the lessee, ROU assets represent the Company’s right to use an underlying asset for the lease term and lease liabilities represent an obligation to make lease payments arising from the lease. ROU assets and lease liabilities are recognized at the lease commencement date based on the present value of lease payments over the lease term. As most of the Company’s leases do not provide an implicit interest rate, the Company uses its incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. The lease terms used to calculate the ROU asset and related lease liability include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. Lease expense for operating leases is recognized on a straight-line basis over the lease term as an operating expense while the expense for finance leases is recognized as amortization expense and interest expense. The Company has lease agreements which require payments for lease and non-lease components and has elected to account for these as a single lease component for our building and office equipment leases, but as separate components for our vehicle leases.

Our revenue under subscription agreements relates to both operating-type lease (“OTL”) arrangements or sales-type lease (“STL”) arrangements. Determination of an OTL or STL is primarily determined as a result of the length of the contract as compared to the estimated useful life of the instrument, among other factors. A STL results in earlier recognition of instrument revenue. The cost of the customer-leased instruments is removed from inventory and recognized in the Consolidated Statements of Income. There is no residual value taken into consideration as it does not meet our capitalization requirements. Instrument lease revenue for OTL agreements is recognized on a straight-line basis over the life of the lease and included with the predominant non-lease components in consumable revenue. The costs of customer-leased instruments are recorded within property and equipment in the accompanying Consolidated Balance Sheets and depreciated over the instrument’s estimated useful life. The depreciation expense is reflected in cost of revenue in the accompanying Consolidated Statements of Income. The OTLs and STLs are not cancellable until after an initial term and include an option to renew.
For lease arrangements with lease and non-lease components where the Company is the lessor, the Company allocates the contracts transaction price to the lease and non-lease components on a relative standalone selling price basis using the Company’s best estimate of the standalone selling price of each distinct product or service in the contract. The primary method used to estimate standalone selling price is the price observed in standalone sales to customers of a prior period. Changes in these values can impact the amount of consideration allocated to each component of the contract. When prices in standalone sales are not available, we may use a cost-plus margin approach. Allocation of the transaction price is determined at the inception of the lease arrangement. The Company’s leases consist of leases with fixed and variable lease payments. For those leases with variable lease payments, the variable lease payment is typically based upon purchase of consumables used with the leased instruments and included in consumable revenue.
Accounting Pronouncements Not Yet Adopted

In June 2016, the FASB issued ASU 2016-13, Financial Instruments - Credit Losses (Topic 326), which requires that financial assets measured at amortized cost be presented at the net amount expected to be collected. The allowance for credit losses is a valuation account that is deducted from the amortized cost basis of the financial asset to present the net carrying value at the amount expected to be collected. The income statement reflects the measurement of credit losses for newly recognized financial assets, as well as the increases or decreases of expected credit losses that have taken place during the period. The measurement of expected credit losses is based upon historical experience, current conditions and reasonable and supportable forecasts that affect the collectability of the reported amount. In November 2018, the FASB issued ASU 2018-19, Codification Improvements to Topic 326, Financial Instruments - Credit Losses. This ASU clarifies that receivables from operating leases are accounted for using the lease guidance and not as financial instruments. The amendments in this update are effective for fiscal years beginning after December 15, 2019 and interim periods within those annual periods. Early adoption for fiscal year beginning after December 15, 2018 is permitted. We will adopt the provisions of this ASU in the first quarter of 2020. We are currently evaluating the effect of this update on our consolidated financial statements.
XML 20 R9.htm IDEA: XBRL DOCUMENT v3.19.1
REVENUE
 3 Months Ended
Mar. 31, 2019
Revenue from Contract with Customer [Abstract]  
REVENUE
REVENUE

We separate our goods and services among:

•
Point of Care laboratory products including instruments, consumables and services;
•
Point of Care imaging products including instruments, software and services;
•
Single use pharmaceuticals, vaccines and diagnostic tests primarily related to companion animals; and
•
Other vaccines and pharmaceuticals ("OVP").
The following table summarizes our Core Companion Animal ("CCA") revenue (in thousands):
 
Three Months Ended March 31,
 
2019
 
2018
Point of Care laboratory revenue:
$
15,961

 
$
13,641

    Consumables
12,317

 
10,821

    Sales-type leases
1,742

 
1,538

    Outright instrument sales
1,528

 
811

    Other
374

 
471

 
 
 
 
Point of Care imaging revenue:
5,410

 
5,972

    Outright instrument sales
4,546

 
5,137

    Service revenue
562

 
556

    Operating type leases and other
302

 
279

 
 
 
 
Other CCA revenue:
3,345

 
7,206

    Other pharmaceuticals, vaccines and diagnostic tests
3,246

 
7,109

    Research and development, license and royalty revenue
99

 
97

 
 
 
 
Total CCA revenue
$
24,716

 
$
26,819


Revenue from our OVP segment consists of revenue generated from contract manufacturing agreements and from other license, research and development revenue. The following table summarizes our OVP revenue (in thousands):
 
Three Months Ended March 31,
 
2019
 
2018
Contract manufacturing
$
4,666

 
$
5,791

License, research and development
129

 
155

Total OVP revenue
$
4,795

 
$
5,946



Remaining Performance Obligations

Remaining performance obligations represent the aggregate transaction price allocated to performance obligations with an original contract term greater than one year which are fully or partially unsatisfied at the end of the period. Remaining performance obligations include noncancelable purchase orders, the non-lease portion of minimum purchase commitments under long-term supply arrangements, extended warranty, service and other long-term contracts. Remaining performance obligations do not include revenue from contracts with customers with an original term of one year or less, revenue from long-term supply arrangements with no minimum purchase requirements, revenue expected from purchases made in excess of the minimum purchase requirements, or revenue from instruments leased to customers. While the remaining performance obligation disclosure is similar in concept to backlog, the definition of remaining performance obligations excludes leases and contracts that provide the customer with the right to cancel or terminate for convenience with no substantial penalty, even if historical experience indicates the likelihood of cancellation or termination is remote. Additionally, the Company has elected to exclude contracts with customers with an original term of one year or less from remaining performance obligations.

As of March 31, 2019, the aggregate amount of the transaction price allocated to remaining minimum performance obligations was approximately $87.2 million. As of March 31, 2019, the Company expects to recognize revenue as follows (in thousands):
Year Ending December 31,
Revenue
2019 (remaining)
$
18,023

2020
21,101

2021
17,078

2022
13,925

2023
10,337

Thereafter
6,727

 
$
87,191



Contract Balances

The timing of revenue recognition, billings and cash collections results in billed accounts receivable, unbilled receivables (contract assets) and deferred revenue, and customer deposits and billings in excess of revenue recognized (contract liabilities) on the Condensed Consolidated Balance Sheets. In addition, the Company defers certain costs incurred to obtain contracts (contract costs).

Contract Receivables

Certain unbilled receivable balances related to long-term contracts for which we provide a free term to the customer but have recognized revenue are recorded in other current and other non-current assets. We have no further performance obligations related to these receivable balances and the collection of these balances occurs over the term of the underlying contract. The balances as of March 31, 2019 were $0.9 million and $3.4 million for current and non-current assets, respectively, shown net of related unearned interest. The balances as of December 31, 2018 were $0.9 million and $3.3 million for current and non-current assets, respectively, shown net of related unearned interest.

Contract Liabilities

The Company receives cash payments from customers for licensing fees or other arrangements that extend for a specified term. These contract liabilities are classified as either current or long-term in the Condensed Consolidated Balance Sheets based on the timing of when the Company expects to recognize revenue. As of March 31, 2019 and December 31, 2018, contract liabilities were $9.2 million and $9.6 million, respectively, and are included within "Current portion of deferred revenue, and other" and "Deferred revenue, net of current portion" in the accompanying Condensed Consolidated Balance Sheets. The decrease in the contract liability balance during the three-month period ended March 31, 2019 is $0.7 million of revenue recognized during the period, offset by $0.4 million of additional deferred sales in 2019.

Contract Costs

The Company capitalizes certain direct incremental costs incurred to obtain customer contracts, typically sales-related commissions, where the recognition period for the related revenue is greater than one year. Contract costs are classified as current or non-current, and are included in "Other current assets" and "Other non-current assets" in the Condensed Consolidated Balance Sheets based on the timing of when the Company expects to recognize the expense. Contract costs are generally amortized into selling and marketing expense with a certain percentage recognized immediately based upon placement of the instrument with the remainder recognized on a straight-line basis (which is consistent with the transfer of control for the related goods or services) over the average term of the underlying contracts, approximately 6 years. Management assesses these costs for impairment at least quarterly on a portfolio basis and as “triggering” events occur that indicate it is more-likely-than-not that an impairment exists. The balance of contract costs as of March 31, 2019 and December 31, 2018 was $2.5 million and $2.5 million, respectively. Amortization expense for the three-month period ended March 31, 2019 was approximately $0.2 million, offset by approximately $0.3 million of additional contract costs capitalized.

Contract liabilities are reported on the accompanying Condensed Consolidated Balance Sheets on a contract-by-contract basis whereas contract costs are calculated and reported on a portfolio basis.
XML 21 R10.htm IDEA: XBRL DOCUMENT v3.19.1
ACQUISITION AND RELATED PARTY ITEMS
 3 Months Ended
Mar. 31, 2019
Business Combinations and Related Party Disclosures [Abstract]  
ACQUISITION AND RELATED PARTY ITEMS
ACQUISITIONS AND RELATED PARTY ITEMS
Optomed
On February 22, 2019, Heska acquired 70% of the equity of Optomed, a French-based endoscopy company, in exchange for approximately $0.2 million in cash and the assumption of approximately $1.5 million in debt. As part of the purchase, Heska entered into put options and call options on the remaining 30% minority interest. The written put options can be exercised based on the achievement of certain financial conditions over a specified period of time for a fixed amount. The options are not currently exercisable at the acquisition date or the reporting date. The estimated value of the non-controlling interest is inclusive of the probability weighted outcome of the options described herein. The Company is in process of finalizing its purchase price allocation. As part of the purchase agreement, Heska has committed to a purchase from the minority interest holder, within six months from the acquisition date, real estate in the amount of approximately $1.0 million, which is currently under lease by Optomed.
Cuattro Veterinary Acquisitions
In February 2013, the Company acquired a majority interest in Cuattro Veterinary USA, LLC, which was owned by Kevin S. Wilson, among other members. The subsidiary was subsequently renamed Heska Imaging US, LLC ("US Imaging"). The remaining minority position in US Imaging was subject to purchase by Heska under a performance-based put option which was exercised in March 2017. In May 2017, we purchased the remaining minority interest position in US Imaging.

In May 2016, the Company closed a transaction to acquire Cuattro Veterinary, LLC ("International Imaging"), which was owned by Kevin S. Wilson, among other members. International Imaging is a provider to international markets of digital radiography technologies for veterinarians. As a leading provider of advanced veterinary diagnostic and specialty products, we made the acquisition in an effort to combine International Imaging's global reach with our domestic success in the imaging and laboratory markets in the United States.

In June 2017, the Company consolidated its assets and liabilities in the US Imaging and International Imaging companies into Heska Imaging, LLC ("Heska Imaging"). Cuattro, LLC ("Cuattro") is owned by Kevin S. Wilson, the CEO and President of the Company in addition to Mrs. Wilson and trusts for the benefit of Mr. and Mrs. Wilson's children and family. Steven M. Asakowicz and Rodney A. Lippincott, members of Cuattro Veterinary USA, LLC and Cuattro International prior the acquisitions, each serve as Executive Vice President, Companion Animal Health Sales for the Company.
Purchase Agreement for Certain Assets
On December 21, 2018, the Company closed a transaction (the "Asset Acquisition") to acquire certain assets from Cuattro, all related to the CCA segment. Pursuant to the Asset Acquisition, dated November 26, 2018, the Company issued 54,763 shares of the Company's common stock, $0.01 par value per share (the "Common Stock"), to Cuattro on the Closing Date, at an aggregate value equal to approximately $5.4 million based on the adjusted closing price per share of the Common Stock as reported on the Nasdaq Stock Market on the Asset Acquisition agreement date. These shares were issued to Cuattro in a private placement in reliance upon an exemption from the registration requirements of the Securities Act pursuant to Section 4(a)(2) thereof and the safe harbor provided by Rule 506 of Regulation D promulgated thereunder. In addition to the Common Stock, the Company paid cash in the amount of $2.8 million to Cuattro as part of the transaction. The total purchase price was determined based on a valuation report from an independent third party. Part of the Asset Acquisition was an agreement to terminate the supply and license agreement that Heska had been operating under since the acquisition of Cuattro Veterinary USA, LLC.
The Company evaluated the acquisition of the purchased assets under ASC 805, Business Combinations and ASU 2017-01, Business Combinations (Topic 805) and concluded that as substantially all of the fair value of the gross assets acquired is concentrated in an identifiable group of similar assets, the transaction did not meet the requirements to be accounted for as a business combination and therefore was accounted for as an asset acquisition. Accordingly, the purchase price of the purchased assets was allocated entirely to an identifiable intangible asset. In addition to the software assets acquired, Cuattro is obligated, without further compensation, to assist the Company with the implementation of third-party image hosting platform and necessary data migration.
Other Related Party Activities
Cuattro charged Heska Imaging $6.0 thousand and $1.7 million during the three months ended March 31, 2019 and 2018, respectively. The charge in 2019 relates to minor inventory purchases as the Company transitions the digital imaging software assets away from Cuattro. The charge in 2018 was primarily for digital imaging products, pursuant to an underlying supply contract which was terminated in December 2018.

The Company had no receivables from or payables to Cuattro as of March 31, 2019. Heska Imaging owed Cuattro $0.2 million as of December 31, 2018, which is reported in "Due to – related parties" on the Company's Condensed Consolidated Balance Sheets.
XML 22 R11.htm IDEA: XBRL DOCUMENT v3.19.1
INVESTMENTS IN UNCONSOLIDATED AFFILIATES
 3 Months Ended
Mar. 31, 2019
Equity Method Investments and Joint Ventures [Abstract]  
INVESTMENTS IN UNCONSOLIDATED AFFILIATES
INVESTMENTS IN UNCONSOLIDATED AFFILIATES
The carrying values of investments in unconsolidated affiliates, categorized by type of investment, is as follows (in thousands):
 
March 31, 2019
 
December 31, 2018
Equity method investment
$
4,819

 
$
5,000

Non-marketable equity security investment
3,018

 
3,018

 
$
7,837

 
$
8,018


Equity Method Investment
On September 24, 2018, we invested $5.1 million, including costs, in exchange for a 28.7% interest of a business as part of our product development strategy. The Company accounts for this investment using the equity method of accounting. Under the equity method, the carrying value of the investment is adjusted for the Company's proportionate share of the investee's reported earnings or losses with the corresponding share of earnings or losses reported as Equity in Losses of Unconsolidated Affiliates, listed below Net income before equity in losses of unconsolidated affiliates within the Condensed Consolidated Statements of Income. Additionally, the Company also entered into a 15-year Manufacturing Supply Agreement, which grants the Company global exclusivity to specified products.
Non-Marketable Equity Security Investment

On August 8, 2018, the Company invested $3.0 million, including costs, in MBio Diagnostics, Inc. ("MBio"), in exchange for preferred stock, representing a 6.9% interest in MBio. The Company’s investment in MBio is a non-marketable equity security, recorded using the measurement alternative of cost minus impairment, if any, plus or minus changes resulting from qualifying observable price changes.

As part of the agreement, the Company entered into a Supply and License Agreement with MBio, which provides that MBio produce and commercialize products that will enhance the Company's diagnostic portfolio. As part of this agreement, the Company made an upfront payment to MBio of $1.0 million related to a worldwide exclusive license agreement over a 20-year period, recorded in both short and long-term other assets. In addition, the agreement provides for an additional contingent payment from Heska to MBio of $10.0 million, relating to the successful achievement of sales milestones. This potential future milestone payment has not yet been accrued as it is not deemed by the Company to be probable at this time.

Both parties in this arrangement are active participants and are exposed to significant risks and rewards dependent on the commercial success of the activities of the collaboration. The parties are actively working on developing and testing the product as well as funding the research and development. Heska classifies the amounts paid for MBio's research and development work within the CCA segment research and development operating expenses. Expense is recognized ratably when incurred and in accordance with the development plan.
XML 23 R12.htm IDEA: XBRL DOCUMENT v3.19.1
INCOME TAXES
 3 Months Ended
Mar. 31, 2019
Income Tax Disclosure [Abstract]  
INCOME TAXES
INCOME TAXES

Our total income tax benefit for our (loss) income before income taxes were as follows (in thousands):
 
 
Three Months Ended March 31,
 
 
2019
 
2018
(Loss) income before income taxes
 
$
(59
)
 
$
1,875

Total income tax benefit
 
(1,010
)
 
(280
)

    
There were cash refunds of $0.1 million for income taxes, net of payments, for the three months ended March 31, 2019, and there were $18 thousand in cash payments for income taxes, net of refunds, for the three months ended March 31, 2018. The Company’s tax benefit increased to $1.0 million for the three months ended March 31, 2019, compared to the tax benefit of $0.3 million for the three months ended March 31, 2018. The increase in tax benefits is due to an increase in stock-based compensation excess tax benefits recognized in our income statement. In the first quarter of 2019, the Company recognized $1.1 million in excess tax benefits related to employee share based compensation compared to $0.8 million recognized in the first quarter of 2018.
XML 24 R13.htm IDEA: XBRL DOCUMENT v3.19.1
LEASES
 3 Months Ended
Mar. 31, 2019
Leases [Abstract]  
LEASES, LESSEE
LEASES

Lessee Accounting

The Company leases buildings, office equipment, and vehicles. The Company’s finance leases were not material as of March 31, 2019 and for the three-month period then ended. ROU assets arising from finance leases are included in Property and equipment, net in the accompanying Condensed Consolidated Balance Sheets. The current portion of the finance lease liabilities are included in Current portion of deferred revenue, and other and the non-current portion of the finance lease liabilities are included in Line of credit and other long term borrowings in the accompanying Condensed Consolidated Balance Sheets.

For the three months ended March 31, 2019, operating lease expense was $0.6 million, including immaterial variable lease costs.

Supplemental cash flow information related to the Company's operating leases for the three months ended March 31, 2019 was as follows (in thousands):

Cash paid for amounts included in the measurement of operating lease liabilities
$
444

ROU assets obtained in exchange for operating lease obligations
293


The following table presents the weighted average remaining lease term and weighted average discount rate related to the Company's operating leases as of March 31, 2019:

Weighted average remaining lease term
4.4 years

Weighted average discount rate
4.45
%

The following table presents the maturity of the Company's operating lease liabilities as of March 31, 2019 (in thousands):
Remainder of 2019
$
1,396

2020
1,611

2021
1,453

2022
1,320

2023
1,766

Total operating lease payments
7,546

Less: imputed interest
731

Total operating lease liabilities
$
6,815



Lessor Accounting
 
In our CCA segment, primarily related to our Point of Care laboratory products, the Company enters into sales-type leases as part of our subscription agreements. The following table presents the maturity of the Company's undiscounted lease receivables as of March 31, 2019 (in thousands):

Year Ending December 31,
 
Remainder of 2019
$
2,409

2020
3,430

2021
3,364

2022
2,989

2023
2,147

Thereafter
1,501

 
$
15,840
LEASES, LESSOR
LEASES

Lessee Accounting

The Company leases buildings, office equipment, and vehicles. The Company’s finance leases were not material as of March 31, 2019 and for the three-month period then ended. ROU assets arising from finance leases are included in Property and equipment, net in the accompanying Condensed Consolidated Balance Sheets. The current portion of the finance lease liabilities are included in Current portion of deferred revenue, and other and the non-current portion of the finance lease liabilities are included in Line of credit and other long term borrowings in the accompanying Condensed Consolidated Balance Sheets.

For the three months ended March 31, 2019, operating lease expense was $0.6 million, including immaterial variable lease costs.

Supplemental cash flow information related to the Company's operating leases for the three months ended March 31, 2019 was as follows (in thousands):

Cash paid for amounts included in the measurement of operating lease liabilities
$
444

ROU assets obtained in exchange for operating lease obligations
293


The following table presents the weighted average remaining lease term and weighted average discount rate related to the Company's operating leases as of March 31, 2019:

Weighted average remaining lease term
4.4 years

Weighted average discount rate
4.45
%

The following table presents the maturity of the Company's operating lease liabilities as of March 31, 2019 (in thousands):
Remainder of 2019
$
1,396

2020
1,611

2021
1,453

2022
1,320

2023
1,766

Total operating lease payments
7,546

Less: imputed interest
731

Total operating lease liabilities
$
6,815



Lessor Accounting
 
In our CCA segment, primarily related to our Point of Care laboratory products, the Company enters into sales-type leases as part of our subscription agreements. The following table presents the maturity of the Company's undiscounted lease receivables as of March 31, 2019 (in thousands):

Year Ending December 31,
 
Remainder of 2019
$
2,409

2020
3,430

2021
3,364

2022
2,989

2023
2,147

Thereafter
1,501

 
$
15,840
XML 25 R14.htm IDEA: XBRL DOCUMENT v3.19.1
EARNINGS PER SHARE
 3 Months Ended
Mar. 31, 2019
Earnings Per Share [Abstract]  
EARNINGS PER SHARE
EARNINGS PER SHARE

Basic earnings per share ("EPS") is computed by dividing net income attributable to the Company by the weighted-average number of common shares outstanding during the period. The computation of diluted EPS is similar to the computation of basic EPS except that the numerator is increased to exclude charges that would not have been incurred, and the denominator is increased to include the number of additional common shares that would have been outstanding (using the if-converted and treasury stock methods), if securities containing potentially dilutive common shares (stock options and restricted stock units but excluding options to purchase fractional shares resulting from the Company's December 2010 1-for-10 reverse stock split) had been converted to common shares, and if such assumed conversion is dilutive.

The following is a reconciliation of the weighted-average shares outstanding used in the calculation of basic and diluted EPS for the three months ended March 31, 2019 and 2018 (in thousands, except per share data):
 
Three Months Ended March 31,
 
2019
 
2018
Net income attributable to Heska Corporation
$
814

 
$
2,155

 
 
 
 
Basic weighted-average common shares outstanding
7,459

 
7,102

Assumed exercise of dilutive stock options and restricted shares
506

 
609

Diluted weighted-average common shares outstanding
$
7,965

 
$
7,711

 
 
 
 
Basic earnings per share attributable to Heska Corporation
$
0.11

 
$
0.30

Diluted earnings per share attributable to Heska Corporation
$
0.10

 
$
0.28



The following stock options and restricted shares were excluded from the computation of diluted EPS because they would have been anti-dilutive (in thousands):
 
Three Months Ended March 31,
 
2019
 
2018
Stock options
86

 
244
XML 26 R15.htm IDEA: XBRL DOCUMENT v3.19.1
GOODWILL AND OTHER INTANGIBLES
 3 Months Ended
Mar. 31, 2019
Goodwill and Intangible Assets Disclosure [Abstract]  
GOOWILL AND OTHER INTANGIBLES
GOODWILL AND OTHER INTANGIBLES

The following summarizes the change in goodwill during the three months ended March 31, 2019 (in thousands):
Carrying amount, December 31, 2018
$
26,679

Goodwill attributable to acquisitions (subject to change)
643

Foreign currency adjustments
(11
)
Carrying amount, March 31, 2019
$
27,311



Other intangibles consisted of the following (in thousands):
 
March 31, 2019
 
December 31, 2018
 
Gross Carrying Amount
 
Accumulated Amortization
 
Net Carrying Amount
 
Gross Carrying Amount
 
Accumulated Amortization
 
Net Carrying Amount
Developed technology
$
8,200

 
$
(205
)
 
$
7,995

 
$
8,200

 
$
—

 
$
8,200

Customer relationships and other
3,793

 
(1,865
)
 
1,928

 
3,303

 
(1,739
)
 
1,564

Total intangible assets
$
11,993

 
$
(2,070
)
 
$
9,923

 
$
11,503

 
$
(1,739
)
 
$
9,764


Amortization expense relating to other intangibles was as follows (in thousands):
 
Three Months Ended March 31,
 
2019
 
2018
Amortization expense
$
303

 
$
97



Estimated amortization expense related to intangibles for each of the five years from 2019 (remaining) through 2023 and thereafter is as follows (in thousands):
Year Ending December 31,
 
2019 (remaining)
$
968

2020
1,284

2021
1,280

2022
1,262

2023
915

Thereafter
4,214

 
$
9,923
XML 27 R16.htm IDEA: XBRL DOCUMENT v3.19.1
PROPERTY AND EQUIPMENT
 3 Months Ended
Mar. 31, 2019
Property, Plant and Equipment [Abstract]  
PROPERTY AND EQUIPMENT
PROPERTY AND EQUIPMENT, NET
Property and equipment, net, consisted of the following (in thousands):
 
March 31,
 
December 31,
 
2019
 
2018
Land
$
377

 
$
377

Building
2,978

 
2,978

Machinery and equipment
33,591

 
33,087

Office furniture and equipment
1,767

 
1,687

Computer hardware and software
4,725

 
4,704

Leasehold and building improvements
10,086

 
9,953

Construction in progress
947

 
1,274

 
54,471

 
54,060

Less accumulated depreciation
(38,960
)
 
(38,079
)
Total property and equipment, net
$
15,511

 
$
15,981


Depreciation expense was $1.0 million and $1.1 million for the three months ended March 31, 2019 and 2018, respectively.
The Company has subscription agreements whereby its instruments in inventory may be placed at a customer's location on a rental basis. The cost of these instruments is transferred to machinery and equipment and depreciated, typically over a 5 to 7 year period depending on the circumstance under which the instrument is placed with the customer. Our cost of instruments under operating leases as of March 31, 2019 and December 31, 2018, was $11.0 million and $10.8 million, respectively, before accumulated depreciation of $6.4 million and $6.1 million, respectively.
XML 28 R17.htm IDEA: XBRL DOCUMENT v3.19.1
INVENTORIES, NET
 3 Months Ended
Mar. 31, 2019
Inventory Disclosure [Abstract]  
INVENTORIES, NET
INVENTORIES, NET

Inventories, net, consisted of the following (in thousands):
 
 
March 31,
 
December 31,
 
 
2019
 
2018
Raw materials
 
$
16,626

 
$
15,000

Work in process
 
3,214

 
3,592

Finished goods
 
8,869

 
8,085

Allowance for excess or obsolete inventory
 
(1,321
)
 
(1,573
)
Total inventory, net
 
$
27,388

 
$
25,104



Inventories are measured on a first-in, first-out basis and stated at lower of cost or net realizable value.
XML 29 R18.htm IDEA: XBRL DOCUMENT v3.19.1
ACCRUED LIABILITIES
 3 Months Ended
Mar. 31, 2019
Payables and Accruals [Abstract]  
ACCRUED LIABILITIES
ACCRUED LIABILITIES
Accrued liabilities consisted of the following (in thousands):
 
March 31,
2019
 
December 31,
2018
Accrued settlement (see Note 14)
$
6,750

 
$
6,750

Accrued payroll and employee benefits
840

 
759

Accrued property taxes
232

 
632

Inventory in transit
1,281

 
327

Other
1,544

 
1,674

Total accrued liabilities
$
10,647

 
$
10,142


Other accrued liabilities consists of items that are individually less than 5% of total current liabilities.
XML 30 R19.htm IDEA: XBRL DOCUMENT v3.19.1
CAPITAL STOCK
 3 Months Ended
Mar. 31, 2019
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
CAPITAL STOCK
CAPITAL STOCK
Stock Option Plans
The fair value of each option grant was estimated on the date of grant using the Black-Scholes option-pricing model with the following weighted average assumptions for options granted in the three months ended March 31, 2019 and 2018.
 
Three Months Ended March 31,
 
2019
 
2018
Risk-free interest rate
2.45%
 
2.64%
Expected lives
4.7 years
 
4.9 years
Expected volatility
39%
 
40%
Expected dividend yield
0%
 
0%

A summary of our stock option plans is as follows:
 
Three Months Ended March 31,
 
Year Ended December 31,
 
2019
 
2018
 
 
 
 
Options
 
Weighted Average Exercise Price
 
 
 
 
Options
 
Weighted Average Exercise Price
Outstanding at beginning of period
620,553

 
$
40.741

 
630,847

 
$
29.312

Granted at market
1,200

 
$
98.970

 
153,700

 
$
75.244

Forfeited
—

 
$
—

 
(18,978
)
 
$
53.010

Expired
—

 
$
—

 
(896
)
 
$
25.740

Exercised
(122,895
)
 
$
17.013

 
(144,120
)
 
$
65.414

Outstanding at end of period
498,858

 
$
46.727

 
620,553

 
$
40.741

Exercisable at end of period
319,523

 
$
31.026

 
386,176

 
$
21.214


The total estimated fair value of stock options granted during the three months ended March 31, 2019 and 2018 was computed to be approximately $43 thousand and $3.5 million, respectively. The amounts are amortized ratably over the vesting periods of the options. The weighted average estimated fair value of options granted during the three months ended March 31, 2019 and 2018 was computed to be approximately $36.18 and $26.69, respectively. The total intrinsic value of options exercised during the three months ended March 31, 2019 and 2018 was $9.9 million and $406 thousand, respectively. The cash proceeds from options exercised during the three months ended March 31, 2019 and 2018 was $84 thousand and $121 thousand, respectively.
The following table summarizes information about stock options outstanding and exercisable at March 31, 2019:
 
 
Options Outstanding
 
Options Exercisable
Exercise Prices
 
Number of
Options
Outstanding
at
March 31, 2019
 
Weighted
Average
Remaining
Contractual
Life in Years
 
Weighted
Average
Exercise
Price
 
Number of
Options
Exercisable
at
March 31, 2019
 
Weighted
Average
Exercise
Price
$ 4.50 - $ 7.36
 
101,502

 
3.65
 
$
6.807

 
101,502

 
$
6.807

$ 7.37 - $ 32.21
 
94,485

 
5.05
 
$
15.917

 
93,758

 
$
15.793

$ 32.22 - $ 62.50
 
61,104

 
6.84
 
$
39.783

 
44,672

 
$
39.693

$ 62.51 - $ 69.77
 
130,000

 
8.93
 
$
69.770

 
43,337

 
$
69.770

$ 69.78 - $ 108.25
 
111,767

 
8.20
 
$
86.020

 
36,254

 
$
81.236

$ 4.50 - $ 108.25
 
498,858

 
6.70
 
$
46.727

 
319,523

 
$
31.026


As of March 31, 2019, there was approximately $4.7 million in total unrecognized compensation cost related to outstanding stock options. That cost is expected to be recognized over a weighted average period of 1.62 years, with all cost to be recognized by the end of February 2023, assuming all options vest according to the vesting schedules in place at March 31, 2019. As of March 31, 2019, the aggregate intrinsic value of outstanding options was approximately $20.0 million and the aggregate intrinsic value of exercisable options was approximately $17.4 million.
The Company issues new shares upon share option exercise, which may be netted or withheld to meet strike price or related tax obligations.
Employee Stock Purchase Plan (the "ESPP")

For the three months ended March 31, 2019 and 2018, we issued 2,583 and 3,127 shares under the ESPP, respectively.
For the three months ended March 31, 2019 and 2018, we estimated the fair values of stock purchase rights granted under the ESPP using the Black-Scholes pricing model. The weighted average assumptions used for the periods presented were as follows:
 
Three Months Ended March 31,
 
2019
 
2018
Risk-free interest rate
2.35%
 
1.03%
Expected lives
1.1 years
 
1.2 years
Expected volatility
40%
 
44%
Expected dividend yield
0%
 
0%

For the three months ended March 31, 2019 and 2018, the weighted-average fair value of the purchase rights granted was $18.97 and $14.28 per share, respectively.
Restricted Stock Issuance
We have granted non-vested restricted stock awards (“restricted stock”) to management and non-employee directors pursuant to the 1997 Plan. The restricted stock awards have varying vesting periods, but generally become fully vested between one and four years after the grant date, depending on the specific award, performance targets met for performance-based awards granted to management, and vesting periods for time based awards. Management performance-based awards are granted at the target amount of shares that may be earned. We valued the restricted stock awards related to service and/or company performance targets based on grant date fair value and expense over the period when achievement of those conditions is deemed probable. For restricted stock awards related to market conditions, we utilize a Monte Carlo simulation model to estimate grant date fair value and expense over the requisite period. We recognize forfeitures as they occur. There were no modifications that affected our accounting for restricted stock awards in the three months ended March 31, 2019 or 2018.
The following table summarizes restricted stock transactions for the three months ended March 31, 2019:
 
RSAs
 
Weighted-Average Grant Date Fair Value Per Award
Non-vested as of December 31, 2018
259,430

 
$
74.26

     Granted
117

 
77.52

     Vested
—

 
—

     Forfeited
—

 
—

Non-vested as of March 31, 2019
259,547

 
$
74.26


The weighted average grant date fair value of awards granted was $77.52 and $62.73 for the three months ended March 31, 2019 and 2018, respectively. Fair value of restricted stock vested was $0.0 and $4.2 million for the three months ended March 31, 2019 and 2018, respectively.

As of March 31, 2019, there was approximately $2.5 million of total unrecognized compensation cost related to restricted stock with market and time vesting conditions. The Company expects to recognize this expense over a weighted average period of 1.4 years. As of March 31, 2019, we reviewed each of the underlying corporate performance targets and determined that approximately 167,000 of shares of common stock were related to company performance targets in which we did not deem achievement probable. No compensation expense had been recorded at any period prior to March 31, 2019.
Restrictions on the transfer of Company stock

The Company's Restated Certificate of Incorporation, as amended (the "Certificate of Incorporation"), places restrictions (the "Transfer Restrictions") on the transfer of the Company's stock that could adversely affect the Company's ability to utilize its domestic Federal Net Operating Loss Position. In particular, the Transfer Restrictions prevent the transfer of shares without the approval of the Company's Board of Directors if, as a consequence of such transfer, an individual, entity or groups of individuals or entities would become a 5-percent holder under Section 382 of the Internal Revenue Code of 1986, as amended, and the related Treasury regulations, and also prevents any existing 5-percent holder from increasing his or her ownership position in the Company without the approval of the Company's Board of Directors. Any transfer of shares in violation of the Transfer Restrictions (a "Transfer Violation") shall be void ab initio under the Certificate of Incorporation, and the Company's Board of Directors has procedures under the Certificate of Incorporation to remedy a Transfer Violation including requiring the shares causing such Transfer Violation to be sold and any profit resulting from such sale to be transferred to a charitable entity chosen by the Company's Board of Directors in specified circumstances.
XML 31 R20.htm IDEA: XBRL DOCUMENT v3.19.1
ACCUMULATED OTHER COMPREHENSIVE INCOME
 3 Months Ended
Mar. 31, 2019
Equity [Abstract]  
ACCUMULATED OTHER COMPREHENSIVE INCOME
ACCUMULATED OTHER COMPREHENSIVE INCOME
Accumulated other comprehensive income (loss) consisted of the following (in thousands):
 
Minimum Pension Liability
 
Foreign Currency Translation
 
Total Accumulated Other Comprehensive Income
Balances at December 31, 2018
$
(419
)
 
$
696

 
$
277

Current period other comprehensive loss
—

 
(62
)
 
(62
)
Balances at March 31, 2019
$
(419
)
 
$
634

 
$
215
XML 32 R21.htm IDEA: XBRL DOCUMENT v3.19.1
COMMITMENTS AND CONTINGENCIES
 3 Months Ended
Mar. 31, 2019
Commitments and Contingencies Disclosure [Abstract]  
COMMITMENTS AND CONTINGENCIES
COMMITMENTS AND CONTINGENCIES
Royalty Agreements
The Company holds certain rights to market and manufacture products developed or created under certain research, development, and licensing agreements with various entities. In connection with such agreements, the Company has agreed to pay the entities royalties on net product sales. In each of the three months ended March 31, 2019 and 2018, royalties of $0.1 million became payable under these agreements.
Warranties

The Company's current terms and conditions of sale include a limited warranty that its products and services will conform to published specifications at the time of shipment and a more extensive warranty related to certain of its products. The Company also sells a renewal warranty for certain of its products. The typical remedy for breach of warranty is to correct or replace any defective product, and if not possible or practical, the Company will accept the return of the defective product and refund the amount paid. Historically, the Company has incurred minimal warranty costs. The Company's warranty reserve was $0.2 million at both March 31, 2019 and December 31, 2018.

Litigation
From time to time, the Company may be involved in litigation relating to claims arising out of its operations. The Company records accruals for outstanding legal matters when it believes it is probable that a loss will be incurred, and the amount can be reasonably estimated.

On October 10, 2018, we reached an agreement in principle to settle the complaint that was filed against the Company by Shaun Fauley on March 12, 2015 in the U.S. District Court Northern District of Illinois alleging our transmittal of unauthorized faxes in violation of the federal Telephone Consumer Protection Act of 1991, as amended by the Junk Fax Prevention Act of 2005, as a class action (the "Fauley Complaint"). The settlement, which received the Court's approval on February 28, 2019 and was not subsequently appealed by a class member, required us to make available a total of $6.75 million to pay class members, as well as to pay attorneys' fees and expenses to legal counsel to the class. The Company recorded the loss provision in the third quarter of 2018 in connection with the settlement agreement and does not have insurance coverage for the Fauley Complaint. The payment in respect of the settlement was made in full on April 3, 2019, and all activity related to the Fauley Complaint has ceased.
As of March 31, 2019, the Company was not a party to any other legal proceedings that were expected, individually or in the aggregate, to have a material adverse effect on its business, financial condition, or operating results.

Off-Balance Sheet Commitments

Unconditional Purchase Obligations
The Company has contractual obligations with suppliers for unconditional annual minimum inventory purchases in the amounts of $12.2 million as of March 31, 2019.
XML 33 R22.htm IDEA: XBRL DOCUMENT v3.19.1
INTEREST AND OTHER EXPENSE, NET
 3 Months Ended
Mar. 31, 2019
Other Income and Expenses [Abstract]  
INTEREST AND OTHER EXPENSE, NET
INTEREST AND OTHER INCOME, NET
Interest and other income, net, consisted of the following (in thousands):
 
Three Months Ended March 31,
 
2019
 
2018
Interest income
$
(92
)
 
$
(56
)
Interest expense
77

 
65

Other income, net
(1
)
 
(13
)
Total interest and other income, net
$
(16
)
 
$
(4
)

Cash paid for interest for the three months ended March 31, 2019 and 2018 was $56 thousand and $27 thousand, respectively.
XML 34 R23.htm IDEA: XBRL DOCUMENT v3.19.1
CREDIT FACILITY
 3 Months Ended
Mar. 31, 2019
Debt Disclosure [Abstract]  
CREDIT FACILITY
CREDIT FACILITY

On July 27, 2017, and subsequently amended in May and December 2018, we entered into a Credit Agreement (the "Credit Agreement") with JPMorgan Chase Bank, N.A. ("Chase") which provides for a revolving credit facility up to $30.0 million (the "Credit Facility"). The Credit Facility provides us with the ability to borrow up to $30.0 million although the amount of the Credit Facility may be increased by an additional $20.0 million up to a total of $50.0 million subject to receipt of additional lender commitments and other conditions. Any interest on borrowings due is to be charged at either the (i) rate of interest per annum publicly announced from time to time by Chase as its prime rate in effect at its principal offices in New York City, subject to a floor, minus 1.65%, or (ii) the interest rate per annum equal to (a) LIBOR for the interest period in effect multiplied by (b) Chase's Statutory Reserve Rate (as defined in the Credit Agreement), plus 1.10% and payable monthly. There is an annual minimum interest charge of $60 thousand under the Credit Agreement. Chase holds first right of priority over all other liens, if any were to exist. Borrowings under the Credit Facility are subject to certain financial and non-financial covenants and are available for various corporate purposes, including general working capital, capital investments, and certain permitted acquisitions. Failure to comply with any of the covenants, representations or warranties could result in our being in default on the loan and could cause all outstanding amounts payable to Chase to become immediately due and payable or impact our ability to borrow under the agreement. The Credit Agreement also permits us to issue letters of credit, although there are currently none outstanding. The maturity date of the Credit Facility is July 27, 2020. The foregoing discussion of the Credit Facility is a summary only and is qualified in its entirety by reference to the full text of the Credit Agreement, a copy of which has been filed as an exhibit to the Company's Current Report on Form 8-K filed with the SEC on August 2, 2017, and the Facility Amendment, a copy of which has been filed as an exhibit to the Company's Current Report on Form 10-Q filed with the SEC on August 8, 2018, each of which are incorporated herein by reference.

At March 31, 2019, we had a $6.0 million line of credit outstanding under the Credit Facility and we were in compliance with all financial covenants. In April 2019, we used this Credit Facility to make a $6.75 million payment to settle all claims associated with the Fauley Complaint that is further discussed in Note 14 of this Form 10-Q.
XML 35 R24.htm IDEA: XBRL DOCUMENT v3.19.1
SEGMENT REPORTING
 3 Months Ended
Mar. 31, 2019
Segment Reporting [Abstract]  
SEGMENT REPORTING
SEGMENT REPORTING
The Company is composed of two reportable segments, CCA and OVP. The CCA segment includes Point of Care diagnostic laboratory instruments and consumables, and Point of Care digital imaging diagnostic instruments and software services as well as single use diagnostic and other tests, pharmaceuticals and vaccines, primarily for canine and feline use. These products are sold directly by the Company as well as through independent third-party distributors and through other distribution relationships. CCA segment products manufactured at the Des Moines, Iowa production facility included in the OVP segment's assets are transferred at cost and are not recorded as revenue for the OVP segment. The OVP segment includes private label vaccine and pharmaceutical production, primarily for cattle, but also for other animals including small mammals. All OVP products are sold by third parties under third-party labels.

Summarized financial information concerning the Company's reportable segments is shown in the following tables (in thousands):
Three Months Ended March 31, 2019
 
Core
Companion
Animal
 
Other Vaccines and Pharmaceuticals
 
 
 
Total
Total revenue
 
$
24,716

 
$
4,795

 
$
29,511

Operating loss
 
(51
)
 
(24
)
 
(75
)
Loss before income taxes
 
(35
)
 
(24
)
 
(59
)
Capital expenditures
 
44

 
190

 
234

Depreciation and amortization
 
947

 
318

 
1,265

Three Months Ended March 31, 2018
 
Core
Companion
Animal
 
Other Vaccines and Pharmaceuticals
 
 
 
Total
Total revenue
 
$
26,819

 
$
5,946

 
$
32,765

Operating income (loss)
 
1,923

 
(52
)
 
1,871

Income (loss) before income taxes
 
1,927

 
(52
)
 
1,875

Capital expenditures
 
57

 
318

 
375

Depreciation and amortization
 
908

 
288

 
1,196



Asset information by reportable segment as of March 31, 2019 is as follows (in thousands):
Three Months Ended March 31, 2019
 
Core
Companion
Animal
 
Other Vaccines and Pharmaceuticals
 
Total
Investments in unconsolidated affiliates
 
$
7,837

 
$
—

 
$
7,837

Total assets
 
138,076

 
24,704

 
162,780

Net assets
 
95,683

 
26,256

 
121,939


Asset information by reportable segment as of December 31, 2018 is as follows (in thousands):
Year Ended December 31, 2018
 
Core
Companion
Animal
 
Other Vaccines and Pharmaceuticals
 
Total
Investments in unconsolidated affiliates
 
$
8,018

 
$
—

 
$
8,018

Total assets
 
133,586

 
22,866

 
156,452

Net assets
 
96,129

 
26,280

 
122,409
XML 36 R25.htm IDEA: XBRL DOCUMENT v3.19.1
OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)
 3 Months Ended
Mar. 31, 2019
Accounting Policies [Abstract]  
Basis of Presentation and Consolidation
In the opinion of management, the accompanying unaudited Condensed Consolidated Financial Statements contain all adjustments, consisting of normal, recurring adjustments, necessary to present fairly the financial position of the Company as of March 31, 2019 and December 31, 2018, the results of our operations, statements of stockholders' equity and cash flows for the three months ended March 31, 2019 and 2018.
The unaudited Condensed Consolidated Financial Statements included herein have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission ("SEC"). Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America ("GAAP") have been condensed or omitted pursuant to such rules and regulations. Our unaudited Condensed Consolidated Financial Statements include our accounts and the accounts of our wholly-owned subsidiaries since their respective dates of acquisitions. All intercompany accounts and transactions have been eliminated in consolidation. Where our ownership of a subsidiary is less than 100%, the non-controlling interest is reported on our Condensed Consolidated Balance Sheets. The non-controlling interest in our consolidated net income is reported as "Net loss attributable to redeemable non-controlling interest" on our Condensed Consolidated Statements of Income. These unaudited Condensed Consolidated Financial Statements should be read in conjunction with the audited Consolidated Financial Statements and Notes thereto contained in our Annual Report on Form 10-K for the fiscal year ended December 31, 2018 and other financial information filed with the SEC.
Use of Estimates
The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates are required when establishing the allowance for doubtful accounts and the net realizable value of inventory; determining future costs associated with warranties provided; determining the period over which our obligations are fulfilled under agreements to license product rights and/or technology rights; evaluating long-lived and intangible assets and investments for estimated useful lives and impairment; estimating the useful lives of instruments under leasing arrangements; determining the allocation of purchase price under purchase accounting; estimating the expense associated with the granting of stock; determining the need for, and the amount of a valuation allowance on deferred tax assets; and determining the value of the non-controlling interest in a business combination.
Recent Accounting Pronouncements
Adoption of New Accounting Pronouncements

Effective January 1, 2019, we adopted ASU 2018-07, Compensation – Stock Compensation (Topic 718), Improvements to Non-employee Share-Based Payment Accounting. This ASU is intended to simplify aspects of share-based compensation issued to non-employees by making the guidance consistent with accounting for employee share-based compensation. Guidance related to the stock compensation granted to employees is followed for non-employees, including the measurement date, valuation approach and performance conditions. The expense is recognized in the same period as though cash were paid for the good or service, ratably over the service period. The adoption of this ASU did not have an impact on our consolidated financial statements but did have a minimal impact on our related disclosures.

Effective January 1, 2019, we adopted ASU 2018-02, Income Statement-Reporting Comprehensive Income (Topic 220): Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income. The ASU permits companies to elect a reclassification of the disproportionate tax effects in accumulated other comprehensive income ("AOCI") caused by the Tax Cuts and Jobs Act of 2017 to retained earnings. As of March 31, 2019, the Company does not have any disproportionate income tax effects in AOCI to reclassify. However, if the Company did have disproportionate income tax effects in AOCI in the future, it would reclassify them to retained earnings.

In February 2016, the FASB issued ASU 2016-02, Leases (Topic 842), which supersedes ASC 840, Leases. This update requires lessees to recognize a right-of-use (“ROU”) asset and a lease liability for all leases, including operating leases, with terms greater than 12 months on its balance sheet. The update also expands the required quantitative and qualitative disclosures by lessees and lessors about the amount, timing and uncertainty of cash flows arising from leases. The accounting for lessors does not fundamentally change except for changes to conform and align guidance to the lessee guidance as well as to the new revenue recognition guidance in ASU 2014-09, Revenue from Contracts with Customers (Topic 606). Subsequent to the issuance of Topic 842, the FASB clarified the guidance through several ASUs; hereinafter the collection of lease guidance is referred to as “ASC 842”.

The Company adopted ASC 842 on January 1, 2019, using the modified retrospective approach for all lease arrangements at the beginning of the period of adoption. Results for reporting periods beginning January 1, 2019 are presented under ASC 842, while prior period amounts were not adjusted and continue to be reported in accordance with the Company’s historic accounting under ASC 840, Leases. For leases that commenced before the effective date of ASC 842, the Company elected the permitted practical expedients to not reassess the following: (i) whether any expired or existing contracts contain leases; (ii) the lease classification for any expired or existing leases; and (iii) initial direct costs for any existing leases. The Company also elected to exclude leases with a term of 12 months or less from the recognized ROU assets and lease liabilities.

Adoption of the standard did not have a material net impact in our Condensed Consolidated Balance Sheets, Condensed Consolidated Statements of Income or Condensed Consolidated Statements of Cash Flows. The most significant impact was the recognition of ROU assets and lease liabilities for the operating leases, of which we are the lessee. As a result of the cumulative impact of adopting ASC 842, the Company recorded operating lease ROU assets of $6.5 million and operating lease liabilities of $6.9 million as of January 1, 2019, primarily related to building, vehicle, and office equipment leases, based on the present value of the future lease payments on the date of adoption. As a lessor, accounting for our subscription agreements will remain substantially unchanged. Refer to Note 6 for additional disclosures required by ASC 842.
The Company determines if an arrangement is a lease at inception based on whether control of an identified asset is transferred. For leases where the Company is the lessee, ROU assets represent the Company’s right to use an underlying asset for the lease term and lease liabilities represent an obligation to make lease payments arising from the lease. ROU assets and lease liabilities are recognized at the lease commencement date based on the present value of lease payments over the lease term. As most of the Company’s leases do not provide an implicit interest rate, the Company uses its incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. The lease terms used to calculate the ROU asset and related lease liability include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. Lease expense for operating leases is recognized on a straight-line basis over the lease term as an operating expense while the expense for finance leases is recognized as amortization expense and interest expense. The Company has lease agreements which require payments for lease and non-lease components and has elected to account for these as a single lease component for our building and office equipment leases, but as separate components for our vehicle leases.

Our revenue under subscription agreements relates to both operating-type lease (“OTL”) arrangements or sales-type lease (“STL”) arrangements. Determination of an OTL or STL is primarily determined as a result of the length of the contract as compared to the estimated useful life of the instrument, among other factors. A STL results in earlier recognition of instrument revenue. The cost of the customer-leased instruments is removed from inventory and recognized in the Consolidated Statements of Income. There is no residual value taken into consideration as it does not meet our capitalization requirements. Instrument lease revenue for OTL agreements is recognized on a straight-line basis over the life of the lease and included with the predominant non-lease components in consumable revenue. The costs of customer-leased instruments are recorded within property and equipment in the accompanying Consolidated Balance Sheets and depreciated over the instrument’s estimated useful life. The depreciation expense is reflected in cost of revenue in the accompanying Consolidated Statements of Income. The OTLs and STLs are not cancellable until after an initial term and include an option to renew.
For lease arrangements with lease and non-lease components where the Company is the lessor, the Company allocates the contracts transaction price to the lease and non-lease components on a relative standalone selling price basis using the Company’s best estimate of the standalone selling price of each distinct product or service in the contract. The primary method used to estimate standalone selling price is the price observed in standalone sales to customers of a prior period. Changes in these values can impact the amount of consideration allocated to each component of the contract. When prices in standalone sales are not available, we may use a cost-plus margin approach. Allocation of the transaction price is determined at the inception of the lease arrangement. The Company’s leases consist of leases with fixed and variable lease payments. For those leases with variable lease payments, the variable lease payment is typically based upon purchase of consumables used with the leased instruments and included in consumable revenue.
Accounting Pronouncements Not Yet Adopted

In June 2016, the FASB issued ASU 2016-13, Financial Instruments - Credit Losses (Topic 326), which requires that financial assets measured at amortized cost be presented at the net amount expected to be collected. The allowance for credit losses is a valuation account that is deducted from the amortized cost basis of the financial asset to present the net carrying value at the amount expected to be collected. The income statement reflects the measurement of credit losses for newly recognized financial assets, as well as the increases or decreases of expected credit losses that have taken place during the period. The measurement of expected credit losses is based upon historical experience, current conditions and reasonable and supportable forecasts that affect the collectability of the reported amount. In November 2018, the FASB issued ASU 2018-19, Codification Improvements to Topic 326, Financial Instruments - Credit Losses. This ASU clarifies that receivables from operating leases are accounted for using the lease guidance and not as financial instruments. The amendments in this update are effective for fiscal years beginning after December 15, 2019 and interim periods within those annual periods. Early adoption for fiscal year beginning after December 15, 2018 is permitted. We will adopt the provisions of this ASU in the first quarter of 2020. We are currently evaluating the effect of this update on our consolidated financial statements.
XML 37 R26.htm IDEA: XBRL DOCUMENT v3.19.1
REVENUE (Tables)
 3 Months Ended
Mar. 31, 2019
Revenue from Contract with Customer [Abstract]  
Disaggregation of Revenue
The following table summarizes our Core Companion Animal ("CCA") revenue (in thousands):
 
Three Months Ended March 31,
 
2019
 
2018
Point of Care laboratory revenue:
$
15,961

 
$
13,641

    Consumables
12,317

 
10,821

    Sales-type leases
1,742

 
1,538

    Outright instrument sales
1,528

 
811

    Other
374

 
471

 
 
 
 
Point of Care imaging revenue:
5,410

 
5,972

    Outright instrument sales
4,546

 
5,137

    Service revenue
562

 
556

    Operating type leases and other
302

 
279

 
 
 
 
Other CCA revenue:
3,345

 
7,206

    Other pharmaceuticals, vaccines and diagnostic tests
3,246

 
7,109

    Research and development, license and royalty revenue
99

 
97

 
 
 
 
Total CCA revenue
$
24,716

 
$
26,819


Revenue from our OVP segment consists of revenue generated from contract manufacturing agreements and from other license, research and development revenue. The following table summarizes our OVP revenue (in thousands):
 
Three Months Ended March 31,
 
2019
 
2018
Contract manufacturing
$
4,666

 
$
5,791

License, research and development
129

 
155

Total OVP revenue
$
4,795

 
$
5,946
Schedule of Timing of Revenue Expected to be Recognized
As of March 31, 2019, the Company expects to recognize revenue as follows (in thousands):
Year Ending December 31,
Revenue
2019 (remaining)
$
18,023

2020
21,101

2021
17,078

2022
13,925

2023
10,337

Thereafter
6,727

 
$
87,191
XML 38 R27.htm IDEA: XBRL DOCUMENT v3.19.1
INVESTMENTS IN UNCONSOLIDATED AFFILIATES (Tables)
 3 Months Ended
Mar. 31, 2019
Equity Method Investments and Joint Ventures [Abstract]  
Carrying values of investments in unconsolidated entities
The carrying values of investments in unconsolidated affiliates, categorized by type of investment, is as follows (in thousands):
 
March 31, 2019
 
December 31, 2018
Equity method investment
$
4,819

 
$
5,000

Non-marketable equity security investment
3,018

 
3,018

 
$
7,837

 
$
8,018
XML 39 R28.htm IDEA: XBRL DOCUMENT v3.19.1
INCOME TAXES (Tables)
 3 Months Ended
Mar. 31, 2019
Income Tax Disclosure [Abstract]  
Schedule of components of income tax expense
Our total income tax benefit for our (loss) income before income taxes were as follows (in thousands):
 
 
Three Months Ended March 31,
 
 
2019
 
2018
(Loss) income before income taxes
 
$
(59
)
 
$
1,875

Total income tax benefit
 
(1,010
)
 
(280
)
XML 40 R29.htm IDEA: XBRL DOCUMENT v3.19.1
LEASES (Tables)
 3 Months Ended
Mar. 31, 2019
Leases [Abstract]  
Additional lease information
Supplemental cash flow information related to the Company's operating leases for the three months ended March 31, 2019 was as follows (in thousands):

Cash paid for amounts included in the measurement of operating lease liabilities
$
444

ROU assets obtained in exchange for operating lease obligations
293


The following table presents the weighted average remaining lease term and weighted average discount rate related to the Company's operating leases as of March 31, 2019:

Weighted average remaining lease term
4.4 years

Weighted average discount rate
4.45
%
Schedule of maturity of operating leases
The following table presents the maturity of the Company's operating lease liabilities as of March 31, 2019 (in thousands):
Remainder of 2019
$
1,396

2020
1,611

2021
1,453

2022
1,320

2023
1,766

Total operating lease payments
7,546

Less: imputed interest
731

Total operating lease liabilities
$
6,815
Lessor, maturity of undiscounted lease receivables
The following table presents the maturity of the Company's undiscounted lease receivables as of March 31, 2019 (in thousands):

Year Ending December 31,
 
Remainder of 2019
$
2,409

2020
3,430

2021
3,364

2022
2,989

2023
2,147

Thereafter
1,501

 
$
15,840
XML 41 R30.htm IDEA: XBRL DOCUMENT v3.19.1
EARNINGS PER SHARE (Tables)
 3 Months Ended
Mar. 31, 2019
Earnings Per Share [Abstract]  
Reconciliation of basic and diluted earnings per share
The following is a reconciliation of the weighted-average shares outstanding used in the calculation of basic and diluted EPS for the three months ended March 31, 2019 and 2018 (in thousands, except per share data):
 
Three Months Ended March 31,
 
2019
 
2018
Net income attributable to Heska Corporation
$
814

 
$
2,155

 
 
 
 
Basic weighted-average common shares outstanding
7,459

 
7,102

Assumed exercise of dilutive stock options and restricted shares
506

 
609

Diluted weighted-average common shares outstanding
$
7,965

 
$
7,711

 
 
 
 
Basic earnings per share attributable to Heska Corporation
$
0.11

 
$
0.30

Diluted earnings per share attributable to Heska Corporation
$
0.10

 
$
0.28
Schedule of antidilutive securities excluded from computation of earnings per share
The following stock options and restricted shares were excluded from the computation of diluted EPS because they would have been anti-dilutive (in thousands):
 
Three Months Ended March 31,
 
2019
 
2018
Stock options
86

 
244
XML 42 R31.htm IDEA: XBRL DOCUMENT v3.19.1
GOODWILL AND OTHER INTANGIBLES (Tables)
 3 Months Ended
Mar. 31, 2019
Goodwill and Intangible Assets Disclosure [Abstract]  
Schedule of changes in goodwill
The following summarizes the change in goodwill during the three months ended March 31, 2019 (in thousands):
Carrying amount, December 31, 2018
$
26,679

Goodwill attributable to acquisitions (subject to change)
643

Foreign currency adjustments
(11
)
Carrying amount, March 31, 2019
$
27,311
Schedule of other intangible assets
Other intangibles consisted of the following (in thousands):
 
March 31, 2019
 
December 31, 2018
 
Gross Carrying Amount
 
Accumulated Amortization
 
Net Carrying Amount
 
Gross Carrying Amount
 
Accumulated Amortization
 
Net Carrying Amount
Developed technology
$
8,200

 
$
(205
)
 
$
7,995

 
$
8,200

 
$
—

 
$
8,200

Customer relationships and other
3,793

 
(1,865
)
 
1,928

 
3,303

 
(1,739
)
 
1,564

Total intangible assets
$
11,993

 
$
(2,070
)
 
$
9,923

 
$
11,503

 
$
(1,739
)
 
$
9,764
Schedule of amortization expense on intangible assets
Amortization expense relating to other intangibles was as follows (in thousands):
 
Three Months Ended March 31,
 
2019
 
2018
Amortization expense
$
303

 
$
97
Schedule of estimated future amortization expense
Estimated amortization expense related to intangibles for each of the five years from 2019 (remaining) through 2023 and thereafter is as follows (in thousands):
Year Ending December 31,
 
2019 (remaining)
$
968

2020
1,284

2021
1,280

2022
1,262

2023
915

Thereafter
4,214

 
$
9,923
XML 43 R32.htm IDEA: XBRL DOCUMENT v3.19.1
PROPERTY AND EQUIPMENT (Tables)
 3 Months Ended
Mar. 31, 2019
Property, Plant and Equipment [Abstract]  
Schedule of property and equipment
Property and equipment, net, consisted of the following (in thousands):
 
March 31,
 
December 31,
 
2019
 
2018
Land
$
377

 
$
377

Building
2,978

 
2,978

Machinery and equipment
33,591

 
33,087

Office furniture and equipment
1,767

 
1,687

Computer hardware and software
4,725

 
4,704

Leasehold and building improvements
10,086

 
9,953

Construction in progress
947

 
1,274

 
54,471

 
54,060

Less accumulated depreciation
(38,960
)
 
(38,079
)
Total property and equipment, net
$
15,511

 
$
15,981
XML 44 R33.htm IDEA: XBRL DOCUMENT v3.19.1
INVENTORIES, NET (Tables)
 3 Months Ended
Mar. 31, 2019
Inventory Disclosure [Abstract]  
Schedule of inventory
Inventories, net, consisted of the following (in thousands):
 
 
March 31,
 
December 31,
 
 
2019
 
2018
Raw materials
 
$
16,626

 
$
15,000

Work in process
 
3,214

 
3,592

Finished goods
 
8,869

 
8,085

Allowance for excess or obsolete inventory
 
(1,321
)
 
(1,573
)
Total inventory, net
 
$
27,388

 
$
25,104
XML 45 R34.htm IDEA: XBRL DOCUMENT v3.19.1
ACCRUED LIABILITIES (Tables)
 3 Months Ended
Mar. 31, 2019
Payables and Accruals [Abstract]  
Schedule of accrued liabilities
Accrued liabilities consisted of the following (in thousands):
 
March 31,
2019
 
December 31,
2018
Accrued settlement (see Note 14)
$
6,750

 
$
6,750

Accrued payroll and employee benefits
840

 
759

Accrued property taxes
232

 
632

Inventory in transit
1,281

 
327

Other
1,544

 
1,674

Total accrued liabilities
$
10,647

 
$
10,142
XML 46 R35.htm IDEA: XBRL DOCUMENT v3.19.1
CAPITAL STOCK (Tables)
 3 Months Ended
Mar. 31, 2019
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Schedule of weighted average valuation assumptions
The fair value of each option grant was estimated on the date of grant using the Black-Scholes option-pricing model with the following weighted average assumptions for options granted in the three months ended March 31, 2019 and 2018.
 
Three Months Ended March 31,
 
2019
 
2018
Risk-free interest rate
2.45%
 
2.64%
Expected lives
4.7 years
 
4.9 years
Expected volatility
39%
 
40%
Expected dividend yield
0%
 
0%
Schedule of stock options plans
A summary of our stock option plans is as follows:
 
Three Months Ended March 31,
 
Year Ended December 31,
 
2019
 
2018
 
 
 
 
Options
 
Weighted Average Exercise Price
 
 
 
 
Options
 
Weighted Average Exercise Price
Outstanding at beginning of period
620,553

 
$
40.741

 
630,847

 
$
29.312

Granted at market
1,200

 
$
98.970

 
153,700

 
$
75.244

Forfeited
—

 
$
—

 
(18,978
)
 
$
53.010

Expired
—

 
$
—

 
(896
)
 
$
25.740

Exercised
(122,895
)
 
$
17.013

 
(144,120
)
 
$
65.414

Outstanding at end of period
498,858

 
$
46.727

 
620,553

 
$
40.741

Exercisable at end of period
319,523

 
$
31.026

 
386,176

 
$
21.214
Schedule of shares authorized under stock options plans by exercise price
The following table summarizes information about stock options outstanding and exercisable at March 31, 2019:
 
 
Options Outstanding
 
Options Exercisable
Exercise Prices
 
Number of
Options
Outstanding
at
March 31, 2019
 
Weighted
Average
Remaining
Contractual
Life in Years
 
Weighted
Average
Exercise
Price
 
Number of
Options
Exercisable
at
March 31, 2019
 
Weighted
Average
Exercise
Price
$ 4.50 - $ 7.36
 
101,502

 
3.65
 
$
6.807

 
101,502

 
$
6.807

$ 7.37 - $ 32.21
 
94,485

 
5.05
 
$
15.917

 
93,758

 
$
15.793

$ 32.22 - $ 62.50
 
61,104

 
6.84
 
$
39.783

 
44,672

 
$
39.693

$ 62.51 - $ 69.77
 
130,000

 
8.93
 
$
69.770

 
43,337

 
$
69.770

$ 69.78 - $ 108.25
 
111,767

 
8.20
 
$
86.020

 
36,254

 
$
81.236

$ 4.50 - $ 108.25
 
498,858

 
6.70
 
$
46.727

 
319,523

 
$
31.026
Schedule of pricing models
The weighted average assumptions used for the periods presented were as follows:
 
Three Months Ended March 31,
 
2019
 
2018
Risk-free interest rate
2.35%
 
1.03%
Expected lives
1.1 years
 
1.2 years
Expected volatility
40%
 
44%
Expected dividend yield
0%
 
0%
XML 47 R36.htm IDEA: XBRL DOCUMENT v3.19.1
ACCUMULATED OTHER COMPREHENSIVE INCOME (Tables)
 3 Months Ended
Mar. 31, 2019
Equity [Abstract]  
Schedule of accumulated other comprehensive income (loss)
Accumulated other comprehensive income (loss) consisted of the following (in thousands):
 
Minimum Pension Liability
 
Foreign Currency Translation
 
Total Accumulated Other Comprehensive Income
Balances at December 31, 2018
$
(419
)
 
$
696

 
$
277

Current period other comprehensive loss
—

 
(62
)
 
(62
)
Balances at March 31, 2019
$
(419
)
 
$
634

 
$
215
XML 48 R37.htm IDEA: XBRL DOCUMENT v3.19.1
INTEREST AND OTHER EXPENSE, NET (Tables)
 3 Months Ended
Mar. 31, 2019
Other Income and Expenses [Abstract]  
Schedule of interest expense (income) and other income, net
Interest and other income, net, consisted of the following (in thousands):
 
Three Months Ended March 31,
 
2019
 
2018
Interest income
$
(92
)
 
$
(56
)
Interest expense
77

 
65

Other income, net
(1
)
 
(13
)
Total interest and other income, net
$
(16
)
 
$
(4
)
XML 49 R38.htm IDEA: XBRL DOCUMENT v3.19.1
SEGMENT REPORTING (Tables)
 3 Months Ended
Mar. 31, 2019
Segment Reporting [Abstract]  
Reconciliation of other significant reconciling items from segments to consolidated
Summarized financial information concerning the Company's reportable segments is shown in the following tables (in thousands):
Three Months Ended March 31, 2019
 
Core
Companion
Animal
 
Other Vaccines and Pharmaceuticals
 
 
 
Total
Total revenue
 
$
24,716

 
$
4,795

 
$
29,511

Operating loss
 
(51
)
 
(24
)
 
(75
)
Loss before income taxes
 
(35
)
 
(24
)
 
(59
)
Capital expenditures
 
44

 
190

 
234

Depreciation and amortization
 
947

 
318

 
1,265

Three Months Ended March 31, 2018
 
Core
Companion
Animal
 
Other Vaccines and Pharmaceuticals
 
 
 
Total
Total revenue
 
$
26,819

 
$
5,946

 
$
32,765

Operating income (loss)
 
1,923

 
(52
)
 
1,871

Income (loss) before income taxes
 
1,927

 
(52
)
 
1,875

Capital expenditures
 
57

 
318

 
375

Depreciation and amortization
 
908

 
288

 
1,196
Schedule of revenue from external customers and long-lived assets, by geographical areas
Asset information by reportable segment as of March 31, 2019 is as follows (in thousands):
Three Months Ended March 31, 2019
 
Core
Companion
Animal
 
Other Vaccines and Pharmaceuticals
 
Total
Investments in unconsolidated affiliates
 
$
7,837

 
$
—

 
$
7,837

Total assets
 
138,076

 
24,704

 
162,780

Net assets
 
95,683

 
26,256

 
121,939


Asset information by reportable segment as of December 31, 2018 is as follows (in thousands):
Year Ended December 31, 2018
 
Core
Companion
Animal
 
Other Vaccines and Pharmaceuticals
 
Total
Investments in unconsolidated affiliates
 
$
8,018

 
$
—

 
$
8,018

Total assets
 
133,586

 
22,866

 
156,452

Net assets
 
96,129

 
26,280

 
122,409
XML 50 R39.htm IDEA: XBRL DOCUMENT v3.19.1
OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - USD ($)
$ in Thousands
Mar. 31, 2019
Jan. 01, 2019
Error Corrections and Prior Period Adjustments Restatement [Line Items]    
Operating lease right-of-use assets $ 6,414  
Total operating lease liabilities $ 6,815  
ASU 2016-02    
Error Corrections and Prior Period Adjustments Restatement [Line Items]    
Operating lease right-of-use assets   $ 6,500
Total operating lease liabilities   $ 6,900
XML 51 R40.htm IDEA: XBRL DOCUMENT v3.19.1
REVENUE (Details) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Dec. 31, 2018
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]      
Total revenue, net $ 29,511 $ 32,765  
Contract receivables, current 900   $ 900
Contract receivables, noncurrent 3,400   3,300
Current portion of deferred revenue, and other 9,200   9,600
Contract liabilities, revenue recognized 700    
Contract liabilities, increase due to additional deferred sales $ 400    
Average term of underlying contracts 6    
Capitalized contract costs $ 2,500   $ 2,500
Capitalized contract costs, amortization 200    
Capitalized contract costs during the period 300    
Core companion animal      
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]      
Total revenue, net 24,716 26,819  
Point of Care laboratory revenue:      
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]      
Total revenue, net 15,961 13,641  
Consumables      
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]      
Total revenue, net 12,317 10,821  
Sales-type leases      
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]      
Total revenue, net 1,742 1,538  
Outright instrument sales      
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]      
Total revenue, net 1,528 811  
Other      
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]      
Total revenue, net 374 471  
Point of Care imaging revenue:      
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]      
Total revenue, net 5,410 5,972  
Outright instrument sales      
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]      
Total revenue, net 4,546 5,137  
Service revenue      
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]      
Total revenue, net 562 556  
Operating type leases and other      
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]      
Total revenue, net 302 279  
Other CCA revenue:      
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]      
Total revenue, net 3,345 7,206  
Other pharmaceuticals, vaccines and diagnostic tests      
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]      
Total revenue, net 3,246 7,109  
Research and development, license and royalty revenue      
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]      
Total revenue, net 99 97  
Other vaccines and pharmaceuticals      
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]      
Total revenue, net 4,795 5,946  
Contract manufacturing      
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]      
Total revenue, net 4,666 5,791  
License, research and development      
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]      
Total revenue, net $ 129 $ 155  
XML 52 R41.htm IDEA: XBRL DOCUMENT v3.19.1
REVENUE - Performance Obligations (Details)
$ in Thousands
Mar. 31, 2019
USD ($)
Revenue from Contract with Customer [Abstract]  
Remaining performance obligation $ 87,191
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2019-04-01  
Revenue from Contract with Customer [Abstract]  
Remaining performance obligation $ 18,023
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]  
Expected timing of satisfaction 9 months
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2020-01-01  
Revenue from Contract with Customer [Abstract]  
Remaining performance obligation $ 21,101
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]  
Expected timing of satisfaction 1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2021-01-01  
Revenue from Contract with Customer [Abstract]  
Remaining performance obligation $ 17,078
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]  
Expected timing of satisfaction 1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2022-01-01  
Revenue from Contract with Customer [Abstract]  
Remaining performance obligation $ 13,925
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]  
Expected timing of satisfaction 1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-01-01  
Revenue from Contract with Customer [Abstract]  
Remaining performance obligation $ 10,337
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]  
Expected timing of satisfaction 1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-01-01  
Revenue from Contract with Customer [Abstract]  
Remaining performance obligation $ 6,727
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]  
Expected timing of satisfaction
XML 53 R42.htm IDEA: XBRL DOCUMENT v3.19.1
ACQUISITION AND RELATED PARTY ITEMS (Details) - USD ($)
 3 Months Ended
Feb. 22, 2019
Dec. 21, 2018
Mar. 31, 2019
Mar. 31, 2018
Dec. 31, 2018
Business Acquisition [Line Items]          
Common stock, par value (in dollars per share)   $ 0.01      
Cuattro, LLC | Heska Imaging | Affiliated Entity          
Business Acquisition [Line Items]          
Related party - amount of transaction     $ 6,000 $ 1,700,000  
Heska Imaging | Affiliated Entity          
Business Acquisition [Line Items]          
Due to related parties         $ 200,000
Optomed          
Business Acquisition [Line Items]          
Minority interest 30.00%        
Cuattro, LLC          
Business Acquisition [Line Items]          
Equity transferred as consideration for asset acquisition (in shares)   54,763      
Equity transferred as consideration for asset acquisition, value   $ 5,400,000      
Payments for asset acquisitions   $ 2,800,000      
Optomed          
Business Acquisition [Line Items]          
Percentage of voting interest acquired 70.00%        
Cash consideration transferred $ 200,000        
Committed purchase amount $ 1,000,000        
XML 54 R43.htm IDEA: XBRL DOCUMENT v3.19.1
INVESTMENTS IN UNCONSOLIDATED AFFILIATES (Details) - USD ($)
$ in Thousands
Sep. 24, 2018
Aug. 08, 2018
Mar. 31, 2019
Dec. 31, 2018
Schedule of Equity Method Investments [Line Items]        
Investments in unconsolidated affiliates     $ 4,819 $ 5,000
Non-marketable equity security investment     3,018 3,018
Investments     $ 7,837 $ 8,018
General Fluidics Corporation        
Schedule of Equity Method Investments [Line Items]        
Supply commitment term 15 years      
General Fluidics Corporation        
Schedule of Equity Method Investments [Line Items]        
Payments to acquire equity method investments $ 5,100      
Ownership percentage 28.70%      
MBio Diagnostics, Inc.        
Schedule of Equity Method Investments [Line Items]        
Payments to acquire non-marketable securities   $ 3,000    
Non-Marketable equity security investment, ownership percentage   6.90%    
Intangible asset acquired   $ 1,000    
Intangible assets acquired, useful life   20 years    
Contingent consideration on milestones   $ 10,000    
XML 55 R44.htm IDEA: XBRL DOCUMENT v3.19.1
INCOME TAXES (Details) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Income Tax Disclosure [Abstract]    
Income before income taxes $ (59) $ 1,875
Total income tax benefit (1,010) (280)
Cash paid for income taxes 100 18
Excess tax benefits related to employee share-based compensation $ 1,100 $ 800
XML 56 R45.htm IDEA: XBRL DOCUMENT v3.19.1
LEASES - LESEE ACCOUNTING (Details)
$ in Thousands
 3 Months Ended
Mar. 31, 2019
USD ($)
Leases [Abstract]  
Operating lease expense $ 600
Cash paid for amounts included in the measurement of operating lease liabilities 444
ROU assets obtained in exchange for operating lease obligations $ 293
Weighted average remaining lease term 4 years 4 months 23 days
Weighted average discount rate 4.45%
Operating Lease Liabilities, Payments Due [Abstract]  
Remainder of 2019 $ 1,396
2020 1,611
2021 1,453
2022 1,320
2023 1,766
Total operating lease payments 7,546
Less: imputed interest 731
Total operating lease liabilities $ 6,815
XML 57 R46.htm IDEA: XBRL DOCUMENT v3.19.1
LEASES - LESSOR ACCOUNTING (Details)
$ in Thousands
Mar. 31, 2019
USD ($)
Lessor, Operating Lease, Payments, Fiscal Year Maturity [Abstract]  
Remainder of 2019 $ 2,409
2020 3,430
2021 3,364
2022 2,989
2023 2,147
Thereafter 1,501
Lessor, Operating Lease, Payments to be Received $ 15,840
XML 58 R47.htm IDEA: XBRL DOCUMENT v3.19.1
EARNINGS PER SHARE (Details)
$ / shares in Units, shares in Thousands, $ in Thousands
 1 Months Ended 3 Months Ended
Dec. 31, 2010
Mar. 31, 2019
USD ($)
$ / shares
shares
Mar. 31, 2018
USD ($)
$ / shares
shares
Earnings Per Share [Abstract]      
Reverse stock split conversion ratio 0.10    
Net income after equity in losses of unconsolidated affiliates | $   $ 814 $ 2,155
Basic weighted-average common shares outstanding (in shares)   7,459 7,102
Assumed exercise of dilutive stock options and restricted shares   506 609
Diluted weighted-average common shares outstanding   7,965 7,711
Basic earnings per share attributable to Heska Corporation (in dollars per share) | $ / shares   $ 0.11 $ 0.30
Diluted earnings per share attributable to Heska Corporation (in dollars per share) | $ / shares   $ 0.10 $ 0.28
Stock Options And Restricted Units      
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Stock options and restricted units excluded from computation of earnings per share   86 244
XML 59 R48.htm IDEA: XBRL DOCUMENT v3.19.1
GOODWILL AND OTHER INTANGIBLES (Details) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Dec. 31, 2018
Goodwill [Roll Forward]      
Carrying amount, December 31, 2018 $ 26,679    
Goodwill, Acquired During Period 643    
Foreign currency adjustments (11)    
Carrying amount, March 31, 2019 27,311    
Finite-Lived Intangible Assets, Net [Abstract]      
Gross carrying amount 11,993   $ 11,503
Accumulated amortization (2,070)   (1,739)
Net carrying amount 9,923   9,764
Amortization expense 303 $ 97  
Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]      
2019 (remaining) 968    
2020 1,284    
2021 1,280    
2022 1,262    
2023 915    
Thereafter 4,214    
Net carrying amount 9,923   9,764
Developed technology      
Finite-Lived Intangible Assets, Net [Abstract]      
Gross carrying amount 8,200   8,200
Accumulated amortization (205)   0
Net carrying amount 7,995   8,200
Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]      
Net carrying amount 7,995   8,200
Customer relationships and other      
Finite-Lived Intangible Assets, Net [Abstract]      
Gross carrying amount 3,793   3,303
Accumulated amortization (1,865)   (1,739)
Net carrying amount 1,928   1,564
Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]      
Net carrying amount $ 1,928   $ 1,564
XML 60 R49.htm IDEA: XBRL DOCUMENT v3.19.1
PROPERTY AND EQUIPMENT (Details) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Dec. 31, 2018
Property, Plant and Equipment [Line Items]      
Property and equipment, gross $ 54,471   $ 54,060
Less accumulated depreciation (38,960)   (38,079)
Total property and equipment, net 15,511   15,981
Depreciation and amortization 1,000 $ 1,100  
Operating leases, gross 11,000   10,800
Operating leases, accumulated depreciation 6,400   6,100
Land      
Property, Plant and Equipment [Line Items]      
Property and equipment, gross 377   377
Building      
Property, Plant and Equipment [Line Items]      
Property and equipment, gross 2,978   2,978
Machinery and equipment      
Property, Plant and Equipment [Line Items]      
Property and equipment, gross 33,591   33,087
Office furniture and equipment      
Property, Plant and Equipment [Line Items]      
Property and equipment, gross 1,767   1,687
Computer hardware and software      
Property, Plant and Equipment [Line Items]      
Property and equipment, gross 4,725   4,704
Leasehold and building improvements      
Property, Plant and Equipment [Line Items]      
Property and equipment, gross 10,086   9,953
Construction in progress      
Property, Plant and Equipment [Line Items]      
Property and equipment, gross $ 947   $ 1,274
Machinery and equipment | Minimum      
Property, Plant and Equipment [Line Items]      
Property plant and equipment, useful life 5 years    
Machinery and equipment | Maximum      
Property, Plant and Equipment [Line Items]      
Property plant and equipment, useful life 7 years    
XML 61 R50.htm IDEA: XBRL DOCUMENT v3.19.1
INVENTORIES, NET (Details) - USD ($)
$ in Thousands
Mar. 31, 2019
Dec. 31, 2018
Inventory Disclosure [Abstract]    
Raw materials $ 16,626 $ 15,000
Work in process 3,214 3,592
Finished goods 8,869 8,085
Allowance for excess or obsolete inventory (1,321) (1,573)
Total inventory, net $ 27,388 $ 25,104
XML 62 R51.htm IDEA: XBRL DOCUMENT v3.19.1
ACCRUED LIABILITIES (Details) - USD ($)
$ in Thousands
Mar. 31, 2019
Dec. 31, 2018
Payables and Accruals [Abstract]    
Accrued settlement $ 6,750 $ 6,750
Accrued payroll and employee benefits 840 759
Accrued property taxes 232 632
Inventory in transit 1,281 327
Other 1,544 1,674
Total accrued liabilities $ 10,647 $ 10,142
Percentage of total current liabilities 5.00%  
XML 63 R52.htm IDEA: XBRL DOCUMENT v3.19.1
CAPITAL STOCK - OPTION ACTIVITY (Details) - $ / shares
 3 Months Ended 12 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Dec. 31, 2018
Employee Stock Option      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Risk-free interest rate (as a percent) 2.45% 2.64%  
Expected lives (in years) 4 years 8 months 6 days 4 years 10 months 24 days  
Expected volatility (as a percent) 39.00% 40.00%  
Expected dividend rate (as a percent) 0.00% 0.00%  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]      
Outstanding at beginning of period 620,553 630,847 630,847
Granted at market 1,200   153,700
Forfeited 0   (18,978)
Expired 0   (896)
Exercised (122,895)   (144,120)
Outstanding at end of period 498,858   620,553
Exercisable at end of period 319,523   386,176
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]      
Outstanding at beginning of period (in dollars per share) $ 40.741 $ 29.312 $ 29.312
Granted at market (in dollars per share) 98.970   75.244
Forfeited (in dollars per share) 0.000   53.010
Expired (in dollars per share) 0.000   25.740
Exercised (in dollars per share) 17.013   65.414
Outstanding at ending of period (in dollars per share) 46.727   40.741
Exercisable at end of period (in dollars per share) $ 31.026   $ 21.214
Employee Stock      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Risk-free interest rate (as a percent) 2.35% 1.03%  
Expected lives (in years) 1 year 1 month 6 days 1 year 2 months 18 days  
Expected volatility (as a percent) 40.00% 44.00%  
Expected dividend rate (as a percent) 0.00% 0.00%  
XML 64 R53.htm IDEA: XBRL DOCUMENT v3.19.1
CAPITAL STOCK - NARRATIVE (Details) - USD ($)
$ / shares in Units, $ in Thousands
 3 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Fair value of stock options granted during period $ 43 $ 3,500
Weighted average grant date fair value $ 36.18 $ 26.69
Intrinsic value of options exercised $ 9,900 $ 406
Proceeds from stock options exercised $ 84 $ 121
Weighted average purchase price of shares purchased (in dollars per share) $ 18.97 $ 14.28
Employee Stock Option    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Intrinsic value of options exercised $ 17,400  
Total unrecognized compensation expense related to outstanding stock options $ 4,700  
Period for recognition of unrecognized compensation expense 1 year 7 months 13 days  
Intrinsic value of options outstanding $ 20,000  
Employee Stock    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Shares issued during period 2,583 3,127
Restricted Stock    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Total unrecognized compensation expense related to outstanding stock options $ 2,500  
Period for recognition of unrecognized compensation expense 1 year 4 months 26 days  
Weighted average purchase price of shares purchased (in dollars per share) $ 77.52 $ 62.73
Fair value of stock vested $ 0 $ 4,200
Performance shares, nonprobable performance targets (in shares) 167,000  
Restricted Stock | Minimum    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Award vesting period 1 year  
Restricted Stock | Maximum    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Award vesting period 4 years  
XML 65 R54.htm IDEA: XBRL DOCUMENT v3.19.1
CAPITAL STOCK - EXERCISE PRICE (Details)
 3 Months Ended
Mar. 31, 2019
$ / shares
shares
$ 4.50 - $ 7.36  
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]  
Number of Options Outstanding at March 31, 2019 | shares 101,502
Weighted Average Remaining Contractual Life in Years 3 years 7 months 25 days
Weighted Average Exercise Price $ 6.807
Number of Options Exercisable at March 31, 2019 | shares 101,502
Weighted Average Exercise Price $ 6.807
Exercise price range, lower (in dollars per share) 4.50
Exercise price range, upper (in dollars per share) $ 7.36
$ 7.37 - $ 32.21  
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]  
Number of Options Outstanding at March 31, 2019 | shares 94,485
Weighted Average Remaining Contractual Life in Years 5 years 20 days
Weighted Average Exercise Price $ 15.917
Number of Options Exercisable at March 31, 2019 | shares 93,758
Weighted Average Exercise Price $ 15.793
Exercise price range, lower (in dollars per share) 7.37
Exercise price range, upper (in dollars per share) $ 32.21
$ 32.22 - $ 62.50  
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]  
Number of Options Outstanding at March 31, 2019 | shares 61,104
Weighted Average Remaining Contractual Life in Years 6 years 10 months 3 days
Weighted Average Exercise Price $ 39.783
Number of Options Exercisable at March 31, 2019 | shares 44,672
Weighted Average Exercise Price $ 39.693
Exercise price range, lower (in dollars per share) 32.22
Exercise price range, upper (in dollars per share) $ 62.50
$ 62.51 - $ 69.77  
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]  
Number of Options Outstanding at March 31, 2019 | shares 130,000
Weighted Average Remaining Contractual Life in Years 8 years 11 months 6 days
Weighted Average Exercise Price $ 69.770
Number of Options Exercisable at March 31, 2019 | shares 43,337
Weighted Average Exercise Price $ 69.770
Exercise price range, lower (in dollars per share) 62.51
Exercise price range, upper (in dollars per share) $ 69.77
$ 69.78 - $ 108.25  
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]  
Number of Options Outstanding at March 31, 2019 | shares 111,767
Weighted Average Remaining Contractual Life in Years 8 years 2 months 13 days
Weighted Average Exercise Price $ 86.020
Number of Options Exercisable at March 31, 2019 | shares 36,254
Weighted Average Exercise Price $ 81.236
Exercise price range, lower (in dollars per share) 69.78
Exercise price range, upper (in dollars per share) $ 108.25
$ 4.50 - $ 108.25  
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]  
Number of Options Outstanding at March 31, 2019 | shares 498,858
Weighted Average Remaining Contractual Life in Years 6 years 8 months 13 days
Weighted Average Exercise Price $ 46.727
Number of Options Exercisable at March 31, 2019 | shares 319,523
Weighted Average Exercise Price $ 31.026
Exercise price range, lower (in dollars per share) 4.40
Exercise price range, upper (in dollars per share) $ 108.25
XML 66 R55.htm IDEA: XBRL DOCUMENT v3.19.1
CAPITAL STOCK CAPITAL STOCK - RESTRICTED STOCK (Details) - $ / shares
shares in Thousands
 3 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]    
Granted (in dollars per share) $ 18.97 $ 14.28
Restricted Stock    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]    
Non-vested balance (in shares) 259,430  
Granted (in shares) 117  
Vested (in shares) 0  
Forfeited (in shares) 0  
Non-vested balance (in shares) 259,547  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]    
Non-vested balance (in dollars per share) $ 74.26  
Granted (in dollars per share) 77.52 $ 62.73
Vested (in dollars per share) 0.00  
Forfeited (in dollars per share) 0.00  
Non-vested balance (in dollars per share) $ 74.26  
XML 67 R56.htm IDEA: XBRL DOCUMENT v3.19.1
ACCUMULATED OTHER COMPREHENSIVE INCOME (Details)
$ in Thousands
 3 Months Ended
Mar. 31, 2019
USD ($)
Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]  
Beginning balance $ 122,409
Ending balance 121,277
Total Accumulated Other Comprehensive Income  
Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]  
Beginning balance 277
Current period other comprehensive loss (62)
Ending balance 215
Minimum Pension Liability  
Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]  
Beginning balance (419)
Current period other comprehensive loss 0
Ending balance (419)
Foreign Currency Translation  
Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]  
Beginning balance 696
Current period other comprehensive loss (62)
Ending balance $ 634
XML 68 R57.htm IDEA: XBRL DOCUMENT v3.19.1
COMMITMENTS AND CONTINGENCIES (Details) - USD ($)
$ in Thousands
 3 Months Ended
Oct. 16, 2018
Mar. 31, 2019
Mar. 31, 2018
Dec. 31, 2018
Commitments and Contingencies Disclosure [Abstract]        
Increase in royalties payable   $ 100 $ 100  
Warranty reserve   200   $ 200
Litigation settlement, amount $ 6,750      
Unconditional annual minimum inventory purchases   $ 12,200    
XML 69 R58.htm IDEA: XBRL DOCUMENT v3.19.1
INTEREST AND OTHER EXPENSE, NET (Details) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Other Income and Expenses [Abstract]    
Interest income $ (92) $ (56)
Interest expense 77 65
Other, net (1) (13)
Total interest and other income, net (16) (4)
Cash paid for interest $ 56 $ 27
XML 70 R59.htm IDEA: XBRL DOCUMENT v3.19.1
CREDIT FACILITY (Details) - USD ($)
 1 Months Ended
Jul. 27, 2017
Apr. 30, 2019
Mar. 31, 2019
Subsequent Event      
Debt Instrument [Line Items]      
Payments for legal settlements   $ 6,750,000  
Line of Credit | Revolving Credit Facility      
Debt Instrument [Line Items]      
Maximum borrowing capacity $ 30,000,000.0    
Additional maximum borrowing capacity increase 20,000,000.0    
Contingent maximum borrowing capacity $ 50,000,000.0    
Basis spread on variable rate 1.10%    
Minimum annual interest charge $ 60,000    
Long-term line of credit     $ 6,000,000
Line of Credit | Revolving Credit Facility | London Interbank Offered Rate (LIBOR)      
Debt Instrument [Line Items]      
Basis spread on variable rate 1.65%    
XML 71 R60.htm IDEA: XBRL DOCUMENT v3.19.1
SEGMENT REPORTING - NARRATIVE (Details)
 3 Months Ended
Mar. 31, 2019
segment
Segment Reporting [Abstract]  
Number of reportable segments 2
XML 72 R61.htm IDEA: XBRL DOCUMENT v3.19.1
SEGMENT REPORTING (Details) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Dec. 31, 2018
Segment Reporting, Other Significant Reconciling Item [Line Items]      
Total revenue $ 29,511 $ 32,765  
Operating income (loss) (75) 1,871  
Income before income taxes (59) 1,875  
Capital expenditures 234 375  
Depreciation and amortization 1,265 1,196  
Investments in unconsolidated affiliates 7,837   $ 8,018
Assets 162,780   156,452
Net Assets 121,939   122,409
Operating Segments | Core Companion Animal Health      
Segment Reporting, Other Significant Reconciling Item [Line Items]      
Total revenue 24,716 26,819  
Operating income (loss) (51) 1,923  
Income before income taxes (35) 1,927  
Capital expenditures 44 57  
Depreciation and amortization 947 908  
Investments in unconsolidated affiliates 7,837   8,018
Assets 138,076   133,586
Net Assets 95,683   96,129
Operating Segments | Other Vaccines, Pharmaceuticals and Products      
Segment Reporting, Other Significant Reconciling Item [Line Items]      
Total revenue 4,795 5,946  
Operating income (loss) (24) (52)  
Income before income taxes (24) (52)  
Capital expenditures 190 318  
Depreciation and amortization 318 $ 288  
Investments in unconsolidated affiliates 0   0
Assets 24,704   22,866
Net Assets $ 26,256   $ 26,280
EXCEL 73 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 74 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 75 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 76 FilingSummary.xml IDEA: XBRL DOCUMENT 3.19.1 html 163 308 1 false 67 0 false 5 false false R1.htm 0001000 - Document - Document and Entity Information Sheet http://Heska.com/role/DocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 1001000 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS Sheet http://Heska.com/role/CondensedConsolidatedBalanceSheets CONDENSED CONSOLIDATED BALANCE SHEETS Statements 2 false false R3.htm 1001501 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) Sheet http://Heska.com/role/CondensedConsolidatedBalanceSheetsParenthetical CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) Statements 3 false false R4.htm 1002000 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF INCOME Sheet http://Heska.com/role/CondensedConsolidatedStatementsOfIncome CONDENSED CONSOLIDATED STATEMENTS OF INCOME Statements 4 false false R5.htm 1003000 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME Sheet http://Heska.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME Statements 5 false false R6.htm 1004000 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY Sheet http://Heska.com/role/CondensedConsolidatedStatementsOfStockholdersEquity CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY Statements 6 false false R7.htm 1005000 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS Sheet http://Heska.com/role/CondensedConsolidatedStatementsOfCashFlows CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS Statements 7 false false R8.htm 2101100 - Disclosure - OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Sheet http://Heska.com/role/OperationsAndSummaryOfSignificantAccountingPolicies OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Notes 8 false false R9.htm 2103100 - Disclosure - REVENUE Sheet http://Heska.com/role/Revenue REVENUE Notes 9 false false R10.htm 2104100 - Disclosure - ACQUISITION AND RELATED PARTY ITEMS Sheet http://Heska.com/role/AcquisitionAndRelatedPartyItems ACQUISITION AND RELATED PARTY ITEMS Notes 10 false false R11.htm 2105100 - Disclosure - INVESTMENTS IN UNCONSOLIDATED AFFILIATES Sheet http://Heska.com/role/InvestmentsInUnconsolidatedAffiliates INVESTMENTS IN UNCONSOLIDATED AFFILIATES Notes 11 false false R12.htm 2107100 - Disclosure - INCOME TAXES Sheet http://Heska.com/role/IncomeTaxes INCOME TAXES Notes 12 false false R13.htm 2108100 - Disclosure - LEASES Sheet http://Heska.com/role/Leases LEASES Notes 13 false false R14.htm 2109100 - Disclosure - EARNINGS PER SHARE Sheet http://Heska.com/role/EarningsPerShare EARNINGS PER SHARE Notes 14 false false R15.htm 2111100 - Disclosure - GOODWILL AND OTHER INTANGIBLES Sheet http://Heska.com/role/GoodwillAndOtherIntangibles GOODWILL AND OTHER INTANGIBLES Notes 15 false false R16.htm 2112100 - Disclosure - PROPERTY AND EQUIPMENT Sheet http://Heska.com/role/PropertyAndEquipment PROPERTY AND EQUIPMENT Notes 16 false false R17.htm 2114100 - Disclosure - INVENTORIES, NET Sheet http://Heska.com/role/InventoriesNet INVENTORIES, NET Notes 17 false false R18.htm 2116100 - Disclosure - ACCRUED LIABILITIES Sheet http://Heska.com/role/AccruedLiabilities ACCRUED LIABILITIES Notes 18 false false R19.htm 2118100 - Disclosure - CAPITAL STOCK Sheet http://Heska.com/role/CapitalStock CAPITAL STOCK Notes 19 false false R20.htm 2119100 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE INCOME Sheet http://Heska.com/role/AccumulatedOtherComprehensiveIncome ACCUMULATED OTHER COMPREHENSIVE INCOME Notes 20 false false R21.htm 2121100 - Disclosure - COMMITMENTS AND CONTINGENCIES Sheet http://Heska.com/role/CommitmentsAndContingencies COMMITMENTS AND CONTINGENCIES Notes 21 false false R22.htm 2122100 - Disclosure - INTEREST AND OTHER EXPENSE, NET Sheet http://Heska.com/role/InterestAndOtherExpenseNet INTEREST AND OTHER EXPENSE, NET Notes 22 false false R23.htm 2123100 - Disclosure - CREDIT FACILITY Sheet http://Heska.com/role/CreditFacility CREDIT FACILITY Notes 23 false false R24.htm 2124100 - Disclosure - SEGMENT REPORTING Sheet http://Heska.com/role/SegmentReporting SEGMENT REPORTING Notes 24 false false R25.htm 2201201 - Disclosure - OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Sheet http://Heska.com/role/OperationsAndSummaryOfSignificantAccountingPoliciesPolicies OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Policies 25 false false R26.htm 2303301 - Disclosure - REVENUE (Tables) Sheet http://Heska.com/role/RevenueTables REVENUE (Tables) Tables http://Heska.com/role/Revenue 26 false false R27.htm 2305301 - Disclosure - INVESTMENTS IN UNCONSOLIDATED AFFILIATES (Tables) Sheet http://Heska.com/role/InvestmentsInUnconsolidatedAffiliatesTables INVESTMENTS IN UNCONSOLIDATED AFFILIATES (Tables) Tables http://Heska.com/role/InvestmentsInUnconsolidatedAffiliates 27 false false R28.htm 2307301 - Disclosure - INCOME TAXES (Tables) Sheet http://Heska.com/role/IncomeTaxesTables INCOME TAXES (Tables) Tables http://Heska.com/role/IncomeTaxes 28 false false R29.htm 2308301 - Disclosure - LEASES (Tables) Sheet http://Heska.com/role/LeasesTables LEASES (Tables) Tables http://Heska.com/role/Leases 29 false false R30.htm 2309301 - Disclosure - EARNINGS PER SHARE (Tables) Sheet http://Heska.com/role/EarningsPerShareTables EARNINGS PER SHARE (Tables) Tables http://Heska.com/role/EarningsPerShare 30 false false R31.htm 2311301 - Disclosure - GOODWILL AND OTHER INTANGIBLES (Tables) Sheet http://Heska.com/role/GoodwillAndOtherIntangiblesTables GOODWILL AND OTHER INTANGIBLES (Tables) Tables http://Heska.com/role/GoodwillAndOtherIntangibles 31 false false R32.htm 2312301 - Disclosure - PROPERTY AND EQUIPMENT (Tables) Sheet http://Heska.com/role/PropertyAndEquipmentTables PROPERTY AND EQUIPMENT (Tables) Tables http://Heska.com/role/PropertyAndEquipment 32 false false R33.htm 2314301 - Disclosure - INVENTORIES, NET (Tables) Sheet http://Heska.com/role/InventoriesNetTables INVENTORIES, NET (Tables) Tables http://Heska.com/role/InventoriesNet 33 false false R34.htm 2316301 - Disclosure - ACCRUED LIABILITIES (Tables) Sheet http://Heska.com/role/AccruedLiabilitiesTables ACCRUED LIABILITIES (Tables) Tables http://Heska.com/role/AccruedLiabilities 34 false false R35.htm 2318301 - Disclosure - CAPITAL STOCK (Tables) Sheet http://Heska.com/role/CapitalStockTables CAPITAL STOCK (Tables) Tables http://Heska.com/role/CapitalStock 35 false false R36.htm 2319301 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE INCOME (Tables) Sheet http://Heska.com/role/AccumulatedOtherComprehensiveIncomeTables ACCUMULATED OTHER COMPREHENSIVE INCOME (Tables) Tables http://Heska.com/role/AccumulatedOtherComprehensiveIncome 36 false false R37.htm 2322301 - Disclosure - INTEREST AND OTHER EXPENSE, NET (Tables) Sheet http://Heska.com/role/InterestAndOtherExpenseNetTables INTEREST AND OTHER EXPENSE, NET (Tables) Tables http://Heska.com/role/InterestAndOtherExpenseNet 37 false false R38.htm 2324301 - Disclosure - SEGMENT REPORTING (Tables) Sheet http://Heska.com/role/SegmentReportingTables SEGMENT REPORTING (Tables) Tables http://Heska.com/role/SegmentReporting 38 false false R39.htm 2401402 - Disclosure - OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) Sheet http://Heska.com/role/OperationsAndSummaryOfSignificantAccountingPoliciesDetails OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) Details http://Heska.com/role/OperationsAndSummaryOfSignificantAccountingPoliciesPolicies 39 false false R40.htm 2403402 - Disclosure - REVENUE (Details) Sheet http://Heska.com/role/RevenueDetails REVENUE (Details) Details http://Heska.com/role/RevenueTables 40 false false R41.htm 2403403 - Disclosure - REVENUE - Performance Obligations (Details) Sheet http://Heska.com/role/RevenuePerformanceObligationsDetails REVENUE - Performance Obligations (Details) Details 41 false false R42.htm 2404401 - Disclosure - ACQUISITION AND RELATED PARTY ITEMS (Details) Sheet http://Heska.com/role/AcquisitionAndRelatedPartyItemsDetails ACQUISITION AND RELATED PARTY ITEMS (Details) Details http://Heska.com/role/AcquisitionAndRelatedPartyItems 42 false false R43.htm 2405402 - Disclosure - INVESTMENTS IN UNCONSOLIDATED AFFILIATES (Details) Sheet http://Heska.com/role/InvestmentsInUnconsolidatedAffiliatesDetails INVESTMENTS IN UNCONSOLIDATED AFFILIATES (Details) Details http://Heska.com/role/InvestmentsInUnconsolidatedAffiliatesTables 43 false false R44.htm 2407402 - Disclosure - INCOME TAXES (Details) Sheet http://Heska.com/role/IncomeTaxesDetails INCOME TAXES (Details) Details http://Heska.com/role/IncomeTaxesTables 44 false false R45.htm 2408402 - Disclosure - LEASES - LESEE ACCOUNTING (Details) Sheet http://Heska.com/role/LeasesLeseeAccountingDetails LEASES - LESEE ACCOUNTING (Details) Details 45 false false R46.htm 2408403 - Disclosure - LEASES - LESSOR ACCOUNTING (Details) Sheet http://Heska.com/role/LeasesLessorAccountingDetails LEASES - LESSOR ACCOUNTING (Details) Details 46 false false R47.htm 2409402 - Disclosure - EARNINGS PER SHARE (Details) Sheet http://Heska.com/role/EarningsPerShareDetails EARNINGS PER SHARE (Details) Details http://Heska.com/role/EarningsPerShareTables 47 false false R48.htm 2411402 - Disclosure - GOODWILL AND OTHER INTANGIBLES (Details) Sheet http://Heska.com/role/GoodwillAndOtherIntangiblesDetails GOODWILL AND OTHER INTANGIBLES (Details) Details http://Heska.com/role/GoodwillAndOtherIntangiblesTables 48 false false R49.htm 2412402 - Disclosure - PROPERTY AND EQUIPMENT (Details) Sheet http://Heska.com/role/PropertyAndEquipmentDetails PROPERTY AND EQUIPMENT (Details) Details http://Heska.com/role/PropertyAndEquipmentTables 49 false false R50.htm 2414402 - Disclosure - INVENTORIES, NET (Details) Sheet http://Heska.com/role/InventoriesNetDetails INVENTORIES, NET (Details) Details http://Heska.com/role/InventoriesNetTables 50 false false R51.htm 2416402 - Disclosure - ACCRUED LIABILITIES (Details) Sheet http://Heska.com/role/AccruedLiabilitiesDetails ACCRUED LIABILITIES (Details) Details http://Heska.com/role/AccruedLiabilitiesTables 51 false false R52.htm 2418402 - Disclosure - CAPITAL STOCK - OPTION ACTIVITY (Details) Sheet http://Heska.com/role/CapitalStockOptionActivityDetails CAPITAL STOCK - OPTION ACTIVITY (Details) Details 52 false false R53.htm 2418403 - Disclosure - CAPITAL STOCK - NARRATIVE (Details) Sheet http://Heska.com/role/CapitalStockNarrativeDetails CAPITAL STOCK - NARRATIVE (Details) Details 53 false false R54.htm 2418404 - Disclosure - CAPITAL STOCK - EXERCISE PRICE (Details) Sheet http://Heska.com/role/CapitalStockExercisePriceDetails CAPITAL STOCK - EXERCISE PRICE (Details) Details 54 false false R55.htm 2418405 - Disclosure - CAPITAL STOCK CAPITAL STOCK - RESTRICTED STOCK (Details) Sheet http://Heska.com/role/CapitalStockCapitalStockRestrictedStockDetails CAPITAL STOCK CAPITAL STOCK - RESTRICTED STOCK (Details) Details 55 false false R56.htm 2419402 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE INCOME (Details) Sheet http://Heska.com/role/AccumulatedOtherComprehensiveIncomeDetails ACCUMULATED OTHER COMPREHENSIVE INCOME (Details) Details http://Heska.com/role/AccumulatedOtherComprehensiveIncomeTables 56 false false R57.htm 2421401 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details) Sheet http://Heska.com/role/CommitmentsAndContingenciesDetails COMMITMENTS AND CONTINGENCIES (Details) Details http://Heska.com/role/CommitmentsAndContingencies 57 false false R58.htm 2422402 - Disclosure - INTEREST AND OTHER EXPENSE, NET (Details) Sheet http://Heska.com/role/InterestAndOtherExpenseNetDetails INTEREST AND OTHER EXPENSE, NET (Details) Details http://Heska.com/role/InterestAndOtherExpenseNetTables 58 false false R59.htm 2423401 - Disclosure - CREDIT FACILITY (Details) Sheet http://Heska.com/role/CreditFacilityDetails CREDIT FACILITY (Details) Details http://Heska.com/role/CreditFacility 59 false false R60.htm 2424402 - Disclosure - SEGMENT REPORTING - NARRATIVE (Details) Sheet http://Heska.com/role/SegmentReportingNarrativeDetails SEGMENT REPORTING - NARRATIVE (Details) Details 60 false false R61.htm 2424403 - Disclosure - SEGMENT REPORTING (Details) Sheet http://Heska.com/role/SegmentReportingDetails SEGMENT REPORTING (Details) Details http://Heska.com/role/SegmentReportingTables 61 false false All Reports Book All Reports hska-20190331.xml hska-20190331.xsd hska-20190331_cal.xml hska-20190331_def.xml hska-20190331_lab.xml hska-20190331_pre.xml http://fasb.org/us-gaap/2018-01-31 http://xbrl.sec.gov/dei/2018-01-31 http://fasb.org/srt/2018-01-31 true true ZIP 78 0001038133-19-000037-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001038133-19-000037-xbrl.zip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�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